返回首页 在线留言 联系我们
首页 > 产品展示 > > 所有 > LKT Labs G3455Ginsenoside Rc Triterpene

产品中心

LKT Labs G3455Ginsenoside Rc Triterpene

  • 型   号:
  • 价   格:

LKT Labs 是一家专注于防癌抗癌特殊化学品研究和开发的公司。主要提供:癌症药物、药物发现试剂盒、天然产物、广泛的生命科学研究试剂、定制合成。
美国LKT Labs 是1988年在美国成立的,为提供先端的药物研发试剂、试剂盒、委托合成,并为药物生产企业提供原料,近几年在农药、水产养殖业有很大程度的开发。LKT Labs G3455Ginsenoside Rc Triterpene

分享到:

LKT Labs 是一家专注于防癌抗癌特殊化学品研究和开发的公司。主要提供:癌症药物、药物发现试剂盒、天然产物、广泛的生命科学研究试剂、定制合成。
美国LKT Labs 是1988年在美国成立的,为全球提供先端的药物研发试剂、试剂盒、委托合成,并为药物生产企业提供原料,最近几年在农药、水产养殖业有很大程度的开发。在LKT Labs 可以找到在其他地方找不到的产品。

LKT Labs G3455 Ginsenoside Rc Triterpene

LKT Labs G3455 Ginsenoside Rc Triterpene

 

LKT Q4370 QKRPSQRSKYL 2 mg 120 Peptide, PKC substrate. MBP 3-14 peptide ≥95% 1390.62 C60H103N21O17 Ambient -20°C Andrea JE, Sutherland C, Winter CK, et al. Substrate-dependent activation requirements and kinetic properties of protein kinase C. FEBS Lett. 1998 Jun 5;429(1):73-7. PMID: 9657386. Not dangerous goods.

LKT Q4370 QKRPSQRSKYL 5 mg 216.1 Peptide, PKC substrate. MBP 3-14 peptide ≥95% 1390.62 C60H103N21O17 Ambient -20°C Andrea JE, Sutherland C, Winter CK, et al. Substrate-dependent activation requirements and kinetic properties of protein kinase C. FEBS Lett. 1998 Jun 5;429(1):73-7. PMID: 9657386. Not dangerous goods.

LKT Q8135 Quinestrol 100 mg 47.6 Synthetic steroid hormone, estrogen analog, used in HRT; ER agonist. Eston, Estrovis, Plestrovis 152-43-2 ≥98% 364.52 C25H32O2 CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC5CCCC5 Ambient Ambient "Li J, Wang H, Zhang J, et al. Abnormal secretion of reproductive hormones and antioxidant status involved in quinestrol-induced reproductive toxicity in adult male rat. Tissue Cell. 2013 Oct 1. pii: S0040-8166(13)00081-5. PMID: 24183492.

 

Liu Q, Qin J, Chen Q, et al. Fertility control of Rattus nitidus using quinestrol: effects on reproductive organs and social behavior. Integr Zool. 2013 Apr;8 Suppl 1:9-17. PMID: 23621467.

 

Lv X, Guo Y, Shi D. Effects of quinestrol on reproductive hormone expression, secretion, and receptor levels in female Mongolian gerbils (Meriones unguiculatus). Theriogenology. 2012 Apr 1;77(6):1223-31. PMID: 22284225.

 

Jaschevatzky OE, Anderman S, Shalit A, et al. The treatment of postmenopausal syndrome by monthly oral doses of quinestrol. Acta Obstet Gynecol Scand. 1979;58(2):175-8. PMID: 452871.

" T Not dangerous goods.

LKT Q8135 Quinestrol 250 mg 95.1 Synthetic steroid hormone, estrogen analog, used in HRT; ER agonist. Eston, Estrovis, Plestrovis 152-43-2 ≥98% 364.52 C25H32O2 CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC5CCCC5 Ambient Ambient "Li J, Wang H, Zhang J, et al. Abnormal secretion of reproductive hormones and antioxidant status involved in quinestrol-induced reproductive toxicity in adult male rat. Tissue Cell. 2013 Oct 1. pii: S0040-8166(13)00081-5. PMID: 24183492.

 

Liu Q, Qin J, Chen Q, et al. Fertility control of Rattus nitidus using quinestrol: effects on reproductive organs and social behavior. Integr Zool. 2013 Apr;8 Suppl 1:9-17. PMID: 23621467.

 

Lv X, Guo Y, Shi D. Effects of quinestrol on reproductive hormone expression, secretion, and receptor levels in female Mongolian gerbils (Meriones unguiculatus). Theriogenology. 2012 Apr 1;77(6):1223-31. PMID: 22284225.

 

Jaschevatzky OE, Anderman S, Shalit A, et al. The treatment of postmenopausal syndrome by monthly oral doses of quinestrol. Acta Obstet Gynecol Scand. 1979;58(2):175-8. PMID: 452871.

" T Not dangerous goods.

LKT Q8135 Quinestrol 1 g 271.7 Synthetic steroid hormone, estrogen analog, used in HRT; ER agonist. Eston, Estrovis, Plestrovis 152-43-2 ≥98% 364.52 C25H32O2 CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC5CCCC5 Ambient Ambient "Li J, Wang H, Zhang J, et al. Abnormal secretion of reproductive hormones and antioxidant status involved in quinestrol-induced reproductive toxicity in adult male rat. Tissue Cell. 2013 Oct 1. pii: S0040-8166(13)00081-5. PMID: 24183492.

 

Liu Q, Qin J, Chen Q, et al. Fertility control of Rattus nitidus using quinestrol: effects on reproductive organs and social behavior. Integr Zool. 2013 Apr;8 Suppl 1:9-17. PMID: 23621467.

 

Lv X, Guo Y, Shi D. Effects of quinestrol on reproductive hormone expression, secretion, and receptor levels in female Mongolian gerbils (Meriones unguiculatus). Theriogenology. 2012 Apr 1;77(6):1223-31. PMID: 22284225.

 

Jaschevatzky OE, Anderman S, Shalit A, et al. The treatment of postmenopausal syndrome by monthly oral doses of quinestrol. Acta Obstet Gynecol Scand. 1979;58(2):175-8. PMID: 452871.

" T Not dangerous goods.

LKT Q8019 Quetiapine Fumarate 1 g 65.6 5-HT1A and σ1/2 agonist, 5-HT2A/2C/6/7, D1-4, histamine H1/2, M1 mAChR, α1A/1B/2C-adrenergic antagonist. 111974-72-2 ≥98% 883.09 2(C21H25N3O2S) C4H4O4 C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C(=CC(=O)O)C(=O)O Ambient Ambient "López-Muñoz F, Alamo C. Active Metabolites as Antidepressant Drugs: The Role of Norquetiapine in the Mechanism of Action of Quetiapine in the Treatment of Mood Disorders. Front Psychiatry. 2013 Sep 12;4:102. PMID: 24062697.

 

Kotagale NR, Mendhi SM, Aglawe MM, et al. Evidences for the involvement of sigma receptors in antidepressant like effect of quetiapine in mice. Eur J Pharmacol. 2013 Feb 28;702(1-3):180-6. PMID: 23399765.

 

Tempier A, He J, Zhu S, et al. Quetiapine modulates conditioned anxiety and alternation behavior in Alzheimer's transgenic mice. Curr Alzheimer Res. 2013 Feb;10(2):199-206. PMID: 22950914.

 

Bi X, Zhang Y, Yan B, et al. Quetiapine prevents oligodendrocyte and myelin loss and promotes maturation of oligodendrocyte progenitors in the hippocampus of global cerebral ischemia mice. J Neurochem. 2012 Oct;123(1):14-20. PMID: 22817262.

 

Ichikawa J, Li Z, Dai J, et al. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism. Brain Res. 2002 Nov 29;956(2):349-57. PMID: 12445705.

 

Richelson E, Souder T. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. PMID: 11132243.

" Not dangerous goods.

LKT Q8019 Quetiapine Fumarate 5 g 234.5 5-HT1A and σ1/2 agonist, 5-HT2A/2C/6/7, D1-4, histamine H1/2, M1 mAChR, α1A/1B/2C-adrenergic antagonist. 111974-72-2 ≥98% 883.09 2(C21H25N3O2S) C4H4O4 C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C(=CC(=O)O)C(=O)O Ambient Ambient "López-Muñoz F, Alamo C. Active Metabolites as Antidepressant Drugs: The Role of Norquetiapine in the Mechanism of Action of Quetiapine in the Treatment of Mood Disorders. Front Psychiatry. 2013 Sep 12;4:102. PMID: 24062697.

 

Kotagale NR, Mendhi SM, Aglawe MM, et al. Evidences for the involvement of sigma receptors in antidepressant like effect of quetiapine in mice. Eur J Pharmacol. 2013 Feb 28;702(1-3):180-6. PMID: 23399765.

 

Tempier A, He J, Zhu S, et al. Quetiapine modulates conditioned anxiety and alternation behavior in Alzheimer's transgenic mice. Curr Alzheimer Res. 2013 Feb;10(2):199-206. PMID: 22950914.

 

Bi X, Zhang Y, Yan B, et al. Quetiapine prevents oligodendrocyte and myelin loss and promotes maturation of oligodendrocyte progenitors in the hippocampus of global cerebral ischemia mice. J Neurochem. 2012 Oct;123(1):14-20. PMID: 22817262.

 

Ichikawa J, Li Z, Dai J, et al. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism. Brain Res. 2002 Nov 29;956(2):349-57. PMID: 12445705.

 

Richelson E, Souder T. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. PMID: 11132243.

" Not dangerous goods.

LKT Q8019 Quetiapine Fumarate 25 g 468.8 5-HT1A and σ1/2 agonist, 5-HT2A/2C/6/7, D1-4, histamine H1/2, M1 mAChR, α1A/1B/2C-adrenergic antagonist. 111974-72-2 ≥98% 883.09 2(C21H25N3O2S) C4H4O4 C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C(=CC(=O)O)C(=O)O Ambient Ambient "López-Muñoz F, Alamo C. Active Metabolites as Antidepressant Drugs: The Role of Norquetiapine in the Mechanism of Action of Quetiapine in the Treatment of Mood Disorders. Front Psychiatry. 2013 Sep 12;4:102. PMID: 24062697.

 

Kotagale NR, Mendhi SM, Aglawe MM, et al. Evidences for the involvement of sigma receptors in antidepressant like effect of quetiapine in mice. Eur J Pharmacol. 2013 Feb 28;702(1-3):180-6. PMID: 23399765.

 

Tempier A, He J, Zhu S, et al. Quetiapine modulates conditioned anxiety and alternation behavior in Alzheimer's transgenic mice. Curr Alzheimer Res. 2013 Feb;10(2):199-206. PMID: 22950914.

 

Bi X, Zhang Y, Yan B, et al. Quetiapine prevents oligodendrocyte and myelin loss and promotes maturation of oligodendrocyte progenitors in the hippocampus of global cerebral ischemia mice. J Neurochem. 2012 Oct;123(1):14-20. PMID: 22817262.

 

Ichikawa J, Li Z, Dai J, et al. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism. Brain Res. 2002 Nov 29;956(2):349-57. PMID: 12445705.

 

Richelson E, Souder T. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000 Nov 24;68(1):29-39. PMID: 11132243.

" Not dangerous goods.

LKT G2969 Growth Hormone Releasing Hexapeptide 1 mg 107.8 Synthetic peptide hormone, met-enkephalin analog, involved in growth hormone secretion; ghrelin agonist. Growth hormone releasing hexapeptide, Skf 110679; GHRP-6 87616-84-0 ≥95% 873.04 C46H56N12O6 CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CC6=CN=CN6)N Ambient -20°C "Baquedano E, Chowen JA, Argente J, et al. Differential effects of GH and GH-releasing peptide-6 on astrocytes. J Endocrinol. 2013 Jul 29;218(3):263-74. PMID: 23792323.

 

Guo S, Gao Q, Jiao Q, et al. Gastric mucosal damage in water immersion stress: mechanism and prevention with GHRP-6. World J Gastroenterol. 2012 Jun 28;18(24):3145-55.PMID: 22791951.

 

Elbassuoni E, Ragy M, Aziz N. Protective effect of GHRP-6 and estrogen supplementation against some cardiometabolic risk factors in ovariectomized rats. Endocr Regul. 2012 Apr;46(2):73-81. PMID: 22540855.

 

Yahashi S, Kang KS, Kaiya H, et al. GHRP-6 mimics ghrelin-induced stimulation of food intake and suppression of locomotor activity in goldfish. Peptides. 2012 Apr;34(2):324-8. PMID: 22349352.

" Not dangerous goods.

LKT G2969 Growth Hormone Releasing Hexapeptide 2 mg 183 Synthetic peptide hormone, met-enkephalin analog, involved in growth hormone secretion; ghrelin agonist. Growth hormone releasing hexapeptide, Skf 110679; GHRP-6 87616-84-0 ≥95% 873.04 C46H56N12O6 CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CC6=CN=CN6)N Ambient -20°C "Baquedano E, Chowen JA, Argente J, et al. Differential effects of GH and GH-releasing peptide-6 on astrocytes. J Endocrinol. 2013 Jul 29;218(3):263-74. PMID: 23792323.

 

Guo S, Gao Q, Jiao Q, et al. Gastric mucosal damage in water immersion stress: mechanism and prevention with GHRP-6. World J Gastroenterol. 2012 Jun 28;18(24):3145-55.PMID: 22791951.

 

Elbassuoni E, Ragy M, Aziz N. Protective effect of GHRP-6 and estrogen supplementation against some cardiometabolic risk factors in ovariectomized rats. Endocr Regul. 2012 Apr;46(2):73-81. PMID: 22540855.

 

Yahashi S, Kang KS, Kaiya H, et al. GHRP-6 mimics ghrelin-induced stimulation of food intake and suppression of locomotor activity in goldfish. Peptides. 2012 Apr;34(2):324-8. PMID: 22349352.

" Not dangerous goods.

LKT G2969 Growth Hormone Releasing Hexapeptide 5 mg 324 Synthetic peptide hormone, met-enkephalin analog, involved in growth hormone secretion; ghrelin agonist. Growth hormone releasing hexapeptide, Skf 110679; GHRP-6 87616-84-0 ≥95% 873.04 C46H56N12O6 CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CC6=CN=CN6)N Ambient -20°C "Baquedano E, Chowen JA, Argente J, et al. Differential effects of GH and GH-releasing peptide-6 on astrocytes. J Endocrinol. 2013 Jul 29;218(3):263-74. PMID: 23792323.

 

Guo S, Gao Q, Jiao Q, et al. Gastric mucosal damage in water immersion stress: mechanism and prevention with GHRP-6. World J Gastroenterol. 2012 Jun 28;18(24):3145-55.PMID: 22791951.

 

Elbassuoni E, Ragy M, Aziz N. Protective effect of GHRP-6 and estrogen supplementation against some cardiometabolic risk factors in ovariectomized rats. Endocr Regul. 2012 Apr;46(2):73-81. PMID: 22540855.

 

Yahashi S, Kang KS, Kaiya H, et al. GHRP-6 mimics ghrelin-induced stimulation of food intake and suppression of locomotor activity in goldfish. Peptides. 2012 Apr;34(2):324-8. PMID: 22349352.

" Not dangerous goods.

LKT I7459 1-Isothiocyanato-8-(methylsulfinyl)-octane 25 mg 182.5 ITC found in Nasturtium officinale (watercress). 8-Methylsulfinyloctyl isothiocyanate ≥98% 233.4 C10H19NOS2 Ambient -20°C Rose P, Faulkner K, Williamson G, et al. 7-Methylsulfinylheptyl and 8-methylsulfinyloctyl isothiocyanates from watercress are potent inducers of phase II enzymes. Carcinogenesis. 2000 Nov;21(11):1983-8. PMID: 11062158. Not dangerous goods.

LKT I7459 1-Isothiocyanato-8-(methylsulfinyl)-octane 50 mg 303.3 ITC found in Nasturtium officinale (watercress). 8-Methylsulfinyloctyl isothiocyanate ≥98% 233.4 C10H19NOS2 Ambient -20°C Rose P, Faulkner K, Williamson G, et al. 7-Methylsulfinylheptyl and 8-methylsulfinyloctyl isothiocyanates from watercress are potent inducers of phase II enzymes. Carcinogenesis. 2000 Nov;21(11):1983-8. PMID: 11062158. Not dangerous goods.

LKT I7459 1-Isothiocyanato-8-(methylsulfinyl)-octane 100 mg 545.9 ITC found in Nasturtium officinale (watercress). 8-Methylsulfinyloctyl isothiocyanate ≥98% 233.4 C10H19NOS2 Ambient -20°C Rose P, Faulkner K, Williamson G, et al. 7-Methylsulfinylheptyl and 8-methylsulfinyloctyl isothiocyanates from watercress are potent inducers of phase II enzymes. Carcinogenesis. 2000 Nov;21(11):1983-8. PMID: 11062158. Not dangerous goods.

LKT P6858 Procarbazine Hydrochloride 100 mg 67.9 Hydrazine derivative, DNA alkylator; MAO inhibitor. N-(1-Methylethyl)-4-[(2- methylhydrazino)methyl]- benzamide hydrochloride Matulane; Natulan 366-70-1 ≥97% 257.76 C12H19N3O HCl CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl Ambient Ambient Soluble in water. "Ogawa K, Hiraku Y, Oikawa S, et al. Molecular mechanisms of DNA damage induced by procarbazine in the presence of Cu(II). Mutat Res. 2003 Aug 5;539(1-2):145-55. PMID: 12948823.

 

Kyrtopoulos SA, Anderson LM, Chhabra SK, et al. DNA adducts and the mechanism of carcinogenesis and cytotoxicity of methylating agents of environmental and clinical significance. Cancer Detect Prev. 1997;21(5):391-405. PMID: 9307842.

" T Not dangerous goods.

LKT P6858 Procarbazine Hydrochloride 500 mg 176.6 Hydrazine derivative, DNA alkylator; MAO inhibitor. N-(1-Methylethyl)-4-[(2- methylhydrazino)methyl]- benzamide hydrochloride Matulane; Natulan 366-70-1 ≥97% 257.76 C12H19N3O HCl CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl Ambient Ambient Soluble in water. "Ogawa K, Hiraku Y, Oikawa S, et al. Molecular mechanisms of DNA damage induced by procarbazine in the presence of Cu(II). Mutat Res. 2003 Aug 5;539(1-2):145-55. PMID: 12948823.

 

Kyrtopoulos SA, Anderson LM, Chhabra SK, et al. DNA adducts and the mechanism of carcinogenesis and cytotoxicity of methylating agents of environmental and clinical significance. Cancer Detect Prev. 1997;21(5):391-405. PMID: 9307842.

" T Not dangerous goods.

LKT P6858 Procarbazine Hydrochloride 1 g 271.7 Hydrazine derivative, DNA alkylator; MAO inhibitor. N-(1-Methylethyl)-4-[(2- methylhydrazino)methyl]- benzamide hydrochloride Matulane; Natulan 366-70-1 ≥97% 257.76 C12H19N3O HCl CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl Ambient Ambient Soluble in water. "Ogawa K, Hiraku Y, Oikawa S, et al. Molecular mechanisms of DNA damage induced by procarbazine in the presence of Cu(II). Mutat Res. 2003 Aug 5;539(1-2):145-55. PMID: 12948823.

 

Kyrtopoulos SA, Anderson LM, Chhabra SK, et al. DNA adducts and the mechanism of carcinogenesis and cytotoxicity of methylating agents of environmental and clinical significance. Cancer Detect Prev. 1997;21(5):391-405. PMID: 9307842.

" T Not dangerous goods.

LKT R0161 Rapamycin 1 mg 33.7 Macrolide originally produced by Streptomyces; mTOR inhibitor. Sirolimus; Rapamune; AY-22989 53123-88-9 ≥98% 914.17 C51H79NO13 CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC Protect from light. Hygroscopic. Ambient 4°C Soluble in ether, chloroform, acetone, methanol, DMF, DMSO (20 mg/mL), and ethanol (up to 2 mM). Sparingly soluble in hexane and petr ether.  Insoluble in water. "Klintmalm GB, Nashan B. The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence. J Transplant. 2014;2014:845438. PMID: 24719752.

 

Tian J, Wang Y, Zhou X, et al. Rapamycin slows IgA nephropathy progression in the rat. Am J Nephrol. 2014;39(3):218-29. PMID: 24603476.

 

Xu X, Wan X, Geng J, et al. Rapamycin regulates connective tissue growth factor expression of lung epithelial cells via phosphoinositide 3-kinase. Exp Biol Med (Maywood). 2013 Sep;238(9):1082-94. PMID: 23986222.

" Xi Not dangerous goods.

LKT R0161 Rapamycin 10 mg 134.8 Macrolide originally produced by Streptomyces; mTOR inhibitor. Sirolimus; Rapamune; AY-22989 53123-88-9 ≥98% 914.17 C51H79NO13 CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC Protect from light. Hygroscopic. Ambient 4°C Soluble in ether, chloroform, acetone, methanol, DMF, DMSO (20 mg/mL), and ethanol (up to 2 mM). Sparingly soluble in hexane and petr ether.  Insoluble in water. "Klintmalm GB, Nashan B. The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence. J Transplant. 2014;2014:845438. PMID: 24719752.

 

Tian J, Wang Y, Zhou X, et al. Rapamycin slows IgA nephropathy progression in the rat. Am J Nephrol. 2014;39(3):218-29. PMID: 24603476.

 

Xu X, Wan X, Geng J, et al. Rapamycin regulates connective tissue growth factor expression of lung epithelial cells via phosphoinositide 3-kinase. Exp Biol Med (Maywood). 2013 Sep;238(9):1082-94. PMID: 23986222.

" Xi Not dangerous goods.

LKT R0161 Rapamycin 25 mg 224.7 Macrolide originally produced by Streptomyces; mTOR inhibitor. Sirolimus; Rapamune; AY-22989 53123-88-9 ≥98% 914.17 C51H79NO13 CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC Protect from light. Hygroscopic. Ambient 4°C Soluble in ether, chloroform, acetone, methanol, DMF, DMSO (20 mg/mL), and ethanol (up to 2 mM). Sparingly soluble in hexane and petr ether.  Insoluble in water. "Klintmalm GB, Nashan B. The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence. J Transplant. 2014;2014:845438. PMID: 24719752.

 

Tian J, Wang Y, Zhou X, et al. Rapamycin slows IgA nephropathy progression in the rat. Am J Nephrol. 2014;39(3):218-29. PMID: 24603476.

 

Xu X, Wan X, Geng J, et al. Rapamycin regulates connective tissue growth factor expression of lung epithelial cells via phosphoinositide 3-kinase. Exp Biol Med (Maywood). 2013 Sep;238(9):1082-94. PMID: 23986222.

" Xi Not dangerous goods.

LKT R1774 Resiniferatoxin 1 mg 122.3 Capsaicin analog found in Euphorbia; PKC and TRPV agonist. "6,7-Deepoxy-6,7-didehydro-5-deoxy-21-dephenyl-21-

(phenylmethyl)daphnetoxin 20-(3-hydroxy-5-

methoxybenzeneacetate)" Reciniferatoxin; RTX 57444-62-9 ≥98% 628.73 C37H40O9 CC1CC2(C3C4C1(C5C=C(C(=O)C5(CC(=C4)COC(=O)CC6=CC(=C(C=C6)O)OC)O)C)OC(O3)(O2)CC7=CC=CC=C7)C(=C)C Ambient -20°C Soluble in DMSO or ethanol. "Jiang CY, Fujita T, Yue HY, et al. Effect of resiniferatoxin on glutamatergic spontaneous excitatory synaptic transmission in substantia gelatinosa neurons of the adult rat spinal cord. Neuroscience. 2009 Dec 29;164(4):1833-44. PMID: 19778582.

 

Tang W, Song B, Zhou ZS, et al. Intrathecal administration of resiniferatoxin produces analgesia against prostatodynia in rats. Chin Med J (Engl). 2007 Sep 20;120(18):1616-21. PMID: 17908482.

 

Horie S, Yamamoto H, Michael GJ, et al. Protective role of vanilloid receptor type 1 in HCl-induced gastric mucosal lesions in rats. Scand J Gastroenterol. 2004 Apr;39(4):303-12. PMID: 15125461.

 

Geiges D, Meyer T, Marte B, et al. Activation of protein kinase C subtypes alpha, gamma, delta, epsilon, zeta, and eta by tumor-promoting and nontumor-promoting agents. Biochem Pharmacol. 1997 Mar 21;53(6):865-75. PMID: 9113106.

 

Woods AJ, Stock MJ, Gupta AN, et al. Thermoregulatory effects of resiniferatoxin in the rat. Eur J Pharmacol. 1994 Oct 24;264(2):125-33. PMID: 7851474.

 

Andrews PL, Bhandari P. Resinferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret. Neuropharmacology. 1993 Aug;32(8):799-806. PMID: 8413843.

" Xi, T, C "UN number: 2923     Class: 8 (6.1)     Packing Group: II

Proper shipping name: Corrosive solid, toxi, n.o.s. (Resiniferatoxin)"

LKT R1774 Resiniferatoxin 5 mg 564 Capsaicin analog found in Euphorbia; PKC and TRPV agonist. "6,7-Deepoxy-6,7-didehydro-5-deoxy-21-dephenyl-21-

(phenylmethyl)daphnetoxin 20-(3-hydroxy-5-

methoxybenzeneacetate)" Reciniferatoxin; RTX 57444-62-9 ≥98% 628.73 C37H40O9 CC1CC2(C3C4C1(C5C=C(C(=O)C5(CC(=C4)COC(=O)CC6=CC(=C(C=C6)O)OC)O)C)OC(O3)(O2)CC7=CC=CC=C7)C(=C)C Ambient -20°C Soluble in DMSO or ethanol. "Jiang CY, Fujita T, Yue HY, et al. Effect of resiniferatoxin on glutamatergic spontaneous excitatory synaptic transmission in substantia gelatinosa neurons of the adult rat spinal cord. Neuroscience. 2009 Dec 29;164(4):1833-44. PMID: 19778582.

 

Tang W, Song B, Zhou ZS, et al. Intrathecal administration of resiniferatoxin produces analgesia against prostatodynia in rats. Chin Med J (Engl). 2007 Sep 20;120(18):1616-21. PMID: 17908482.

 

Horie S, Yamamoto H, Michael GJ, et al. Protective role of vanilloid receptor type 1 in HCl-induced gastric mucosal lesions in rats. Scand J Gastroenterol. 2004 Apr;39(4):303-12. PMID: 15125461.

 

Geiges D, Meyer T, Marte B, et al. Activation of protein kinase C subtypes alpha, gamma, delta, epsilon, zeta, and eta by tumor-promoting and nontumor-promoting agents. Biochem Pharmacol. 1997 Mar 21;53(6):865-75. PMID: 9113106.

 

Woods AJ, Stock MJ, Gupta AN, et al. Thermoregulatory effects of resiniferatoxin in the rat. Eur J Pharmacol. 1994 Oct 24;264(2):125-33. PMID: 7851474.

 

Andrews PL, Bhandari P. Resinferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret. Neuropharmacology. 1993 Aug;32(8):799-806. PMID: 8413843.

" Xi, T, C "UN number: 2923     Class: 8 (6.1)     Packing Group: II

Proper shipping name: Corrosive solid, toxi, n.o.s. (Resiniferatoxin)"

LKT R1774 Resiniferatoxin 10 mg 1060 Capsaicin analog found in Euphorbia; PKC and TRPV agonist. "6,7-Deepoxy-6,7-didehydro-5-deoxy-21-dephenyl-21-

(phenylmethyl)daphnetoxin 20-(3-hydroxy-5-

methoxybenzeneacetate)" Reciniferatoxin; RTX 57444-62-9 ≥98% 628.73 C37H40O9 CC1CC2(C3C4C1(C5C=C(C(=O)C5(CC(=C4)COC(=O)CC6=CC(=C(C=C6)O)OC)O)C)OC(O3)(O2)CC7=CC=CC=C7)C(=C)C Ambient -20°C Soluble in DMSO or ethanol. "Jiang CY, Fujita T, Yue HY, et al. Effect of resiniferatoxin on glutamatergic spontaneous excitatory synaptic transmission in substantia gelatinosa neurons of the adult rat spinal cord. Neuroscience. 2009 Dec 29;164(4):1833-44. PMID: 19778582.

 

Tang W, Song B, Zhou ZS, et al. Intrathecal administration of resiniferatoxin produces analgesia against prostatodynia in rats. Chin Med J (Engl). 2007 Sep 20;120(18):1616-21. PMID: 17908482.

 

Horie S, Yamamoto H, Michael GJ, et al. Protective role of vanilloid receptor type 1 in HCl-induced gastric mucosal lesions in rats. Scand J Gastroenterol. 2004 Apr;39(4):303-12. PMID: 15125461.

 

Geiges D, Meyer T, Marte B, et al. Activation of protein kinase C subtypes alpha, gamma, delta, epsilon, zeta, and eta by tumor-promoting and nontumor-promoting agents. Biochem Pharmacol. 1997 Mar 21;53(6):865-75. PMID: 9113106.

 

Woods AJ, Stock MJ, Gupta AN, et al. Thermoregulatory effects of resiniferatoxin in the rat. Eur J Pharmacol. 1994 Oct 24;264(2):125-33. PMID: 7851474.

 

Andrews PL, Bhandari P. Resinferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret. Neuropharmacology. 1993 Aug;32(8):799-806. PMID: 8413843.

" Xi, T, C "UN number: 2923     Class: 8 (6.1)     Packing Group: II

Proper shipping name: Corrosive solid, toxi, n.o.s. (Resiniferatoxin)"

LKT S1059 Scopolamine Hydrobromide Trihydrate 1 g 54.4 Tropane alkaloid found in Solanaceae plants; M1 mAChR antagonist. Scopolamine hydrobromide; Scopolammonium 6533-68-2 ≥98% 438.32 C17H21NO4HBr 3H2O CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4.Br Ambient Ambient Soluble in water (≥600 mg/mL), ethanol (50 mg/mL). Slightly soluble in chloroform.  "Jung IH, Lee HE, Park SJ, et al. Ameliorating effect of spinosin, a C-glycoside flavonoid, on scopolamine-induced memory impairment in mice. Pharmacol Biochem Behav. 2014 May;120:88-94. PMID: 24582850.

 

Drevets WC, Zarate CA Jr, Furey ML. Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review. Biol Psychiatry. 2013 Jun 15;73(12):1156-63. PMID: 23200525.

" Xn "UN number: 1544     Class:  6.1     Packing group:  III

Proper shipping name:  Alkaloid salts, solid, n.o.s. (Scopolamine hydrobromide)

Reportable quantity (RQ):     Marine pollutant:  No     Poison inhalation hazard:  No"

LKT S1059 Scopolamine Hydrobromide Trihydrate 5 g 169.9 Tropane alkaloid found in Solanaceae plants; M1 mAChR antagonist. Scopolamine hydrobromide; Scopolammonium 6533-68-2 ≥98% 438.32 C17H21NO4HBr 3H2O CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4.Br Ambient Ambient Soluble in water (≥600 mg/mL), ethanol (50 mg/mL). Slightly soluble in chloroform.  "Jung IH, Lee HE, Park SJ, et al. Ameliorating effect of spinosin, a C-glycoside flavonoid, on scopolamine-induced memory impairment in mice. Pharmacol Biochem Behav. 2014 May;120:88-94. PMID: 24582850.

 

Drevets WC, Zarate CA Jr, Furey ML. Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review. Biol Psychiatry. 2013 Jun 15;73(12):1156-63. PMID: 23200525.

" Xn "UN number: 1544     Class:  6.1     Packing group:  III

Proper shipping name:  Alkaloid salts, solid, n.o.s. (Scopolamine hydrobromide)

Reportable quantity (RQ):     Marine pollutant:  No     Poison inhalation hazard:  No"

LKT S1059 Scopolamine Hydrobromide Trihydrate 25 g 475.7 Tropane alkaloid found in Solanaceae plants; M1 mAChR antagonist. Scopolamine hydrobromide; Scopolammonium 6533-68-2 ≥98% 438.32 C17H21NO4HBr 3H2O CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4.Br Ambient Ambient Soluble in water (≥600 mg/mL), ethanol (50 mg/mL). Slightly soluble in chloroform.  "Jung IH, Lee HE, Park SJ, et al. Ameliorating effect of spinosin, a C-glycoside flavonoid, on scopolamine-induced memory impairment in mice. Pharmacol Biochem Behav. 2014 May;120:88-94. PMID: 24582850.

 

Drevets WC, Zarate CA Jr, Furey ML. Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review. Biol Psychiatry. 2013 Jun 15;73(12):1156-63. PMID: 23200525.

" Xn "UN number: 1544     Class:  6.1     Packing group:  III

Proper shipping name:  Alkaloid salts, solid, n.o.s. (Scopolamine hydrobromide)

Reportable quantity (RQ):     Marine pollutant:  No     Poison inhalation hazard:  No"

LKT T7056 Troglitazone 10 mg 89.3 Thiazolidinedione; PPARγ agonist, ATP-sensitive K+ channel blocker. 5-[[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl- 2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]-2,4- thiazolidinedione Noscal; Prelay; Rezulin; Romozin 97322-87-7 ≥97% 441.54 C24H27NO5S CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O Troglitazone is sparingly soluble in aqueous buffers. For maximum solubility in aqueous buffers, troglitazone should first be dissolved in DMSO and then diluted with the aqueous buffer of choice. Troglitazone has a solubility of 100µg/ml in a 1:6 solution of DMSO:PBS (pH 7.2) using this method. We do not recommend storing the aqueous solution for more than one day.  Stock solutions are stable for up to 3 months at -20°C. Ambient Ambient Soluble in DMSO 15mg/mL, and dimethyl formide. Slightly soluble in 100% ethanol (warm). "Chen HM, Zhang DG, Wu JX, et al. Ubiquitination of p53 is involved in troglitazone induced apoptosis in cervical cancer cells. Asian Pac J Cancer Prev. 2014;15(5):2313-8. PMID: 24716976.

 

Deng R, Nie A, Jian F, et al. Acute exposure of beta-cells to troglitazone decreases insulin hypersecretion via activating AMPK. Biochim Biophys Acta. 2014 Jan;1840(1):577-85. PMID: 24144566.

 

Zhou B, Buckley ST, Patel V, et al. Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism. PLoS One. 2012;7(6):e38827. PMID: 22745681.

 

Park YS, Lillehoj EP, Kato K, et al. PPARγ inhibits airway epithelial cell inflammatory response through a MUC1-dependent mechanism. Am J Physiol Lung Cell Mol Physiol. 2012 Apr 1;302(7):L679-87. PMID: 22268120.

 

Rashid-Kolvear F, Taboski MA, Nguyen J, et al. Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells. BMC Cancer. 2010 Jul 22;10:390. PMID: 20650001.

 

Ozaki S, Minamisono T, Yamashita T, et al. Supersaturation-nucleation behavior of poorly soluble drugs and its impact on the oral absorption of drugs in thermodynamically high-energy forms. J Pharm Sci. 2012 Jan;101(1):214-222. PMID: 21918988.

" Xn, T Not dangerous goods.

LKT T7056 Troglitazone 50 mg 343.4 Thiazolidinedione; PPARγ agonist, ATP-sensitive K+ channel blocker. 5-[[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl- 2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]-2,4- thiazolidinedione Noscal; Prelay; Rezulin; Romozin 97322-87-7 ≥97% 441.54 C24H27NO5S CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O Troglitazone is sparingly soluble in aqueous buffers. For maximum solubility in aqueous buffers, troglitazone should first be dissolved in DMSO and then diluted with the aqueous buffer of choice. Troglitazone has a solubility of 100µg/ml in a 1:6 solution of DMSO:PBS (pH 7.2) using this method. We do not recommend storing the aqueous solution for more than one day.  Stock solutions are stable for up to 3 months at -20°C. Ambient Ambient Soluble in DMSO 15mg/mL, and dimethyl formide. Slightly soluble in 100% ethanol (warm). "Chen HM, Zhang DG, Wu JX, et al. Ubiquitination of p53 is involved in troglitazone induced apoptosis in cervical cancer cells. Asian Pac J Cancer Prev. 2014;15(5):2313-8. PMID: 24716976.

 

Deng R, Nie A, Jian F, et al. Acute exposure of beta-cells to troglitazone decreases insulin hypersecretion via activating AMPK. Biochim Biophys Acta. 2014 Jan;1840(1):577-85. PMID: 24144566.

 

Zhou B, Buckley ST, Patel V, et al. Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism. PLoS One. 2012;7(6):e38827. PMID: 22745681.

 

Park YS, Lillehoj EP, Kato K, et al. PPARγ inhibits airway epithelial cell inflammatory response through a MUC1-dependent mechanism. Am J Physiol Lung Cell Mol Physiol. 2012 Apr 1;302(7):L679-87. PMID: 22268120.

 

Rashid-Kolvear F, Taboski MA, Nguyen J, et al. Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells. BMC Cancer. 2010 Jul 22;10:390. PMID: 20650001.

 

Ozaki S, Minamisono T, Yamashita T, et al. Supersaturation-nucleation behavior of poorly soluble drugs and its impact on the oral absorption of drugs in thermodynamically high-energy forms. J Pharm Sci. 2012 Jan;101(1):214-222. PMID: 21918988.

" Xn, T Not dangerous goods.

LKT T7056 Troglitazone 100 mg 508.3 Thiazolidinedione; PPARγ agonist, ATP-sensitive K+ channel blocker. 5-[[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl- 2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]-2,4- thiazolidinedione Noscal; Prelay; Rezulin; Romozin 97322-87-7 ≥97% 441.54 C24H27NO5S CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O Troglitazone is sparingly soluble in aqueous buffers. For maximum solubility in aqueous buffers, troglitazone should first be dissolved in DMSO and then diluted with the aqueous buffer of choice. Troglitazone has a solubility of 100µg/ml in a 1:6 solution of DMSO:PBS (pH 7.2) using this method. We do not recommend storing the aqueous solution for more than one day.  Stock solutions are stable for up to 3 months at -20°C. Ambient Ambient Soluble in DMSO 15mg/mL, and dimethyl formide. Slightly soluble in 100% ethanol (warm). "Chen HM, Zhang DG, Wu JX, et al. Ubiquitination of p53 is involved in troglitazone induced apoptosis in cervical cancer cells. Asian Pac J Cancer Prev. 2014;15(5):2313-8. PMID: 24716976.

 

Deng R, Nie A, Jian F, et al. Acute exposure of beta-cells to troglitazone decreases insulin hypersecretion via activating AMPK. Biochim Biophys Acta. 2014 Jan;1840(1):577-85. PMID: 24144566.

 

Zhou B, Buckley ST, Patel V, et al. Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism. PLoS One. 2012;7(6):e38827. PMID: 22745681.

 

Park YS, Lillehoj EP, Kato K, et al. PPARγ inhibits airway epithelial cell inflammatory response through a MUC1-dependent mechanism. Am J Physiol Lung Cell Mol Physiol. 2012 Apr 1;302(7):L679-87. PMID: 22268120.

 

Rashid-Kolvear F, Taboski MA, Nguyen J, et al. Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells. BMC Cancer. 2010 Jul 22;10:390. PMID: 20650001.

 

Ozaki S, Minamisono T, Yamashita T, et al. Supersaturation-nucleation behavior of poorly soluble drugs and its impact on the oral absorption of drugs in thermodynamically high-energy forms. J Pharm Sci. 2012 Jan;101(1):214-222. PMID: 21918988.

" Xn, T Not dangerous goods.

LKT G3556 Ginsenoside Rg3 5 mg 169.9 Triterpene saponin found in species of Panax; γ2 GABA-A agonist, Kv7.1 K+ channel activator, α10 nAChR antagonist. 20-(R)-Ginsenoside Rg3 38243-03-7 ≥98% 785.01 C42H72O13 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)O)C Ambient 4°C Soluble in methanol 0.1mg/mL.  DMSO to 5 mM. "Zhang YH, Li HD, Li B, et al. Ginsenoside Rg3 induces DNA damage in human osteosarcoma cells and reduces MNNG-induced DNA damage and apoptosis in normal human cells. Oncol Rep. 2014 Feb;31(2):919-25. PMID: 24337872.

 

Lee B, Sur B, Park J, et al. Ginsenoside rg3 alleviates lipopolysaccharide-induced learning and memory impairments by anti-inflammatory activity in rats. Biomol Ther (Seoul). 2013 Sep 30;21(5):381-90. PMID: 24244826.

 

Lee BH, Choi SH, Hwang SH, et al. Effects of ginsenoside Rg3 on α9α10 nicotinic acetylcholine receptor-mediated ion currents. Biol Pharm Bull. 2013;36(5):812-8. PMID: 23649337.

 

Lee BH, Kim HJ, Chung L, et al. Ginsenoside Rg₃ regulates GABAA receptor channel activity: involvement of interaction with the γ₂ subunit. Eur J Pharmacol. 2013 Apr 5;705(1-3):119-25. PMID: 23499684.

 

Park SM, Choi MS, Sohn NW, et al. Ginsenoside Rg3 attenuates microglia activation following systemic lipopolysaccharide treatment in mice. Biol Pharm Bull. 2012;35(9):1546-52. PMID: 22975507.

 

Wei X, Su F, Su X, et al. Stereospecific antioxidant effects of ginsenoside Rg3 on oxidative stress induced by cyclophosphamide in mice. Fitoterapia. 2012 Jun;83(4):636-42. PMID: 22310172.

 

Kim JW, Jung SY, Kwon YH, et al. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells. Cancer Biol Ther. 2012 May;13(7):504-15. PMID: 22406998.

" Xn Not dangerous goods.

LKT G3556 Ginsenoside Rg3 10 mg 285.4 Triterpene saponin found in species of Panax; γ2 GABA-A agonist, Kv7.1 K+ channel activator, α10 nAChR antagonist. 20-(R)-Ginsenoside Rg3 38243-03-7 ≥98% 785.01 C42H72O13 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)O)C Ambient 4°C Soluble in methanol 0.1mg/mL.  DMSO to 5 mM. "Zhang YH, Li HD, Li B, et al. Ginsenoside Rg3 induces DNA damage in human osteosarcoma cells and reduces MNNG-induced DNA damage and apoptosis in normal human cells. Oncol Rep. 2014 Feb;31(2):919-25. PMID: 24337872.

 

Lee B, Sur B, Park J, et al. Ginsenoside rg3 alleviates lipopolysaccharide-induced learning and memory impairments by anti-inflammatory activity in rats. Biomol Ther (Seoul). 2013 Sep 30;21(5):381-90. PMID: 24244826.

 

Lee BH, Choi SH, Hwang SH, et al. Effects of ginsenoside Rg3 on α9α10 nicotinic acetylcholine receptor-mediated ion currents. Biol Pharm Bull. 2013;36(5):812-8. PMID: 23649337.

 

Lee BH, Kim HJ, Chung L, et al. Ginsenoside Rg₃ regulates GABAA receptor channel activity: involvement of interaction with the γ₂ subunit. Eur J Pharmacol. 2013 Apr 5;705(1-3):119-25. PMID: 23499684.

 

Park SM, Choi MS, Sohn NW, et al. Ginsenoside Rg3 attenuates microglia activation following systemic lipopolysaccharide treatment in mice. Biol Pharm Bull. 2012;35(9):1546-52. PMID: 22975507.

 

Wei X, Su F, Su X, et al. Stereospecific antioxidant effects of ginsenoside Rg3 on oxidative stress induced by cyclophosphamide in mice. Fitoterapia. 2012 Jun;83(4):636-42. PMID: 22310172.

 

Kim JW, Jung SY, Kwon YH, et al. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells. Cancer Biol Ther. 2012 May;13(7):504-15. PMID: 22406998.

" Xn Not dangerous goods.

LKT G3556 Ginsenoside Rg3 25 mg 543.6 Triterpene saponin found in species of Panax; γ2 GABA-A agonist, Kv7.1 K+ channel activator, α10 nAChR antagonist. 20-(R)-Ginsenoside Rg3 38243-03-7 ≥98% 785.01 C42H72O13 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)O)C Ambient 4°C Soluble in methanol 0.1mg/mL.  DMSO to 5 mM. "Zhang YH, Li HD, Li B, et al. Ginsenoside Rg3 induces DNA damage in human osteosarcoma cells and reduces MNNG-induced DNA damage and apoptosis in normal human cells. Oncol Rep. 2014 Feb;31(2):919-25. PMID: 24337872.

 

Lee B, Sur B, Park J, et al. Ginsenoside rg3 alleviates lipopolysaccharide-induced learning and memory impairments by anti-inflammatory activity in rats. Biomol Ther (Seoul). 2013 Sep 30;21(5):381-90. PMID: 24244826.

 

Lee BH, Choi SH, Hwang SH, et al. Effects of ginsenoside Rg3 on α9α10 nicotinic acetylcholine receptor-mediated ion currents. Biol Pharm Bull. 2013;36(5):812-8. PMID: 23649337.

 

Lee BH, Kim HJ, Chung L, et al. Ginsenoside Rg₃ regulates GABAA receptor channel activity: involvement of interaction with the γ₂ subunit. Eur J Pharmacol. 2013 Apr 5;705(1-3):119-25. PMID: 23499684.

 

Park SM, Choi MS, Sohn NW, et al. Ginsenoside Rg3 attenuates microglia activation following systemic lipopolysaccharide treatment in mice. Biol Pharm Bull. 2012;35(9):1546-52. PMID: 22975507.

 

Wei X, Su F, Su X, et al. Stereospecific antioxidant effects of ginsenoside Rg3 on oxidative stress induced by cyclophosphamide in mice. Fitoterapia. 2012 Jun;83(4):636-42. PMID: 22310172.

 

Kim JW, Jung SY, Kwon YH, et al. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells. Cancer Biol Ther. 2012 May;13(7):504-15. PMID: 22406998.

" Xn Not dangerous goods.

LKT I0901 Icariin 100 mg 101.9 Flavonol glycoside originally found in Epimedium; PDE5 inhibitor. 3-[(6-Deoxy-α-L-mannopyranosyl)oxy]-7-(β-D- glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one 489-32-7 ≥97% 676.66 C33H40O15 CC1C(C(C(C(O1)OC2=C(OC3=C(C2=O)C(=CC(=C3CC=C(C)C)OC4C(C(C(C(O4)CO)O)O)O)O)C5=CC=C(C=C5)OC)O)O)O Store in a cool, dry place. Keep away from direct light. Shelf life is 18 months. Ambient 4°C Soluble in pyridine. Insoluble in water, alcohol, chloroform, acetone, methanol or ethyl acetate. "Zhao F, Tang YZ, Liu ZQ. Protective effect of icariin on DNA against radical-induced oxidative damage. J Pharm Pharmacol. 2007 Dec;59(12):1729-32. PMID: 18053336.

 

Luo Y, Nie J, Gong QH, et al. Protective effects of icariin against learning and memory deficits induced by aluminium in rats. Clin Exp Pharmacol Physiol. 2007 Aug;34(8):792-5. PMID: 17600559.

 

Chen KM, Ge BF, Liu XY, et al. Icariin inhibits the osteoclast formation induced by RANKL and macrophage-colony stimulating factor in mouse bone marrow culture. Pharmazie. 2007 May;62(5):388-91. PMID: 17557750.

 

Ning H, Xin ZC, Lin G, et al. Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells. Urology. 2006 Dec;68(6):1350-4. PMID: 17169663.

 

Pan Y, Kong L, Xia X, et al. Antidepressant-like effect of icariin and its possible mechanism in mice. Pharmacol Biochem Behav. 2005 Dec;82(4):686-94. PMID: 16380159.

" Not dangerous goods.

LKT I0901 Icariin 500 mg 407.7 Flavonol glycoside originally found in Epimedium; PDE5 inhibitor. 3-[(6-Deoxy-α-L-mannopyranosyl)oxy]-7-(β-D- glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one 489-32-7 ≥97% 676.66 C33H40O15 CC1C(C(C(C(O1)OC2=C(OC3=C(C2=O)C(=CC(=C3CC=C(C)C)OC4C(C(C(C(O4)CO)O)O)O)O)C5=CC=C(C=C5)OC)O)O)O Store in a cool, dry place. Keep away from direct light. Shelf life is 18 months. Ambient 4°C Soluble in pyridine. Insoluble in water, alcohol, chloroform, acetone, methanol or ethyl acetate. "Zhao F, Tang YZ, Liu ZQ. Protective effect of icariin on DNA against radical-induced oxidative damage. J Pharm Pharmacol. 2007 Dec;59(12):1729-32. PMID: 18053336.

 

Luo Y, Nie J, Gong QH, et al. Protective effects of icariin against learning and memory deficits induced by aluminium in rats. Clin Exp Pharmacol Physiol. 2007 Aug;34(8):792-5. PMID: 17600559.

 

Chen KM, Ge BF, Liu XY, et al. Icariin inhibits the osteoclast formation induced by RANKL and macrophage-colony stimulating factor in mouse bone marrow culture. Pharmazie. 2007 May;62(5):388-91. PMID: 17557750.

 

Ning H, Xin ZC, Lin G, et al. Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells. Urology. 2006 Dec;68(6):1350-4. PMID: 17169663.

 

Pan Y, Kong L, Xia X, et al. Antidepressant-like effect of icariin and its possible mechanism in mice. Pharmacol Biochem Behav. 2005 Dec;82(4):686-94. PMID: 16380159.

" Not dangerous goods.

LKT I0901 Icariin 1 g 679.5 Flavonol glycoside originally found in Epimedium; PDE5 inhibitor. 3-[(6-Deoxy-α-L-mannopyranosyl)oxy]-7-(β-D- glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one 489-32-7 ≥97% 676.66 C33H40O15 CC1C(C(C(C(O1)OC2=C(OC3=C(C2=O)C(=CC(=C3CC=C(C)C)OC4C(C(C(C(O4)CO)O)O)O)O)C5=CC=C(C=C5)OC)O)O)O Store in a cool, dry place. Keep away from direct light. Shelf life is 18 months. Ambient 4°C Soluble in pyridine. Insoluble in water, alcohol, chloroform, acetone, methanol or ethyl acetate. "Zhao F, Tang YZ, Liu ZQ. Protective effect of icariin on DNA against radical-induced oxidative damage. J Pharm Pharmacol. 2007 Dec;59(12):1729-32. PMID: 18053336.

 

Luo Y, Nie J, Gong QH, et al. Protective effects of icariin against learning and memory deficits induced by aluminium in rats. Clin Exp Pharmacol Physiol. 2007 Aug;34(8):792-5. PMID: 17600559.

 

Chen KM, Ge BF, Liu XY, et al. Icariin inhibits the osteoclast formation induced by RANKL and macrophage-colony stimulating factor in mouse bone marrow culture. Pharmazie. 2007 May;62(5):388-91. PMID: 17557750.

 

Ning H, Xin ZC, Lin G, et al. Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells. Urology. 2006 Dec;68(6):1350-4. PMID: 17169663.

 

Pan Y, Kong L, Xia X, et al. Antidepressant-like effect of icariin and its possible mechanism in mice. Pharmacol Biochem Behav. 2005 Dec;82(4):686-94. PMID: 16380159.

" Not dangerous goods.

LKT M3353 Minocycline Hydrochloride 100 mg 88.3 Tetracycline; protein translation inhibitor, MMP inhibitor. [4S-(4α,4aα,5aα,12aα)]-4,7-Bis(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a- tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide hydrochloride Dynacin; Klinomycin; Minocin; Vectrin 13614-98-7 ≥98% 493.94 C23H27N3O7 HCl CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C.Cl Hygroscopic. Protect from light. Sensitive to surface oxidation. Ambient 4°C Soluble in dilute acids or bases. "Mora M, Medina-Leendertz SJ, Bonilla E, et al. Minocycline, but not ascorbic acid, increases motor activity and extends the life span of Drosophila melanogaster. Invest Clin. 2013 Jun;54(2):161-70. PMID: 23947005.

 

Blacker DJ, Prentice D, Alvaro A, et al. Reducing haemorrhagic transformation after thrombolysis for stroke: a strategy utilising minocycline. Stroke Res Treat. 2013;2013:362961. PMID: 23691430.

 

Kong F, Chen S, Cheng Y, et al. Minocycline attenuates cognitive impairment induced by isoflurane anesthesia in aged rats. PLoS One. 2013 Apr 17;8(4):e61385. PMID: 23613842.

 

Watabe M, Kato TA, Tsuboi S, et al. Minocycline, a microglial inhibitor, reduces 'honey trap' risk in human economic exchange. Sci Rep. 2013;3:1685. PMID: 23595250.

 

Ataie-Kachoie P, Morris DL, Pourgholami MH. Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies. PLoS One. 2013 Apr 8;8(4):e60817. PMID: 23593315.

 

Giuliani F, Hader W, Yong VW. Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction. J Leukoc Biol. 2005 Jul;78(1):135-43. PMID: 15817702.

 

 

Song Y, Wei EQ, Zhang WP, et al. Minocycline protects PC12 cells from ischemic-like injury and inhibits 5-lipoxygenase activation. Neuroreport. 2004 Oct 5;15(14):2181-4. PMID: 15371729.

 

Zhu S, Stavrovskaya IG, Drozda M, et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 2002 May 2;417(6884):74-8. PMID: 11986668.

 

Waterworth PM. The effect of minocycline on Candida albicans. J Clin Pathol. 1974 Apr;27(4):269-72. PMID: 4212409.

" Xi Not dangerous goods.

LKT M3353 Minocycline Hydrochloride 250 mg 136 Tetracycline; protein translation inhibitor, MMP inhibitor. [4S-(4α,4aα,5aα,12aα)]-4,7-Bis(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a- tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide hydrochloride Dynacin; Klinomycin; Minocin; Vectrin 13614-98-7 ≥98% 493.94 C23H27N3O7 HCl CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C.Cl Hygroscopic. Protect from light. Sensitive to surface oxidation. Ambient 4°C Soluble in dilute acids or bases. "Mora M, Medina-Leendertz SJ, Bonilla E, et al. Minocycline, but not ascorbic acid, increases motor activity and extends the life span of Drosophila melanogaster. Invest Clin. 2013 Jun;54(2):161-70. PMID: 23947005.

 

Blacker DJ, Prentice D, Alvaro A, et al. Reducing haemorrhagic transformation after thrombolysis for stroke: a strategy utilising minocycline. Stroke Res Treat. 2013;2013:362961. PMID: 23691430.

 

Kong F, Chen S, Cheng Y, et al. Minocycline attenuates cognitive impairment induced by isoflurane anesthesia in aged rats. PLoS One. 2013 Apr 17;8(4):e61385. PMID: 23613842.

 

Watabe M, Kato TA, Tsuboi S, et al. Minocycline, a microglial inhibitor, reduces 'honey trap' risk in human economic exchange. Sci Rep. 2013;3:1685. PMID: 23595250.

 

Ataie-Kachoie P, Morris DL, Pourgholami MH. Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies. PLoS One. 2013 Apr 8;8(4):e60817. PMID: 23593315.

 

Giuliani F, Hader W, Yong VW. Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction. J Leukoc Biol. 2005 Jul;78(1):135-43. PMID: 15817702.

 

 

Song Y, Wei EQ, Zhang WP, et al. Minocycline protects PC12 cells from ischemic-like injury and inhibits 5-lipoxygenase activation. Neuroreport. 2004 Oct 5;15(14):2181-4. PMID: 15371729.

 

Zhu S, Stavrovskaya IG, Drozda M, et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 2002 May 2;417(6884):74-8. PMID: 11986668.

 

Waterworth PM. The effect of minocycline on Candida albicans. J Clin Pathol. 1974 Apr;27(4):269-72. PMID: 4212409.

" Xi Not dangerous goods.

LKT M3353 Minocycline Hydrochloride 500 mg 251.5 Tetracycline; protein translation inhibitor, MMP inhibitor. [4S-(4α,4aα,5aα,12aα)]-4,7-Bis(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a- tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide hydrochloride Dynacin; Klinomycin; Minocin; Vectrin 13614-98-7 ≥98% 493.94 C23H27N3O7 HCl CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C.Cl Hygroscopic. Protect from light. Sensitive to surface oxidation. Ambient 4°C Soluble in dilute acids or bases. "Mora M, Medina-Leendertz SJ, Bonilla E, et al. Minocycline, but not ascorbic acid, increases motor activity and extends the life span of Drosophila melanogaster. Invest Clin. 2013 Jun;54(2):161-70. PMID: 23947005.

 

Blacker DJ, Prentice D, Alvaro A, et al. Reducing haemorrhagic transformation after thrombolysis for stroke: a strategy utilising minocycline. Stroke Res Treat. 2013;2013:362961. PMID: 23691430.

 

Kong F, Chen S, Cheng Y, et al. Minocycline attenuates cognitive impairment induced by isoflurane anesthesia in aged rats. PLoS One. 2013 Apr 17;8(4):e61385. PMID: 23613842.

 

Watabe M, Kato TA, Tsuboi S, et al. Minocycline, a microglial inhibitor, reduces 'honey trap' risk in human economic exchange. Sci Rep. 2013;3:1685. PMID: 23595250.

 

Ataie-Kachoie P, Morris DL, Pourgholami MH. Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies. PLoS One. 2013 Apr 8;8(4):e60817. PMID: 23593315.

 

Giuliani F, Hader W, Yong VW. Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction. J Leukoc Biol. 2005 Jul;78(1):135-43. PMID: 15817702.

 

 

Song Y, Wei EQ, Zhang WP, et al. Minocycline protects PC12 cells from ischemic-like injury and inhibits 5-lipoxygenase activation. Neuroreport. 2004 Oct 5;15(14):2181-4. PMID: 15371729.

 

Zhu S, Stavrovskaya IG, Drozda M, et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 2002 May 2;417(6884):74-8. PMID: 11986668.

 

Waterworth PM. The effect of minocycline on Candida albicans. J Clin Pathol. 1974 Apr;27(4):269-72. PMID: 4212409.

" Xi Not dangerous goods.

LKT P6954 Pioglitazone Hydrochloride 100 mg 47.6 Thiazolidinedione; PPARα/γ agonist, mitoNEET modulator. "2,4-Thiazolidinedione, 5-((4-(2-(5-ethyl-2-

pyridinyl)ethoxy)phenyl)methyl)-, monohydrochloride, (+-)- 

" Actos; U-72107A. 112529-15-4 ≥98% 392.91 C19H20N2O3S HCl CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl Ambient 4°C Soluble in DMF, DMSO(79mg/mL). Slightly soluble in ethanol(4mg/mL). acetone or acetonitrile. Practically insoluble in water. Insoluble in ether. "Zhang M, Gao X, Bai SJ, et al. Effect of pioglitazone on expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in ischemic hindlimb of diabetic rats. Eur Rev Med Pharmacol Sci. 2014;18(9):1307-14. PMID: 24867508.

 

Kemp DE, Schinagle M, Gao K, et al. PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression. CNS Drugs. 2014 Jun;28(6):571-81. PMID: 24715548.

 

Paragomi P, Rahimian R, Kazemi MH, et al. Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide. Clin Exp Pharmacol Physiol. 2014 Feb;41(2):118-26. PMID: 24471407.

 

Moezi L, Heidari R, Amirghofran Z, et al. Enhanced anti-ulcer effect of pioglitazone on gastric ulcers in cirrhotic rats: the role of nitric oxide and IL-1β. Pharmacol Rep. 2013;65(1):134-43. PMID: 23563031.

 

Paddock ML, Wiley SE, Axelrod HL, et al. MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone. Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14342-7. PMID: 17766440.

 

Gillies PS, Dunn CJ. Pioglitazone. Drugs. 2000 Aug;60(2):333-43; PMID: 10983737.

 

Yoshida H, Watanabe W, Oomagari H, et al. Citrus flavonoid naringenin inhibits TLR2 expression in adipocytes. J Nutr Biochem. 2013 Jul;24(7):1276-1284. PMID: 23333096.

" Xi Not dangerous goods.

LKT P6954 Pioglitazone Hydrochloride 500 mg 136 Thiazolidinedione; PPARα/γ agonist, mitoNEET modulator. "2,4-Thiazolidinedione, 5-((4-(2-(5-ethyl-2-

pyridinyl)ethoxy)phenyl)methyl)-, monohydrochloride, (+-)- 

" Actos; U-72107A. 112529-15-4 ≥98% 392.91 C19H20N2O3S HCl CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl Ambient 4°C Soluble in DMF, DMSO(79mg/mL). Slightly soluble in ethanol(4mg/mL). acetone or acetonitrile. Practically insoluble in water. Insoluble in ether. "Zhang M, Gao X, Bai SJ, et al. Effect of pioglitazone on expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in ischemic hindlimb of diabetic rats. Eur Rev Med Pharmacol Sci. 2014;18(9):1307-14. PMID: 24867508.

 

Kemp DE, Schinagle M, Gao K, et al. PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression. CNS Drugs. 2014 Jun;28(6):571-81. PMID: 24715548.

 

Paragomi P, Rahimian R, Kazemi MH, et al. Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide. Clin Exp Pharmacol Physiol. 2014 Feb;41(2):118-26. PMID: 24471407.

 

Moezi L, Heidari R, Amirghofran Z, et al. Enhanced anti-ulcer effect of pioglitazone on gastric ulcers in cirrhotic rats: the role of nitric oxide and IL-1β. Pharmacol Rep. 2013;65(1):134-43. PMID: 23563031.

 

Paddock ML, Wiley SE, Axelrod HL, et al. MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone. Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14342-7. PMID: 17766440.

 

Gillies PS, Dunn CJ. Pioglitazone. Drugs. 2000 Aug;60(2):333-43; PMID: 10983737.

 

Yoshida H, Watanabe W, Oomagari H, et al. Citrus flavonoid naringenin inhibits TLR2 expression in adipocytes. J Nutr Biochem. 2013 Jul;24(7):1276-1284. PMID: 23333096.

" Xi Not dangerous goods.

LKT P6954 Pioglitazone Hydrochloride 1 g 203.8 Thiazolidinedione; PPARα/γ agonist, mitoNEET modulator. "2,4-Thiazolidinedione, 5-((4-(2-(5-ethyl-2-

pyridinyl)ethoxy)phenyl)methyl)-, monohydrochloride, (+-)- 

" Actos; U-72107A. 112529-15-4 ≥98% 392.91 C19H20N2O3S HCl CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl Ambient 4°C Soluble in DMF, DMSO(79mg/mL). Slightly soluble in ethanol(4mg/mL). acetone or acetonitrile. Practically insoluble in water. Insoluble in ether. "Zhang M, Gao X, Bai SJ, et al. Effect of pioglitazone on expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in ischemic hindlimb of diabetic rats. Eur Rev Med Pharmacol Sci. 2014;18(9):1307-14. PMID: 24867508.

 

Kemp DE, Schinagle M, Gao K, et al. PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression. CNS Drugs. 2014 Jun;28(6):571-81. PMID: 24715548.

 

Paragomi P, Rahimian R, Kazemi MH, et al. Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide. Clin Exp Pharmacol Physiol. 2014 Feb;41(2):118-26. PMID: 24471407.

 

Moezi L, Heidari R, Amirghofran Z, et al. Enhanced anti-ulcer effect of pioglitazone on gastric ulcers in cirrhotic rats: the role of nitric oxide and IL-1β. Pharmacol Rep. 2013;65(1):134-43. PMID: 23563031.

 

Paddock ML, Wiley SE, Axelrod HL, et al. MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone. Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14342-7. PMID: 17766440.

 

Gillies PS, Dunn CJ. Pioglitazone. Drugs. 2000 Aug;60(2):333-43; PMID: 10983737.

 

Yoshida H, Watanabe W, Oomagari H, et al. Citrus flavonoid naringenin inhibits TLR2 expression in adipocytes. J Nutr Biochem. 2013 Jul;24(7):1276-1284. PMID: 23333096.

" Xi Not dangerous goods.

LKT S8151 Sumatriptan Succinate 100 mg 140.7 Tryptamine; 5-HT1B/1D agonist, TRPV1 antagonist. 3-[2-(Dimethyl-amin)ethyl]-N-methyl-1H-indole-5-methanesulfonamide succinate; GR-43175C 103628-48-4 ≥98% 413.49 C14H21N3O2S C4H6O4 CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O Ambient Ambient "Blumenfeld A, Gennings C, Cady R. Pharmacological synergy: the next frontier on therapeutic advancement for migraine. Headache. 2012 Apr;52(4):636-47. PMID: 22221151.

 

Loyd DR, Weiss G, Henry MA, et al. Serotonin increases the functional activity of capsaicin-sensitive rat trigeminal nociceptors via peripheral serotonin receptors. Pain. 2011 Oct;152(10):2267-76. PMID: 21737202.

 

Muñoz-Islas E, Lozano-Cuenca J, González-Hernández A, et al. Spinal sumatriptan inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors. Eur J Pharmacol. 2009 Aug 1;615(1-3):133-8. PMID: 19460365.

 

Moro E, Crema F, De Ponti F, et al. Triptans and gastric accommodation: pharmacological and therapeutic aspects. Dig Liver Dis. 2004 Jan;36(1):85-92. PMID: 14971822.

" Xi Not dangerous goods.

LKT S8151 Sumatriptan Succinate 250 mg 271.8 Tryptamine; 5-HT1B/1D agonist, TRPV1 antagonist. 3-[2-(Dimethyl-amin)ethyl]-N-methyl-1H-indole-5-methanesulfonamide succinate; GR-43175C 103628-48-4 ≥98% 413.49 C14H21N3O2S C4H6O4 CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O Ambient Ambient "Blumenfeld A, Gennings C, Cady R. Pharmacological synergy: the next frontier on therapeutic advancement for migraine. Headache. 2012 Apr;52(4):636-47. PMID: 22221151.

 

Loyd DR, Weiss G, Henry MA, et al. Serotonin increases the functional activity of capsaicin-sensitive rat trigeminal nociceptors via peripheral serotonin receptors. Pain. 2011 Oct;152(10):2267-76. PMID: 21737202.

 

Muñoz-Islas E, Lozano-Cuenca J, González-Hernández A, et al. Spinal sumatriptan inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors. Eur J Pharmacol. 2009 Aug 1;615(1-3):133-8. PMID: 19460365.

 

Moro E, Crema F, De Ponti F, et al. Triptans and gastric accommodation: pharmacological and therapeutic aspects. Dig Liver Dis. 2004 Jan;36(1):85-92. PMID: 14971822.

" Xi Not dangerous goods.

LKT S8151 Sumatriptan Succinate 1 g 788.7 Tryptamine; 5-HT1B/1D agonist, TRPV1 antagonist. 3-[2-(Dimethyl-amin)ethyl]-N-methyl-1H-indole-5-methanesulfonamide succinate; GR-43175C 103628-48-4 ≥98% 413.49 C14H21N3O2S C4H6O4 CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O Ambient Ambient "Blumenfeld A, Gennings C, Cady R. Pharmacological synergy: the next frontier on therapeutic advancement for migraine. Headache. 2012 Apr;52(4):636-47. PMID: 22221151.

 

Loyd DR, Weiss G, Henry MA, et al. Serotonin increases the functional activity of capsaicin-sensitive rat trigeminal nociceptors via peripheral serotonin receptors. Pain. 2011 Oct;152(10):2267-76. PMID: 21737202.

 

Muñoz-Islas E, Lozano-Cuenca J, González-Hernández A, et al. Spinal sumatriptan inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors. Eur J Pharmacol. 2009 Aug 1;615(1-3):133-8. PMID: 19460365.

 

Moro E, Crema F, De Ponti F, et al. Triptans and gastric accommodation: pharmacological and therapeutic aspects. Dig Liver Dis. 2004 Jan;36(1):85-92. PMID: 14971822.

" Xi Not dangerous goods.

LKT F0010 FAM FLICA® Poly Caspases Assay Kit 25 Tests 292.1 Caspase activity measuring kit. Ambient 4°C

LKT F0010 FAM FLICA® Poly Caspases Assay Kit 100 Tests 849.3 Caspase activity measuring kit. Ambient 4°C

LKT F0011 FAM FLICATM Caspase 1 Assay Kit 25 Tests 322.5 Caspase 1 activity measuring kit. Ambient 4°C

LKT F0011 FAM FLICATM Caspase 1 Assay Kit 100 Tests 904.5 Caspase 1 activity measuring kit. Ambient 4°C

LKT F0012 FAM FLICATM Caspase 2 Assay Kit 25 Tests 291.9 Caspase 2 activity measuring kit. Ambient 4°C

LKT F0012 FAM FLICATM Caspase 2 Assay Kit 100 Tests 849.3 Caspase 2 activity measuring kit. Ambient 4°C

LKT F0013 FAM FLICATM Caspase 3 & 7 Assay Kit 25 Tests 292.1 Caspase 3/7 activity measuring kit. Ambient 4°C

LKT F0013 FAM FLICATM Caspase 3 & 7 Assay Kit 100 Tests 849.3 Caspase 3/7 activity measuring kit. Ambient 4°C

LKT F0014 FAM FLICATM Caspase 6 Assay Kit 25 Tests 292.1 Caspase 6 activity measuring kit. Ambient 4°C

LKT F0014 FAM FLICATM Caspase 6 Assay Kit 100 Tests 849.3 Caspase 6 activity measuring kit. Ambient 4°C

LKT F0015 FAM FLICATM Caspase 8 Assay Kit 25 Tests 292.1 Caspase 8 activity measuring kit. Ambient 4°C

LKT F0015 FAM FLICATM Caspase 8 Assay Kit 100 Tests 849.3 Caspase 8 activity measuring kit. Ambient 4°C

LKT F0016 FAM FLICATM Caspase 9 Assay Kit 25 Tests 292.1 Caspase 9 activity measuring kit. Ambient 4°C

LKT F0016 FAM FLICATM Caspase 9 Assay Kit 100 Tests 849.3 Caspase 9 activity measuring kit. Ambient 4°C

LKT F0017 FAM FLICATM Caspase 10 Assay Kit 25 Tests 292.1 Caspase 10 activity measuring kit. Ambient 4°C

LKT F0017 FAM FLICATM Caspase 10 Assay Kit 100 Tests 849.3 Caspase 10 activity measuring kit. Ambient 4°C

LKT F0018 FAM FLICATM Caspase 13 Assay Kit 25 Tests 292.1 Caspase 13 activity measuring kit. Ambient 4°C

LKT F0018 FAM FLICATM Caspase 13 Assay Kit 100 Tests 849.3 Caspase 13 activity measuring kit. Ambient 4°C

LKT F0019 FAM-Phe-CMK Green FLISPTM Assay Kit 100 Tests 774.9 Phenylalanine-specific serine protease activity measuring kit. Ambient 4°C

LKT F0019 FAM-Phe-CMK Green FLISPTM Assay Kit 25 Tests 275.3 Phenylalanine-specific serine protease activity measuring kit. Ambient 4°C

LKT F0021 FAM-Leu-CMK Green FLISPTM Assay  Kit 100 Tests 774.9 Leucine-specific serine protease activity measuring kit. Ambient 4°C

LKT F0021 FAM-Leu-CMK Green FLISPTM Assay  Kit 25 Tests 275.3 Leucine-specific serine protease activity measuring kit. Ambient 4°C

LKT F0022 FAM-Spacer-Phe-CMK Green FLISPTM Assay Kit 25 Tests 275.3 Serine protease activity measuring kit. Ambient 4°C

LKT F0022 FAM-Spacer-Phe-CMK Green FLISPTM Assay Kit 100 Tests 774.9 Serine protease activity measuring kit. Ambient 4°C

LKT F0023 FAM-Spacer-Leu-CMK Green FLISPTM Assay Kit 100 Tests 774.9 Serine protease activity measuring kit. Ambient 4°C

LKT F0023 FAM-Spacer-Leu-CMK Green FLISPTM Assay Kit 25 Tests 275.3 Serine protease activity measuring kit. Ambient 4°C

LKT F0024 FAM-Leu-DAP Green FLISPTM Assay Kit 25 Tests 275.3 Serine protease activity measuring kit. Ambient 4°C

LKT F0024 FAM-Leu-DAP Green FLISPTM Assay Kit 100 Tests 774.9 Serine protease activity measuring kit. Ambient 4°C

LKT F0048 Famciclovir 50 mg 72.2 Penciclovir prodrug, nucleoside (guanosine) analog; DNA chain terminator. "2-[2-(2-Amino-9H-purin-9-yl)ethyl]-1,3-propanediol

diacetate (ester)" Oravir; Famvir 104227-87-4 ≥98% 321.33 C14H19N5O4 CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C Ambient Ambient Soluble in acetone or methanol. Slightly soluble in ethanol or isopropylalcohol. "Modi S, Van L, Gewirtzman A, et al. Single-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacology. Ther Clin Risk Manag. 2008 Apr;4(2):409-17. PMID: 18728852.

 

Luber AD, Flaherty JF Jr. Famciclovir for treatment of herpesvirus infections. Ann Pharmacother. 1996 Sep;30(9):978-85. PMID: 8876860.

" None Not dangerous goods.

LKT F0048 Famciclovir 100 mg 121.3 Penciclovir prodrug, nucleoside (guanosine) analog; DNA chain terminator. "2-[2-(2-Amino-9H-purin-9-yl)ethyl]-1,3-propanediol

diacetate (ester)" Oravir; Famvir 104227-87-4 ≥98% 321.33 C14H19N5O4 CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C Ambient Ambient Soluble in acetone or methanol. Slightly soluble in ethanol or isopropylalcohol. "Modi S, Van L, Gewirtzman A, et al. Single-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacology. Ther Clin Risk Manag. 2008 Apr;4(2):409-17. PMID: 18728852.

 

Luber AD, Flaherty JF Jr. Famciclovir for treatment of herpesvirus infections. Ann Pharmacother. 1996 Sep;30(9):978-85. PMID: 8876860.

" None Not dangerous goods.

LKT F0048 Famciclovir 500 mg 504.8 Penciclovir prodrug, nucleoside (guanosine) analog; DNA chain terminator. "2-[2-(2-Amino-9H-purin-9-yl)ethyl]-1,3-propanediol

diacetate (ester)" Oravir; Famvir 104227-87-4 ≥98% 321.33 C14H19N5O4 CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C Ambient Ambient Soluble in acetone or methanol. Slightly soluble in ethanol or isopropylalcohol. "Modi S, Van L, Gewirtzman A, et al. Single-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacology. Ther Clin Risk Manag. 2008 Apr;4(2):409-17. PMID: 18728852.

 

Luber AD, Flaherty JF Jr. Famciclovir for treatment of herpesvirus infections. Ann Pharmacother. 1996 Sep;30(9):978-85. PMID: 8876860.

" None Not dangerous goods.

LKT F0150 Famotidine 500 mg 57.8 Histamine H2 antagonist, GSK-3β inhibitor. 3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]- methyl]thio-N-(aminosulfonyl)propanimidamide Amfamox; Dispromil; Famodine; Fanosin; Gaster; Motiax; Pepcid; Ulcetrax 76824-35-6 ≥98% 337.45 C8H15N7O2S3 C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N Ambient Ambient Insoluble in water. Soluble in DMF. "Mohammad M, Al-Masri IM, Issa A, et al. Famotidine inhibits glycogen synthase kinase-3β: an investigation by docking simulation and experimental validation. J Enzyme Inhib Med Chem. 2013 Aug;28(4):690-4. PMID: 22512725.

 

Mozdarani H, Nasirian B, Haeri SA. In vivo gamma-rays induced initial DNA damage and the effect of famotidine in mouse leukocytes as assayed by the alkaline comet assay. J Radiat Res. 2007 Mar;48(2):129-34. PMID: 17299251.

" Not dangerous goods.

LKT F0150 Famotidine 1 g 92.5 Histamine H2 antagonist, GSK-3β inhibitor. 3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]- methyl]thio-N-(aminosulfonyl)propanimidamide Amfamox; Dispromil; Famodine; Fanosin; Gaster; Motiax; Pepcid; Ulcetrax 76824-35-6 ≥98% 337.45 C8H15N7O2S3 C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N Ambient Ambient Insoluble in water. Soluble in DMF. "Mohammad M, Al-Masri IM, Issa A, et al. Famotidine inhibits glycogen synthase kinase-3β: an investigation by docking simulation and experimental validation. J Enzyme Inhib Med Chem. 2013 Aug;28(4):690-4. PMID: 22512725.

 

Mozdarani H, Nasirian B, Haeri SA. In vivo gamma-rays induced initial DNA damage and the effect of famotidine in mouse leukocytes as assayed by the alkaline comet assay. J Radiat Res. 2007 Mar;48(2):129-34. PMID: 17299251.

" Not dangerous goods.

LKT F0150 Famotidine 5 g 335.1 Histamine H2 antagonist, GSK-3β inhibitor. 3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]- methyl]thio-N-(aminosulfonyl)propanimidamide Amfamox; Dispromil; Famodine; Fanosin; Gaster; Motiax; Pepcid; Ulcetrax 76824-35-6 ≥98% 337.45 C8H15N7O2S3 C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N Ambient Ambient Insoluble in water. Soluble in DMF. "Mohammad M, Al-Masri IM, Issa A, et al. Famotidine inhibits glycogen synthase kinase-3β: an investigation by docking simulation and experimental validation. J Enzyme Inhib Med Chem. 2013 Aug;28(4):690-4. PMID: 22512725.

 

Mozdarani H, Nasirian B, Haeri SA. In vivo gamma-rays induced initial DNA damage and the effect of famotidine in mouse leukocytes as assayed by the alkaline comet assay. J Radiat Res. 2007 Mar;48(2):129-34. PMID: 17299251.

" Not dangerous goods.

LKT F0268 Farnesol 50 ml 138.1 Sesquiterpene alcohol found in various essential oils. 3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol 4602-84-0 ≥97% 222.37 C15H26O CC(=CCCC(=CCCC(=CCO)C)C)C Ambient Ambient Insoluble in water. "Wang X, Wang YZ, Zhou Y, et al. Farnesol induces apoptosis-like cell death in the pathogenic fungus Aspergillus flavus. Mycologia. 2014 Jun 3. [Epub ahead of print]. PMID: 24895430.

 

Zhu J, Krom BP, Sanglard D, et al. Farnesol-induced apoptosis in Candida albicans is mediated by Cdr1-p extrusion and depletion of intracellular glutathione. PLoS One. 2011;6(12):e28830. PMID: 22205973.

 

Chaudhary SC, Alam MS, Siddiqui MS, et al. Chemopreventive effect of farnesol on DMBA/TPA-induced skin tumorigenesis: involvement of inflammation, Ras-ERK pathway and apoptosis. Life Sci. 2009 Jul 31;85(5-6):196-205. PMID: 19470390.

 

Wiseman DA, Werner SR, Crowell PL. Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21(Cip1) and p27(Kip1) in human pancreatic adenocarcinoma cells. J Pharmacol Exp Ther. 2007 Mar;320(3):1163-70. PMID: 17138864.

" Xn, Xi, T Not dangerous goods.

LKT F0268 Farnesol 100 ml 223.4 Sesquiterpene alcohol found in various essential oils. 3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol 4602-84-0 ≥97% 222.37 C15H26O CC(=CCCC(=CCCC(=CCO)C)C)C Ambient Ambient Insoluble in water. "Wang X, Wang YZ, Zhou Y, et al. Farnesol induces apoptosis-like cell death in the pathogenic fungus Aspergillus flavus. Mycologia. 2014 Jun 3. [Epub ahead of print]. PMID: 24895430.

 

Zhu J, Krom BP, Sanglard D, et al. Farnesol-induced apoptosis in Candida albicans is mediated by Cdr1-p extrusion and depletion of intracellular glutathione. PLoS One. 2011;6(12):e28830. PMID: 22205973.

 

Chaudhary SC, Alam MS, Siddiqui MS, et al. Chemopreventive effect of farnesol on DMBA/TPA-induced skin tumorigenesis: involvement of inflammation, Ras-ERK pathway and apoptosis. Life Sci. 2009 Jul 31;85(5-6):196-205. PMID: 19470390.

 

Wiseman DA, Werner SR, Crowell PL. Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21(Cip1) and p27(Kip1) in human pancreatic adenocarcinoma cells. J Pharmacol Exp Ther. 2007 Mar;320(3):1163-70. PMID: 17138864.

" Xn, Xi, T Not dangerous goods.

LKT F0275 Fasudil Hydrochloride 100 mg 108.9 ROCK inhibitor. 105628-07-7 ≥98% 327.83 C14H17N3O2S HCl C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3.Cl Ambient Ambient "Peng C, Gu P, Zhou J, et al. Inhibition of rho-kinase by fasudil suppresses formation and progression of experimental abdominal aortic aneurysms. PLoS One. 2013 Nov 14;8(11):e80145. PMID: 24244631.

 

Takata M, Tanaka H, Kimura M, et al. Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis. Br J Pharmacol. 2013 Sep;170(2):341-51.PMID: 23763343.

 

Matoba K, Kawanami D, Okada R, et al. Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α. Kidney Int. 2013 Sep;84(3):545-54. PMID: 23615507.

 

Jiang ZH, Zhang TT, Zhang JF. Protective effects of fasudil hydrochloride post-conditioning on acute myocardial ischemia/reperfusion injury in rats. Cardiol J. 2013;20(2):197-202. PMID: 23558879.

 

Hou SW, Liu CY, Li YH, et al. Fasudil ameliorates disease progression in experimental autoimmune encephalomyelitis, acting possibly through antiinflammatory effect. CNS Neurosci Ther. 2012 Nov;18(11):909-17. PMID: 22994384.

 

Ishiguro M, Kawasaki K, Suzuki Y, et al. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator. Neuroscience. 2012 Sep 18;220:302-12. PMID: 22710066.

 

Raja SG. Evaluation of clinical efficacy of fasudil for the treatment of pulmonary arterial hypertension. Recent Pat Cardiovasc Drug Discov. 2012 Aug;7(2):100-4. PMID: 22670803.

 

Wang N, Guan P, Zhang JP, et al. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways. J Cell Biochem. 2011 Jul;112(7):1920-9. PMID: 21433064.

" Not dangerous goods.

LKT F0275 Fasudil Hydrochloride 250 mg 167.4 ROCK inhibitor. 105628-07-7 ≥98% 327.83 C14H17N3O2S HCl C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3.Cl Ambient Ambient "Peng C, Gu P, Zhou J, et al. Inhibition of rho-kinase by fasudil suppresses formation and progression of experimental abdominal aortic aneurysms. PLoS One. 2013 Nov 14;8(11):e80145. PMID: 24244631.

 

Takata M, Tanaka H, Kimura M, et al. Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis. Br J Pharmacol. 2013 Sep;170(2):341-51.PMID: 23763343.

 

Matoba K, Kawanami D, Okada R, et al. Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α. Kidney Int. 2013 Sep;84(3):545-54. PMID: 23615507.

 

Jiang ZH, Zhang TT, Zhang JF. Protective effects of fasudil hydrochloride post-conditioning on acute myocardial ischemia/reperfusion injury in rats. Cardiol J. 2013;20(2):197-202. PMID: 23558879.

 

Hou SW, Liu CY, Li YH, et al. Fasudil ameliorates disease progression in experimental autoimmune encephalomyelitis, acting possibly through antiinflammatory effect. CNS Neurosci Ther. 2012 Nov;18(11):909-17. PMID: 22994384.

 

Ishiguro M, Kawasaki K, Suzuki Y, et al. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator. Neuroscience. 2012 Sep 18;220:302-12. PMID: 22710066.

 

Raja SG. Evaluation of clinical efficacy of fasudil for the treatment of pulmonary arterial hypertension. Recent Pat Cardiovasc Drug Discov. 2012 Aug;7(2):100-4. PMID: 22670803.

 

Wang N, Guan P, Zhang JP, et al. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways. J Cell Biochem. 2011 Jul;112(7):1920-9. PMID: 21433064.

" Not dangerous goods.

LKT F0275 Fasudil Hydrochloride 1 g 502.3 ROCK inhibitor. 105628-07-7 ≥98% 327.83 C14H17N3O2S HCl C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3.Cl Ambient Ambient "Peng C, Gu P, Zhou J, et al. Inhibition of rho-kinase by fasudil suppresses formation and progression of experimental abdominal aortic aneurysms. PLoS One. 2013 Nov 14;8(11):e80145. PMID: 24244631.

 

Takata M, Tanaka H, Kimura M, et al. Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis. Br J Pharmacol. 2013 Sep;170(2):341-51.PMID: 23763343.

 

Matoba K, Kawanami D, Okada R, et al. Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α. Kidney Int. 2013 Sep;84(3):545-54. PMID: 23615507.

 

Jiang ZH, Zhang TT, Zhang JF. Protective effects of fasudil hydrochloride post-conditioning on acute myocardial ischemia/reperfusion injury in rats. Cardiol J. 2013;20(2):197-202. PMID: 23558879.

 

Hou SW, Liu CY, Li YH, et al. Fasudil ameliorates disease progression in experimental autoimmune encephalomyelitis, acting possibly through antiinflammatory effect. CNS Neurosci Ther. 2012 Nov;18(11):909-17. PMID: 22994384.

 

Ishiguro M, Kawasaki K, Suzuki Y, et al. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator. Neuroscience. 2012 Sep 18;220:302-12. PMID: 22710066.

 

Raja SG. Evaluation of clinical efficacy of fasudil for the treatment of pulmonary arterial hypertension. Recent Pat Cardiovasc Drug Discov. 2012 Aug;7(2):100-4. PMID: 22670803.

 

Wang N, Guan P, Zhang JP, et al. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways. J Cell Biochem. 2011 Jul;112(7):1920-9. PMID: 21433064.

" Not dangerous goods.

LKT F1650 Fenbendazole 5 g 40.7 Benzimidazole; microtubule polymerization inhibitor. [5-(Phenylthio)-1H-benzimidazol-2-yl]carbamic acid methyl ester HOE-881v; Panacur; SafeGard 43210-67-9 ≥98% 299.35 C15H13N3O2S COC(=O)NC1=NC2=C(N1)C=C(C=C2)SC3=CC=CC=C3 Ambient Ambient Insoluble in water. Slightly soluble in most organic solvents.  Soluble in DMSO. "Küster T, Stadelmann B, Aeschbacher D, et al. Activities of fenbendazole in comparison with albendazole against Echinococcus multilocularis metacestodes in vitro and in a murine infection model. Int J Antimicrob Agents. 2014 Apr;43(4):335-42. PMID: 24646943.

 

Lubega GW, Prichard RK. Specific interaction of benzimidazole anthelmintics with tubulin: high-affinity binding and benzimidazole resistance in Haemonchus contortus. Mol Biochem Parasitol. 1990 Jan 15;38(2):221-32. PMID: 2325707.

 

Prichard RK. Anthelmintics for cattle. Vet Clin North Am Food Anim Pract. 1986 Jul;2(2):489-501. PMID: 3488116.

" None Not dangerous goods.

LKT F1650 Fenbendazole 10 g 61.1 Benzimidazole; microtubule polymerization inhibitor. [5-(Phenylthio)-1H-benzimidazol-2-yl]carbamic acid methyl ester HOE-881v; Panacur; SafeGard 43210-67-9 ≥98% 299.35 C15H13N3O2S COC(=O)NC1=NC2=C(N1)C=C(C=C2)SC3=CC=CC=C3 Ambient Ambient Insoluble in water. Slightly soluble in most organic solvents.  Soluble in DMSO. "Küster T, Stadelmann B, Aeschbacher D, et al. Activities of fenbendazole in comparison with albendazole against Echinococcus multilocularis metacestodes in vitro and in a murine infection model. Int J Antimicrob Agents. 2014 Apr;43(4):335-42. PMID: 24646943.

 

Lubega GW, Prichard RK. Specific interaction of benzimidazole anthelmintics with tubulin: high-affinity binding and benzimidazole resistance in Haemonchus contortus. Mol Biochem Parasitol. 1990 Jan 15;38(2):221-32. PMID: 2325707.

 

Prichard RK. Anthelmintics for cattle. Vet Clin North Am Food Anim Pract. 1986 Jul;2(2):489-501. PMID: 3488116.

" None Not dangerous goods.

LKT F1650 Fenbendazole 100 g 339.8 Benzimidazole; microtubule polymerization inhibitor. [5-(Phenylthio)-1H-benzimidazol-2-yl]carbamic acid methyl ester HOE-881v; Panacur; SafeGard 43210-67-9 ≥98% 299.35 C15H13N3O2S COC(=O)NC1=NC2=C(N1)C=C(C=C2)SC3=CC=CC=C3 Ambient Ambient Insoluble in water. Slightly soluble in most organic solvents.  Soluble in DMSO. "Küster T, Stadelmann B, Aeschbacher D, et al. Activities of fenbendazole in comparison with albendazole against Echinococcus multilocularis metacestodes in vitro and in a murine infection model. Int J Antimicrob Agents. 2014 Apr;43(4):335-42. PMID: 24646943.

 

Lubega GW, Prichard RK. Specific interaction of benzimidazole anthelmintics with tubulin: high-affinity binding and benzimidazole resistance in Haemonchus contortus. Mol Biochem Parasitol. 1990 Jan 15;38(2):221-32. PMID: 2325707.

 

Prichard RK. Anthelmintics for cattle. Vet Clin North Am Food Anim Pract. 1986 Jul;2(2):489-501. PMID: 3488116.

" None Not dangerous goods.

LKT F1652 Fenbufen 1 g 40.7 NSAID; COX-1/2 inhibitor. γ-Oxo-[1,1'-biphenyl]-4-butanoic acid Bufemid; Cinopol; Lederfen 36330-85-5 ≥98% 254.28 C16H14O3 C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)CCC(=O)O Ambient Ambient Soluble in dimethyl sulfoxide. "Moore RA, Derry S, McQuay HJ. Single dose oral fenbufen for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007547. PMID: 19821427.

 

Costa D, Moutinho L, Lima JL, et al. Antioxidant activity and inhibition of human neutrophil oxidative burst mediated by arylpropionic acid non-steroidal anti-inflammatory drugs. Biol Pharm Bull. 2006 Aug;29(8):1659-70. PMID: 16880623.

" T "UN number: 2811     Class: 6.1     Packing Group: III

Proper shipping name: Toxic solid, organic, n.o.s. (Fenbufen)"

LKT F1652 Fenbufen 5 g 88.3 NSAID; COX-1/2 inhibitor. γ-Oxo-[1,1'-biphenyl]-4-butanoic acid Bufemid; Cinopol; Lederfen 36330-85-5 ≥98% 254.28 C16H14O3 C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)CCC(=O)O Ambient Ambient Soluble in dimethyl sulfoxide. "Moore RA, Derry S, McQuay HJ. Single dose oral fenbufen for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007547. PMID: 19821427.

 

Costa D, Moutinho L, Lima JL, et al. Antioxidant activity and inhibition of human neutrophil oxidative burst mediated by arylpropionic acid non-steroidal anti-inflammatory drugs. Biol Pharm Bull. 2006 Aug;29(8):1659-70. PMID: 16880623.

" T "UN number: 2811     Class: 6.1     Packing Group: III

Proper shipping name: Toxic solid, organic, n.o.s. (Fenbufen)"

LKT F1652 Fenbufen 10 g 136 NSAID; COX-1/2 inhibitor. γ-Oxo-[1,1'-biphenyl]-4-butanoic acid Bufemid; Cinopol; Lederfen 36330-85-5 ≥98% 254.28 C16H14O3 C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)CCC(=O)O Ambient Ambient Soluble in dimethyl sulfoxide. "Moore RA, Derry S, McQuay HJ. Single dose oral fenbufen for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007547. PMID: 19821427.

 

Costa D, Moutinho L, Lima JL, et al. Antioxidant activity and inhibition of human neutrophil oxidative burst mediated by arylpropionic acid non-steroidal anti-inflammatory drugs. Biol Pharm Bull. 2006 Aug;29(8):1659-70. PMID: 16880623.

" T "UN number: 2811     Class: 6.1     Packing Group: III

Proper shipping name: Toxic solid, organic, n.o.s. (Fenbufen)"

LKT F1654 Fenoldopam Mesylate 25 mg 96.7 Benzazepine derivative; D1 partial agonist, potential α1-adrenergic antagonist. 6-Chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H- 3-benzazepine-7,8-diol methanesulfonate Fenoldopam methanesulfonate; Corlopam 67227-57-0 ≥98% 401.87 C16H16ClNO3S CS(=O)(=O)O.C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O Ambient Ambient Soluble in water.  DMSO 15 mg/mL. "Grider JS, Ott CE, Jackson BA. Dopamine D1 receptor-dependent inhibition of NaCl transport in the rat thick ascending limb: mechanism of action. Eur J Pharmacol. 2003 Jul 25;473(2-3):185-90. PMID: 12892837.

 

Schafer JA, Li L, Sun D. The collecting duct, dopamine and vasopressin-dependent hypertension. Acta Physiol Scand. 2000 Jan;168(1):239-44. PMID: 10691807.

 

Martin SW, Broadley KJ. Renal vasodilatation by dopexamine and fenoldopam due to alpha 1-adrenoceptor blockade. Br J Pharmacol. 1995 May;115(2):349-55. PMID: 7670737.

 

Grenader A, Healy DP. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells. J Pharmacol Exp Ther. 1991 Jul 1;258(1):193-8. PMID: 1677038.

 

Nichols AJ, Ruffolo RR Jr, Brooks DP. The pharmacology of fenoldopam. Am J Hypertens. 1990 Jun;3(6 Pt 2):116S-119S. PMID: 1974439.

" Xi, Xn Not dangerous goods.

LKT F1654 Fenoldopam Mesylate 100 mg 305 Benzazepine derivative; D1 partial agonist, potential α1-adrenergic antagonist. 6-Chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H- 3-benzazepine-7,8-diol methanesulfonate Fenoldopam methanesulfonate; Corlopam 67227-57-0 ≥98% 401.87 C16H16ClNO3S CS(=O)(=O)O.C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O Ambient Ambient Soluble in water.  DMSO 15 mg/mL. "Grider JS, Ott CE, Jackson BA. Dopamine D1 receptor-dependent inhibition of NaCl transport in the rat thick ascending limb: mechanism of action. Eur J Pharmacol. 2003 Jul 25;473(2-3):185-90. PMID: 12892837.

 

Schafer JA, Li L, Sun D. The collecting duct, dopamine and vasopressin-dependent hypertension. Acta Physiol Scand. 2000 Jan;168(1):239-44. PMID: 10691807.

 

Martin SW, Broadley KJ. Renal vasodilatation by dopexamine and fenoldopam due to alpha 1-adrenoceptor blockade. Br J Pharmacol. 1995 May;115(2):349-55. PMID: 7670737.

 

Grenader A, Healy DP. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells. J Pharmacol Exp Ther. 1991 Jul 1;258(1):193-8. PMID: 1677038.

 

Nichols AJ, Ruffolo RR Jr, Brooks DP. The pharmacology of fenoldopam. Am J Hypertens. 1990 Jun;3(6 Pt 2):116S-119S. PMID: 1974439.

" Xi, Xn Not dangerous goods.

LKT F1654 Fenoldopam Mesylate 500 mg 1143.8 Benzazepine derivative; D1 partial agonist, potential α1-adrenergic antagonist. 6-Chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H- 3-benzazepine-7,8-diol methanesulfonate Fenoldopam methanesulfonate; Corlopam 67227-57-0 ≥98% 401.87 C16H16ClNO3S CS(=O)(=O)O.C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O Ambient Ambient Soluble in water.  DMSO 15 mg/mL. "Grider JS, Ott CE, Jackson BA. Dopamine D1 receptor-dependent inhibition of NaCl transport in the rat thick ascending limb: mechanism of action. Eur J Pharmacol. 2003 Jul 25;473(2-3):185-90. PMID: 12892837.

 

Schafer JA, Li L, Sun D. The collecting duct, dopamine and vasopressin-dependent hypertension. Acta Physiol Scand. 2000 Jan;168(1):239-44. PMID: 10691807.

 

Martin SW, Broadley KJ. Renal vasodilatation by dopexamine and fenoldopam due to alpha 1-adrenoceptor blockade. Br J Pharmacol. 1995 May;115(2):349-55. PMID: 7670737.

 

Grenader A, Healy DP. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells. J Pharmacol Exp Ther. 1991 Jul 1;258(1):193-8. PMID: 1677038.

 

Nichols AJ, Ruffolo RR Jr, Brooks DP. The pharmacology of fenoldopam. Am J Hypertens. 1990 Jun;3(6 Pt 2):116S-119S. PMID: 1974439.

" Xi, Xn Not dangerous goods.

LKT F1655 Fenoprofen Calcium Dihydrate 1 g 33.9 NSAID; COX-1/2 inhibitor. α-Methyl-3-phenoxybenzeneacetic acid Lilly 53838 53746-45-5 ≥97% 558.64 2C30H24O6 Ca 2H2O CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].O.O.[Ca+2] Ambient Ambient "Barissa GR, Poggi JC, Donadi EA, et al. Influence of rheumatoid arthritis in the enantioselective disposition of fenoprofen. Chirality. 2004 Nov;16(9):602-8. PMID: 15390088.

 

De Craemer D, Van den Branden C, Pauwels M, et al. Peroxisome-proliferating effects of fenoprofen in mice. Lipids. 1998 May;33(5):539-43. PMID: 9625603.

" Xn Not dangerous goods.

LKT F1655 Fenoprofen Calcium Dihydrate 5 g 61.1 NSAID; COX-1/2 inhibitor. α-Methyl-3-phenoxybenzeneacetic acid Lilly 53838 53746-45-5 ≥97% 558.64 2C30H24O6 Ca 2H2O CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].O.O.[Ca+2] Ambient Ambient "Barissa GR, Poggi JC, Donadi EA, et al. Influence of rheumatoid arthritis in the enantioselective disposition of fenoprofen. Chirality. 2004 Nov;16(9):602-8. PMID: 15390088.

 

De Craemer D, Van den Branden C, Pauwels M, et al. Peroxisome-proliferating effects of fenoprofen in mice. Lipids. 1998 May;33(5):539-43. PMID: 9625603.

" Xn Not dangerous goods.

LKT F1655 Fenoprofen Calcium Dihydrate 10 g 106.1 NSAID; COX-1/2 inhibitor. α-Methyl-3-phenoxybenzeneacetic acid Lilly 53838 53746-45-5 ≥97% 558.64 2C30H24O6 Ca 2H2O CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].O.O.[Ca+2] Ambient Ambient "Barissa GR, Poggi JC, Donadi EA, et al. Influence of rheumatoid arthritis in the enantioselective disposition of fenoprofen. Chirality. 2004 Nov;16(9):602-8. PMID: 15390088.

 

De Craemer D, Van den Branden C, Pauwels M, et al. Peroxisome-proliferating effects of fenoprofen in mice. Lipids. 1998 May;33(5):539-43. PMID: 9625603.

" Xn Not dangerous goods.

LKT F1745 Felodipine 50 mg 93.8 Dihydropyridine; L-type Ca2+ channel blocker. Flodil, Munobal, Penedil, Perfudal, Plendil 72509-76-3 ≥98% 384.25 C18H19Cl2NO4 CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C Ambient Ambient "Tan HW, Xing SS, Bi XP, et al. Felodipine attenuates vascular inflammation in a fructose-induced rat model of metabolic syndrome via the inhibition of NF-kappaB activation. Acta Pharmacol Sin. 2008 Sep;29(9):1051-9. PMID: 18718174.

 

Kal JE, Spaan JA, van Wezel HB. Calcium channel blockade with felodipine does not affect metabolic coronary vasodilation in patients with coronary artery disease. J Cardiovasc Pharmacol. 2002 Feb;39(2):225-33. PMID: 11791008.

 

Koseki N, Deguchi J, Yamashita A, et al. Establishment fo a novel experimental protocol for drug-induced seizure liability screening based on a locomotor activity assay in zebrafish. J Toxicol Sci. 2014 Aug;39(4):579-600. PMID: 25056783.

" Xn Not dangerous goods.

LKT F1745 Felodipine 100 mg 149.9 Dihydropyridine; L-type Ca2+ channel blocker. Flodil, Munobal, Penedil, Perfudal, Plendil 72509-76-3 ≥98% 384.25 C18H19Cl2NO4 CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C Ambient Ambient "Tan HW, Xing SS, Bi XP, et al. Felodipine attenuates vascular inflammation in a fructose-induced rat model of metabolic syndrome via the inhibition of NF-kappaB activation. Acta Pharmacol Sin. 2008 Sep;29(9):1051-9. PMID: 18718174.

 

Kal JE, Spaan JA, van Wezel HB. Calcium channel blockade with felodipine does not affect metabolic coronary vasodilation in patients with coronary artery disease. J Cardiovasc Pharmacol. 2002 Feb;39(2):225-33. PMID: 11791008.

 

Koseki N, Deguchi J, Yamashita A, et al. Establishment fo a novel experimental protocol for drug-induced seizure liability screening based on a locomotor activity assay in zebrafish. J Toxicol Sci. 2014 Aug;39(4):579-600. PMID: 25056783.

" Xn Not dangerous goods.

LKT F1745 Felodipine 250 mg 281.2 Dihydropyridine; L-type Ca2+ channel blocker. Flodil, Munobal, Penedil, Perfudal, Plendil 72509-76-3 ≥98% 384.25 C18H19Cl2NO4 CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C Ambient Ambient "Tan HW, Xing SS, Bi XP, et al. Felodipine attenuates vascular inflammation in a fructose-induced rat model of metabolic syndrome via the inhibition of NF-kappaB activation. Acta Pharmacol Sin. 2008 Sep;29(9):1051-9. PMID: 18718174.

 

Kal JE, Spaan JA, van Wezel HB. Calcium channel blockade with felodipine does not affect metabolic coronary vasodilation in patients with coronary artery disease. J Cardiovasc Pharmacol. 2002 Feb;39(2):225-33. PMID: 11791008.

 

Koseki N, Deguchi J, Yamashita A, et al. Establishment fo a novel experimental protocol for drug-induced seizure liability screening based on a locomotor activity assay in zebrafish. J Toxicol Sci. 2014 Aug;39(4):579-600. PMID: 25056783.

" Xn Not dangerous goods.

LKT F1853 Fenofibrate 5 g 46.7 Fibrate; PPARα agonist. 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid 1-methylethyl ester Ankebin; Elasterin; Fempbrate; Lipantil; Lipoclar; Lipofene; Nolipax; Secalip; Tricor 49562-28-9 ≥98% 360.83 C20H21ClO4 CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl Ambient Ambient Soluble in acetone, ether, benzene and chloroform. Slightly soluble in methanol and ethanol. Practically insoluble in water. "Gao Y, Shen W, Zhang Q, et al. Up-regulation of Hepatic VLDLR via PPARα Is Required for the Triglyceride-Lowering Effect of Fenofibrate. J Lipid Res. 2014 Jun 4. [Epub ahead of print]. PMID: 24899625.

 

Li T, Zhang Q, Zhang J, et al. Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway. BMC Cancer. 2014 Feb 16;14:96. PMID: 24529079.

 

Xie C, Li L, Xu YP, et al. Anti-fibrosis effects of fenofibrate in mice with hepatic fibrosis. Zhonghua Gan Zang Bing Za Zhi. 2013 Dec;21(12):914-9. PMID: 24636293.

" Xn, Xi Not dangerous goods.

LKT F1853 Fenofibrate 25 g 136 Fibrate; PPARα agonist. 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid 1-methylethyl ester Ankebin; Elasterin; Fempbrate; Lipantil; Lipoclar; Lipofene; Nolipax; Secalip; Tricor 49562-28-9 ≥98% 360.83 C20H21ClO4 CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl Ambient Ambient Soluble in acetone, ether, benzene and chloroform. Slightly soluble in methanol and ethanol. Practically insoluble in water. "Gao Y, Shen W, Zhang Q, et al. Up-regulation of Hepatic VLDLR via PPARα Is Required for the Triglyceride-Lowering Effect of Fenofibrate. J Lipid Res. 2014 Jun 4. [Epub ahead of print]. PMID: 24899625.

 

Li T, Zhang Q, Zhang J, et al. Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway. BMC Cancer. 2014 Feb 16;14:96. PMID: 24529079.

 

Xie C, Li L, Xu YP, et al. Anti-fibrosis effects of fenofibrate in mice with hepatic fibrosis. Zhonghua Gan Zang Bing Za Zhi. 2013 Dec;21(12):914-9. PMID: 24636293.

" Xn, Xi Not dangerous goods.

LKT F1853 Fenofibrate 100 g 407.7 Fibrate; PPARα agonist. 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid 1-methylethyl ester Ankebin; Elasterin; Fempbrate; Lipantil; Lipoclar; Lipofene; Nolipax; Secalip; Tricor 49562-28-9 ≥98% 360.83 C20H21ClO4 CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl Ambient Ambient Soluble in acetone, ether, benzene and chloroform. Slightly soluble in methanol and ethanol. Practically insoluble in water. "Gao Y, Shen W, Zhang Q, et al. Up-regulation of Hepatic VLDLR via PPARα Is Required for the Triglyceride-Lowering Effect of Fenofibrate. J Lipid Res. 2014 Jun 4. [Epub ahead of print]. PMID: 24899625.

 

Li T, Zhang Q, Zhang J, et al. Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway. BMC Cancer. 2014 Feb 16;14:96. PMID: 24529079.

 

Xie C, Li L, Xu YP, et al. Anti-fibrosis effects of fenofibrate in mice with hepatic fibrosis. Zhonghua Gan Zang Bing Za Zhi. 2013 Dec;21(12):914-9. PMID: 24636293.

" Xn, Xi Not dangerous goods.

LKT F1854 Fenticonazole Nitrate 100 mg 50.2 Imidazole; 14-α demethylase inhibitor, potential glucosamine-6-phosphate synthase inhibitor. 73151-29-8 ≥98% 518.41 C24H20Cl2N2OS HNO3 C1=CC=C(C=C1)SC2=CC=C(C=C2)COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl.[N+](=O)(O)[O-] Ambient Ambient "Veraldi S, Milani R. Topical fenticonazole in dermatology and gynaecology: current role in therapy. Drugs. 2008;68(15):2183-94. PMID: 18840006.

 

Fernández-Alba J, Valle-Gay A, Dibildox M, et al. Fenticonazole nitrate for treatment of vulvovaginitis: efficacy, safety, and tolerability of 1-gram ovules, administered as ultra-short 2-day regimen. J Chemother. 2004 Apr;16(2):179-86. PMID: 15216954.

 

Palacín C, Tarragó C, Agut J, et al. In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates. Methods Find Exp Clin Pharmacol. 2001 Mar;23(2):61-4. PMID: 11484411.

 

Milewski S, Mignini F, Covelli I, et al. Specific inhibition of acid proteinase secretion in Candida albicans by Lys-Nva-FMDP. J Med Vet Mycol. 1994;32(1):1-11. PMID: 8207618.

 

Graziani G, Cazzulani P. Irritation and toxicity studies with fenticonazole applied topically to the skin and mucous membranes. Arzneimittelforschung. 1981;31(12):2152-4. PMID: 7199317.

" Not dangerous goods.

LKT F1854 Fenticonazole Nitrate 250 mg 80.4 Imidazole; 14-α demethylase inhibitor, potential glucosamine-6-phosphate synthase inhibitor. 73151-29-8 ≥98% 518.41 C24H20Cl2N2OS HNO3 C1=CC=C(C=C1)SC2=CC=C(C=C2)COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl.[N+](=O)(O)[O-] Ambient Ambient "Veraldi S, Milani R. Topical fenticonazole in dermatology and gynaecology: current role in therapy. Drugs. 2008;68(15):2183-94. PMID: 18840006.

 

Fernández-Alba J, Valle-Gay A, Dibildox M, et al. Fenticonazole nitrate for treatment of vulvovaginitis: efficacy, safety, and tolerability of 1-gram ovules, administered as ultra-short 2-day regimen. J Chemother. 2004 Apr;16(2):179-86. PMID: 15216954.

 

Palacín C, Tarragó C, Agut J, et al. In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates. Methods Find Exp Clin Pharmacol. 2001 Mar;23(2):61-4. PMID: 11484411.

 

Milewski S, Mignini F, Covelli I, et al. Specific inhibition of acid proteinase secretion in Candida albicans by Lys-Nva-FMDP. J Med Vet Mycol. 1994;32(1):1-11. PMID: 8207618.

 

Graziani G, Cazzulani P. Irritation and toxicity studies with fenticonazole applied topically to the skin and mucous membranes. Arzneimittelforschung. 1981;31(12):2152-4. PMID: 7199317.

" Not dangerous goods.

LKT F1854 Fenticonazole Nitrate 1 g 251.3 Imidazole; 14-α demethylase inhibitor, potential glucosamine-6-phosphate synthase inhibitor. 73151-29-8 ≥98% 518.41 C24H20Cl2N2OS HNO3 C1=CC=C(C=C1)SC2=CC=C(C=C2)COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl.[N+](=O)(O)[O-] Ambient Ambient "Veraldi S, Milani R. Topical fenticonazole in dermatology and gynaecology: current role in therapy. Drugs. 2008;68(15):2183-94. PMID: 18840006.

 

Fernández-Alba J, Valle-Gay A, Dibildox M, et al. Fenticonazole nitrate for treatment of vulvovaginitis: efficacy, safety, and tolerability of 1-gram ovules, administered as ultra-short 2-day regimen. J Chemother. 2004 Apr;16(2):179-86. PMID: 15216954.

 

Palacín C, Tarragó C, Agut J, et al. In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates. Methods Find Exp Clin Pharmacol. 2001 Mar;23(2):61-4. PMID: 11484411.

 

Milewski S, Mignini F, Covelli I, et al. Specific inhibition of acid proteinase secretion in Candida albicans by Lys-Nva-FMDP. J Med Vet Mycol. 1994;32(1):1-11. PMID: 8207618.

 

Graziani G, Cazzulani P. Irritation and toxicity studies with fenticonazole applied topically to the skin and mucous membranes. Arzneimittelforschung. 1981;31(12):2152-4. PMID: 7199317.

" Not dangerous goods.

LKT F1895 Fexofenadine Hydrochloride 25 mg 75 Histamine H1 antagonist. Allegra, Telfast 153439-40-8 ≥98% 538.12 C32H40ClNO4 CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl Ambient 4°C DMSO to 50 mM, water to 2 mg/mL, ethanol to 107 mg/mL, methanol "Compalati E, Baena-Cagnani R, Penagos M, et al. Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Int Arch Allergy Immunol. 2011;156(1):1-15. PMID: 21969990.

 

Smith SM, Gums JG. Fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders. Expert Opin Drug Metab Toxicol. 2009 Jul;5(7):813-22. PMID: 19545214.

" None Not dangerous goods.

LKT F1895 Fexofenadine Hydrochloride 100 mg 187.4 Histamine H1 antagonist. Allegra, Telfast 153439-40-8 ≥98% 538.12 C32H40ClNO4 CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl Ambient 4°C DMSO to 50 mM, water to 2 mg/mL, ethanol to 107 mg/mL, methanol "Compalati E, Baena-Cagnani R, Penagos M, et al. Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Int Arch Allergy Immunol. 2011;156(1):1-15. PMID: 21969990.

 

Smith SM, Gums JG. Fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders. Expert Opin Drug Metab Toxicol. 2009 Jul;5(7):813-22. PMID: 19545214.

" None Not dangerous goods.

LKT F1895 Fexofenadine Hydrochloride 500 mg 271.8 Histamine H1 antagonist. Allegra, Telfast 153439-40-8 ≥98% 538.12 C32H40ClNO4 CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl Ambient 4°C DMSO to 50 mM, water to 2 mg/mL, ethanol to 107 mg/mL, methanol "Compalati E, Baena-Cagnani R, Penagos M, et al. Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Int Arch Allergy Immunol. 2011;156(1):1-15. PMID: 21969990.

 

Smith SM, Gums JG. Fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders. Expert Opin Drug Metab Toxicol. 2009 Jul;5(7):813-22. PMID: 19545214.

" None Not dangerous goods.

LKT F3204 Fibrinogen-binding Peptide 5 mg 101 GP IIb/IIIa analog, peptide; fibrinogen binding inhibitor. ≥98% 565.63 C25H39H7O8 Ambient -20°C Gartner TK, Loudon R, Taylor DB. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1446-52. PMID: 1953789.

LKT F3205 Fibrinogen γ-chain Dodecapeptide 1 mg 120 Platelet substitute, peptide; GP IIb/IIIa activator. Fibrinogen gamma-chain dodecapeptide ≥98% 1189.29 C50H80N18O16 Ambient -20°C "Tokutomi K, Tagawa T, Korenaga M, et al. Ability of fibrinogen γ-derived dodecapeptides with different sequences to bind to rat platelets. Int J Pharm. 2012 Nov 15;438(1-2):296-301. PMID: 22985603.

 

Nishikawa K, Hagisawa K, Kinoshita M, et al. Fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes rescue thrombocytopenic rabbits from non-compressible liver hemorrhage. J Thromb Haemost. 2012 Oct;10(10):2137-48. PMID: 22905905.

 

Okamura Y, Maekawa I, Teramura Y, et al. Hemostatic effects of phospholipid vesicles carrying fibrinogen gamma chain dodecapeptide in vitro and in vivo. Bioconjug Chem. 2005 Nov-Dec;16(6):1589-96. PMID: 16287259.

" Not dangerous goods.

LKT F3205 Fibrinogen γ-chain Dodecapeptide 2 mg 204.1 Platelet substitute, peptide; GP IIb/IIIa activator. Fibrinogen gamma-chain dodecapeptide ≥98% 1189.29 C50H80N18O16 Ambient -20°C "Tokutomi K, Tagawa T, Korenaga M, et al. Ability of fibrinogen γ-derived dodecapeptides with different sequences to bind to rat platelets. Int J Pharm. 2012 Nov 15;438(1-2):296-301. PMID: 22985603.

 

Nishikawa K, Hagisawa K, Kinoshita M, et al. Fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes rescue thrombocytopenic rabbits from non-compressible liver hemorrhage. J Thromb Haemost. 2012 Oct;10(10):2137-48. PMID: 22905905.

 

Okamura Y, Maekawa I, Teramura Y, et al. Hemostatic effects of phospholipid vesicles carrying fibrinogen gamma chain dodecapeptide in vitro and in vivo. Bioconjug Chem. 2005 Nov-Dec;16(6):1589-96. PMID: 16287259.

" Not dangerous goods.

LKT F3205 Fibrinogen γ-chain Dodecapeptide 5 mg 359.9 Platelet substitute, peptide; GP IIb/IIIa activator. Fibrinogen gamma-chain dodecapeptide ≥98% 1189.29 C50H80N18O16 Ambient -20°C "Tokutomi K, Tagawa T, Korenaga M, et al. Ability of fibrinogen γ-derived dodecapeptides with different sequences to bind to rat platelets. Int J Pharm. 2012 Nov 15;438(1-2):296-301. PMID: 22985603.

 

Nishikawa K, Hagisawa K, Kinoshita M, et al. Fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes rescue thrombocytopenic rabbits from non-compressible liver hemorrhage. J Thromb Haemost. 2012 Oct;10(10):2137-48. PMID: 22905905.

 

Okamura Y, Maekawa I, Teramura Y, et al. Hemostatic effects of phospholipid vesicles carrying fibrinogen gamma chain dodecapeptide in vitro and in vivo. Bioconjug Chem. 2005 Nov-Dec;16(6):1589-96. PMID: 16287259.

" Not dangerous goods.

LKT F3206 Fibrinolysis Inhibiting Factor 5 mg 180 Peptide; fibrinolysis inhibitor. ≥98% 425.49 C18H31N7O5 C1CC(N(C1)C(=O)CN)C(=O)NC(CCCN=C(N)N)C(=O)N2CCCC2C(=O)O Ambient -20°C Nakatsuji T. Acceleration of thrombosis and hemolysis by fibrinolysis inhibiting factor and suppression by Ia antigen expressed on T cells in partially hepatectomized Lewis rats. Int J Hematol. 1996 Oct;64(3-4):181-8. PMID: 8923779. Not dangerous goods.

LKT F3206 Fibrinolysis Inhibiting Factor 2 mg 101.9 Peptide; fibrinolysis inhibitor. ≥98% 425.49 C18H31N7O5 C1CC(N(C1)C(=O)CN)C(=O)NC(CCCN=C(N)N)C(=O)N2CCCC2C(=O)O Ambient -20°C Nakatsuji T. Acceleration of thrombosis and hemolysis by fibrinolysis inhibiting factor and suppression by Ia antigen expressed on T cells in partially hepatectomized Lewis rats. Int J Hematol. 1996 Oct;64(3-4):181-8. PMID: 8923779. Not dangerous goods.

LKT F3206 Fibrinolysis Inhibiting Factor 1 mg 60 Peptide; fibrinolysis inhibitor. ≥98% 425.49 C18H31N7O5 C1CC(N(C1)C(=O)CN)C(=O)NC(CCCN=C(N)N)C(=O)N2CCCC2C(=O)O Ambient -20°C Nakatsuji T. Acceleration of thrombosis and hemolysis by fibrinolysis inhibiting factor and suppression by Ia antigen expressed on T cells in partially hepatectomized Lewis rats. Int J Hematol. 1996 Oct;64(3-4):181-8. PMID: 8923779. Not dangerous goods.

LKT F3207 Fibronectin CS-1 Peptide 1 mg 90.1 Peptide; α4β1 integrin activator. Fibronectin CS1 ≥98% 872.97 C38H64N8O15 Ambient -20°C Soluble in water. "Kamarajan P, Garcia-Pardo A, D'Silva NJ, et al. The CS1 segment of fibronectin is involved in human OSCC pathogenesis by mediating OSCC cell spreading, migration, and invasion. BMC Cancer. 2010 Jun 25;10:330. PMID: 20579373.

 

Yakubenko VP, Lobb RR, Plow EF, et al. Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin. Exp Cell Res. 2000 Oct 10;260(1):73-84. PMID: 11010812.

 

Lehnert K, Print CG, Yang Y, et al. MAdCAM-1 costimulates T cell proliferation exclusively through integrin alpha4beta7, whereas VCAM-1 and CS-1 peptide use alpha4beta1: evidence for ""remote"" costimulation and induction of hyperresponsiveness to B7 molecules. Eur J Immunol. 1998 Nov;28(11):3605-15. PMID: 9842903.

 

Yanaka K, Camarata PJ, Spellman SR, et al. Neuronal protection from cerebral ischemia by synthetic fibronectin peptides to leukocyte adhesion molecules. J Cereb Blood Flow Metab. 1996 Nov;16(6):1120-5. PMID: 8898683.

"

LKT F3207 Fibronectin CS-1 Peptide 2 mg 153 Peptide; α4β1 integrin activator. Fibronectin CS1 ≥98% 872.97 C38H64N8O15 Ambient -20°C Soluble in water. "Kamarajan P, Garcia-Pardo A, D'Silva NJ, et al. The CS1 segment of fibronectin is involved in human OSCC pathogenesis by mediating OSCC cell spreading, migration, and invasion. BMC Cancer. 2010 Jun 25;10:330. PMID: 20579373.

 

Yakubenko VP, Lobb RR, Plow EF, et al. Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin. Exp Cell Res. 2000 Oct 10;260(1):73-84. PMID: 11010812.

 

Lehnert K, Print CG, Yang Y, et al. MAdCAM-1 costimulates T cell proliferation exclusively through integrin alpha4beta7, whereas VCAM-1 and CS-1 peptide use alpha4beta1: evidence for ""remote"" costimulation and induction of hyperresponsiveness to B7 molecules. Eur J Immunol. 1998 Nov;28(11):3605-15. PMID: 9842903.

 

Yanaka K, Camarata PJ, Spellman SR, et al. Neuronal protection from cerebral ischemia by synthetic fibronectin peptides to leukocyte adhesion molecules. J Cereb Blood Flow Metab. 1996 Nov;16(6):1120-5. PMID: 8898683.

"

LKT F3207 Fibronectin CS-1 Peptide 5 mg 270.2 Peptide; α4β1 integrin activator. Fibronectin CS1 ≥98% 872.97 C38H64N8O15 Ambient -20°C Soluble in water. "Kamarajan P, Garcia-Pardo A, D'Silva NJ, et al. The CS1 segment of fibronectin is involved in human OSCC pathogenesis by mediating OSCC cell spreading, migration, and invasion. BMC Cancer. 2010 Jun 25;10:330. PMID: 20579373.

 

Yakubenko VP, Lobb RR, Plow EF, et al. Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin. Exp Cell Res. 2000 Oct 10;260(1):73-84. PMID: 11010812.

 

Lehnert K, Print CG, Yang Y, et al. MAdCAM-1 costimulates T cell proliferation exclusively through integrin alpha4beta7, whereas VCAM-1 and CS-1 peptide use alpha4beta1: evidence for ""remote"" costimulation and induction of hyperresponsiveness to B7 molecules. Eur J Immunol. 1998 Nov;28(11):3605-15. PMID: 9842903.

 

Yanaka K, Camarata PJ, Spellman SR, et al. Neuronal protection from cerebral ischemia by synthetic fibronectin peptides to leukocyte adhesion molecules. J Cereb Blood Flow Metab. 1996 Nov;16(6):1120-5. PMID: 8898683.

"

LKT F3208 Fibrinopeptide B, human 1 mg 120 Antimicrobial peptide, generated during fibrin formation. 36204-23-6 ≥95% 1552.59 C66H93N19O25 CC(C)C(C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)CNC(=O)C3CCC(=O)N3 Ambient -20°C "Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun. 2002 Dec;70(12):6524-33. PMID: 12438321.

 

Huang Q, Teng MK, Niu LW. Purification and characterization of two fibrinogen-clotting enzymes from five-pace snake (Agkistrodon acutus) venom. Toxicon. 1999 Jul;37(7):999-1013. PMID: 10484747.

 

Pardes JB, Takagi H, Martin TA, et al. Decreased levels of alpha 1(I) procollagen mRNA in dermal fibroblasts grown on fibrin gels and in response to fibrinopeptide B. J Cell Physiol. 1995 Jan;162(1):9-14. PMID: 7814454.

" Not dangerous goods.

LKT F3208 Fibrinopeptide B, human 2 mg 204.1 Antimicrobial peptide, generated during fibrin formation. 36204-23-6 ≥95% 1552.59 C66H93N19O25 CC(C)C(C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)CNC(=O)C3CCC(=O)N3 Ambient -20°C "Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun. 2002 Dec;70(12):6524-33. PMID: 12438321.

 

Huang Q, Teng MK, Niu LW. Purification and characterization of two fibrinogen-clotting enzymes from five-pace snake (Agkistrodon acutus) venom. Toxicon. 1999 Jul;37(7):999-1013. PMID: 10484747.

 

Pardes JB, Takagi H, Martin TA, et al. Decreased levels of alpha 1(I) procollagen mRNA in dermal fibroblasts grown on fibrin gels and in response to fibrinopeptide B. J Cell Physiol. 1995 Jan;162(1):9-14. PMID: 7814454.

" Not dangerous goods.

LKT F3208 Fibrinopeptide B, human 5 mg 359.9 Antimicrobial peptide, generated during fibrin formation. 36204-23-6 ≥95% 1552.59 C66H93N19O25 CC(C)C(C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)CNC(=O)C3CCC(=O)N3 Ambient -20°C "Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun. 2002 Dec;70(12):6524-33. PMID: 12438321.

 

Huang Q, Teng MK, Niu LW. Purification and characterization of two fibrinogen-clotting enzymes from five-pace snake (Agkistrodon acutus) venom. Toxicon. 1999 Jul;37(7):999-1013. PMID: 10484747.

 

Pardes JB, Takagi H, Martin TA, et al. Decreased levels of alpha 1(I) procollagen mRNA in dermal fibroblasts grown on fibrin gels and in response to fibrinopeptide B. J Cell Physiol. 1995 Jan;162(1):9-14. PMID: 7814454.

" Not dangerous goods.

LKT F3209 Fibronectin-Binding Protein 2.5 mg 612.4 Peptide, binds fibronectin. 119977-20-7 ≥95% 4309.66 C190H283N49O66 Ambient -20°C Reginald K, Westritschnig K, Linhart B, et al. Staphylococcus aureus fibronectin-binding protein specifically binds IgE from patients with atopic dermatitis and requires antigen presentation for cellular immune responses. J Allergy Clin Immunol. 2011 Jul;128(1):82-91.e8. PMID: 21513970.

LKT F3209 Fibronectin-Binding Protein 1 mg 348 Peptide, binds fibronectin. 119977-20-7 ≥95% 4309.66 C190H283N49O66 Ambient -20°C Reginald K, Westritschnig K, Linhart B, et al. Staphylococcus aureus fibronectin-binding protein specifically binds IgE from patients with atopic dermatitis and requires antigen presentation for cellular immune responses. J Allergy Clin Immunol. 2011 Jul;128(1):82-91.e8. PMID: 21513970.

LKT F3209 Fibronectin-Binding Protein 0.5 mg 204.1 Peptide, binds fibronectin. 119977-20-7 ≥95% 4309.66 C190H283N49O66 Ambient -20°C Reginald K, Westritschnig K, Linhart B, et al. Staphylococcus aureus fibronectin-binding protein specifically binds IgE from patients with atopic dermatitis and requires antigen presentation for cellular immune responses. J Allergy Clin Immunol. 2011 Jul;128(1):82-91.e8. PMID: 21513970.

LKT F3354 Finasteride 100 mg 94.4 Steroid 5-α-reductase inhibitor. (5α,17β)-N-(1,1-Dimethylethyl)-3-oxo-4-azaandrost- 1-ene-17-carboxamide Finastid; Propecia; Proscar; Prostide 98319-26-7 ≥98% 372.54 C23H36N2O2 CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C Ambient Ambient Soluble in chloroform. DMSO, ethanol and methanol. Slighly soluble in water. "Chavez-Dozal AA, Lown L, Jahng M, et al. An in vitro analysis of finasteride activity against Candida albicans urinary biofilm formation and filamentation. Antimicrob Agents Chemother. 2014 Jul 21. [Epub ahead of print]. PMID: 25049253.

 

Masoodi KZ, Ramos Garcia R, Pascal LE, et al. 5α-reductase inhibition suppresses testosterone-induced initial regrowth of regressed xenograft prostate tumors in animal models. Endocrinology. 2013 Jul;154(7):2296-307. PMID: 23671262.

 

Zager MG, Barton HA. A multiscale, mechanism-driven, dynamic model for the effects of 5α-reductase inhibition on prostate maintenance. PLoS One. 2012;7(9):e44359. PMID: 22970204.

" Xn Not dangerous goods.

LKT F3354 Finasteride 500 mg 352.4 Steroid 5-α-reductase inhibitor. (5α,17β)-N-(1,1-Dimethylethyl)-3-oxo-4-azaandrost- 1-ene-17-carboxamide Finastid; Propecia; Proscar; Prostide 98319-26-7 ≥98% 372.54 C23H36N2O2 CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C Ambient Ambient Soluble in chloroform. DMSO, ethanol and methanol. Slighly soluble in water. "Chavez-Dozal AA, Lown L, Jahng M, et al. An in vitro analysis of finasteride activity against Candida albicans urinary biofilm formation and filamentation. Antimicrob Agents Chemother. 2014 Jul 21. [Epub ahead of print]. PMID: 25049253.

 

Masoodi KZ, Ramos Garcia R, Pascal LE, et al. 5α-reductase inhibition suppresses testosterone-induced initial regrowth of regressed xenograft prostate tumors in animal models. Endocrinology. 2013 Jul;154(7):2296-307. PMID: 23671262.

 

Zager MG, Barton HA. A multiscale, mechanism-driven, dynamic model for the effects of 5α-reductase inhibition on prostate maintenance. PLoS One. 2012;7(9):e44359. PMID: 22970204.

" Xn Not dangerous goods.

LKT F3454 Fingolimod Hydrochloride 10 mg 115.3 Sphingosine 1-phosphate antagonist. 2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride 162359-56-0 ≥98% 343.93 C19H32NO2 HCl CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl Ambient Ambient "Li MH, Hla T, Ferrer F. FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway. Pediatr Blood Cancer. 2013 Sep;60(9):1418-23. PMID: 23704073.

 

Takasugi N, Sasaki T, Ebinuma I, et al. FTY720/fingolimod, a sphingosine analogue, reduces amyloid-β production in neurons. PLoS One. 2013 May 7;8(5):e64050. PMID: 23667698.

 

Groves A, Kihara Y, Chun J. Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy. J Neurol Sci. 2013 May 15;328(1-2):9-18. PMID: 23518370.

 

Willis MA, Cohen JA. Fingolimod therapy for multiple sclerosis. Semin Neurol. 2013 Feb;33(1):37-44. PMID: 23709211.

 

Liu Y, Jiang J, Xiao H, et al. The sphingosine-1-phosphate receptor agonist FTY720 and its phosphorylated form affect the function of CD4+CD25+ T cells in vitro. Int J Mol Med. 2012 Jul;30(1):211-9. PMID: 22576630.

 

Spijkers LJ, Alewijnse AE, Peters SL. FTY720 (fingolimod) increases vascular tone and blood pressure in spontaneously hypertensive rats via inhibition of sphingosine kinase. Br J Pharmacol. 2012 Jun;166(4):1411-8. PMID: 22251137.

" Not dangerous goods.

LKT F3454 Fingolimod Hydrochloride 25 mg 254.8 Sphingosine 1-phosphate antagonist. 2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride 162359-56-0 ≥98% 343.93 C19H32NO2 HCl CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl Ambient Ambient "Li MH, Hla T, Ferrer F. FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway. Pediatr Blood Cancer. 2013 Sep;60(9):1418-23. PMID: 23704073.

 

Takasugi N, Sasaki T, Ebinuma I, et al. FTY720/fingolimod, a sphingosine analogue, reduces amyloid-β production in neurons. PLoS One. 2013 May 7;8(5):e64050. PMID: 23667698.

 

Groves A, Kihara Y, Chun J. Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy. J Neurol Sci. 2013 May 15;328(1-2):9-18. PMID: 23518370.

 

Willis MA, Cohen JA. Fingolimod therapy for multiple sclerosis. Semin Neurol. 2013 Feb;33(1):37-44. PMID: 23709211.

 

Liu Y, Jiang J, Xiao H, et al. The sphingosine-1-phosphate receptor agonist FTY720 and its phosphorylated form affect the function of CD4+CD25+ T cells in vitro. Int J Mol Med. 2012 Jul;30(1):211-9. PMID: 22576630.

 

Spijkers LJ, Alewijnse AE, Peters SL. FTY720 (fingolimod) increases vascular tone and blood pressure in spontaneously hypertensive rats via inhibition of sphingosine kinase. Br J Pharmacol. 2012 Jun;166(4):1411-8. PMID: 22251137.

" Not dangerous goods.

LKT F3454 Fingolimod Hydrochloride 100 mg 740.1 Sphingosine 1-phosphate antagonist. 2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride 162359-56-0 ≥98% 343.93 C19H32NO2 HCl CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl Ambient Ambient "Li MH, Hla T, Ferrer F. FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway. Pediatr Blood Cancer. 2013 Sep;60(9):1418-23. PMID: 23704073.

 

Takasugi N, Sasaki T, Ebinuma I, et al. FTY720/fingolimod, a sphingosine analogue, reduces amyloid-β production in neurons. PLoS One. 2013 May 7;8(5):e64050. PMID: 23667698.

 

Groves A, Kihara Y, Chun J. Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy. J Neurol Sci. 2013 May 15;328(1-2):9-18. PMID: 23518370.

 

Willis MA, Cohen JA. Fingolimod therapy for multiple sclerosis. Semin Neurol. 2013 Feb;33(1):37-44. PMID: 23709211.

 

Liu Y, Jiang J, Xiao H, et al. The sphingosine-1-phosphate receptor agonist FTY720 and its phosphorylated form affect the function of CD4+CD25+ T cells in vitro. Int J Mol Med. 2012 Jul;30(1):211-9. PMID: 22576630.

 

Spijkers LJ, Alewijnse AE, Peters SL. FTY720 (fingolimod) increases vascular tone and blood pressure in spontaneously hypertensive rats via inhibition of sphingosine kinase. Br J Pharmacol. 2012 Jun;166(4):1411-8. PMID: 22251137.

" Not dangerous goods.

LKT F3473 Fisetin 100 mg 67 Flavonoid found in various plant sources; matrix metalloproteinase inhibitor, topoisomerase I and II inhibitor. 3,3',4',7-Tetrahydroxyflavone 528-48-3 ≥97% 286.24 C15H10O6 C1=CC(=C(C=C1C2=C(C(=O)C3=C(O2)C=C(C=C3)O)O)O)O Ambient 4°C "Li R, Zhao Y, Chen J, et al. Fisetin inhibits migration, invasion and epithelial-mesenchymal transition of LMP1-positive nasopharyngeal carcinoma cells. Mol Med Rep. 2014 Feb;9(2):413-8. PMID: 24297333.

 

Currais A, Prior M, Dargusch R, et al. Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic mice. Aging Cell. 2013 Dec 17. [Epub ahead of print]. PMID: 24341874.

 

Park JH, Jang YJ, Choi YJ, et al. Fisetin inhibits matrix metalloproteinases and reduces tumor cell invasiveness and endothelial cell tube formation. Nutr Cancer. 2013;65(8):1192-9. PMID: 24099040.

 

Song B, Guan S, Lu J, et al. Suppressive effects of fisetin on mice T lymphocytes in vitro and in vivo. J Surg Res. 2013 Nov;185(1):399-409. PMID: 23993202.

 

Kang KA, Piao MJ, Kim KC, et al. Fisetin attenuates hydrogen peroxide-induced cell damage by scavenging reactive oxygen species and activating protective functions of cellular glutathione system. In Vitro Cell Dev Biol Anim. 2013 Aug 27. [Epub ahead of print]. PMID: 23982916.

" Xi Not dangerous goods.

LKT F3473 Fisetin 500 mg 125.6 Flavonoid found in various plant sources; matrix metalloproteinase inhibitor, topoisomerase I and II inhibitor. 3,3',4',7-Tetrahydroxyflavone 528-48-3 ≥97% 286.24 C15H10O6 C1=CC(=C(C=C1C2=C(C(=O)C3=C(O2)C=C(C=C3)O)O)O)O Ambient 4°C "Li R, Zhao Y, Chen J, et al. Fisetin inhibits migration, invasion and epithelial-mesenchymal transition of LMP1-positive nasopharyngeal carcinoma cells. Mol Med Rep. 2014 Feb;9(2):413-8. PMID: 24297333.

 

Currais A, Prior M, Dargusch R, et al. Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic mice. Aging Cell. 2013 Dec 17. [Epub ahead of print]. PMID: 24341874.

 

Park JH, Jang YJ, Choi YJ, et al. Fisetin inhibits matrix metalloproteinases and reduces tumor cell invasiveness and endothelial cell tube formation. Nutr Cancer. 2013;65(8):1192-9. PMID: 24099040.

 

Song B, Guan S, Lu J, et al. Suppressive effects of fisetin on mice T lymphocytes in vitro and in vivo. J Surg Res. 2013 Nov;185(1):399-409. PMID: 23993202.

 

Kang KA, Piao MJ, Kim KC, et al. Fisetin attenuates hydrogen peroxide-induced cell damage by scavenging reactive oxygen species and activating protective functions of cellular glutathione system. In Vitro Cell Dev Biol Anim. 2013 Aug 27. [Epub ahead of print]. PMID: 23982916.

" Xi Not dangerous goods.

LKT F4400 Flag Peptide 0.5 mg 33.8 Peptide, used to tag proteins for affinity chromatography. "Trypsinogen (human pancreas isoenzyme 2 activation 

peptide), DYKDDDDK" 98849-88-8 ≥95% 1012.99 C41H60N10O20 C1=CC(=CC=C1CC(C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CC(=O)O)N)O Ambient -20°C Einhauer A, Jungbauer A. The FLAG peptide, a versatile fusion tag for the purification of recombinant proteins. J Biochem Biophys Methods. 2001 Oct 30;49(1-3):455-65. PMID: 11694294. Not dangerous goods.

LKT F4400 Flag Peptide 1 mg 56.7 Peptide, used to tag proteins for affinity chromatography. "Trypsinogen (human pancreas isoenzyme 2 activation 

peptide), DYKDDDDK" 98849-88-8 ≥95% 1012.99 C41H60N10O20 C1=CC(=CC=C1CC(C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CC(=O)O)N)O Ambient -20°C Einhauer A, Jungbauer A. The FLAG peptide, a versatile fusion tag for the purification of recombinant proteins. J Biochem Biophys Methods. 2001 Oct 30;49(1-3):455-65. PMID: 11694294. Not dangerous goods.

LKT F4400 Flag Peptide 2.5 mg 101 Peptide, used to tag proteins for affinity chromatography. "Trypsinogen (human pancreas isoenzyme 2 activation 

peptide), DYKDDDDK" 98849-88-8 ≥95% 1012.99 C41H60N10O20 C1=CC(=CC=C1CC(C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CC(=O)O)N)O Ambient -20°C Einhauer A, Jungbauer A. The FLAG peptide, a versatile fusion tag for the purification of recombinant proteins. J Biochem Biophys Methods. 2001 Oct 30;49(1-3):455-65. PMID: 11694294. Not dangerous goods.

LKT F4420 Boc-FLFLF 5 mg 120 Peptide; FRP1 antagonist. "L-Phenylalanine, N-(N-(N-(N-(N-((1,1-

dimethylethoxy)carbonyl)-D-phenylalanyl)-L-leucyl)-D-

phenylalanyl)-L-leucyl)- " 148182-34-7 ≥95% 785.99 C44H59N5O8 CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)OC(C)(C)C Ambient -20°C "Pei L, Zhang J, Zhao F, et al. Annexin 1 exerts anti-nociceptive effects after peripheral inflammatory pain through formyl-peptide-receptor-like 1 in rat dorsal root ganglion. Br J Anaesth. 2011 Dec;107(6):948-58. PMID: 21990306.

 

Ma XJ, Kunimatsu M, Ozaki Y, et al. Putative mechanism for guinea pig ileum contraction by N-formyl peptides. A comparative study of N-formyl and N-acetyl peptides with the N-terminal sequence of the calpain small subunit. Life Sci. 1995;57(5):463-71. PMID: 7623613.

" Not dangerous goods.

LKT F4420 Boc-FLFLF 10 mg 204.1 Peptide; FRP1 antagonist. "L-Phenylalanine, N-(N-(N-(N-(N-((1,1-

dimethylethoxy)carbonyl)-D-phenylalanyl)-L-leucyl)-D-

phenylalanyl)-L-leucyl)- " 148182-34-7 ≥95% 785.99 C44H59N5O8 CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)OC(C)(C)C Ambient -20°C "Pei L, Zhang J, Zhao F, et al. Annexin 1 exerts anti-nociceptive effects after peripheral inflammatory pain through formyl-peptide-receptor-like 1 in rat dorsal root ganglion. Br J Anaesth. 2011 Dec;107(6):948-58. PMID: 21990306.

 

Ma XJ, Kunimatsu M, Ozaki Y, et al. Putative mechanism for guinea pig ileum contraction by N-formyl peptides. A comparative study of N-formyl and N-acetyl peptides with the N-terminal sequence of the calpain small subunit. Life Sci. 1995;57(5):463-71. PMID: 7623613.

" Not dangerous goods.

LKT F4420 Boc-FLFLF 25 mg 359.9 Peptide; FRP1 antagonist. "L-Phenylalanine, N-(N-(N-(N-(N-((1,1-

dimethylethoxy)carbonyl)-D-phenylalanyl)-L-leucyl)-D-

phenylalanyl)-L-leucyl)- " 148182-34-7 ≥95% 785.99 C44H59N5O8 CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)OC(C)(C)C Ambient -20°C "Pei L, Zhang J, Zhao F, et al. Annexin 1 exerts anti-nociceptive effects after peripheral inflammatory pain through formyl-peptide-receptor-like 1 in rat dorsal root ganglion. Br J Anaesth. 2011 Dec;107(6):948-58. PMID: 21990306.

 

Ma XJ, Kunimatsu M, Ozaki Y, et al. Putative mechanism for guinea pig ileum contraction by N-formyl peptides. A comparative study of N-formyl and N-acetyl peptides with the N-terminal sequence of the calpain small subunit. Life Sci. 1995;57(5):463-71. PMID: 7623613.

" Not dangerous goods.

LKT F4482 Fluvastatin Sodium 10 mg 33.9 Statin; HMG-CoA reductase inhibitor, potential RhoA inhibitor. (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methyl- ethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid sodium salt Fluindostatin; XU-62-320; Lescol; Lipaxan; Primexin 93957-55-2 ≥98% 433.45 C24H25FNNaO4 CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)[O-])O)O)C3=CC=C(C=C3)F.[Na+] Ambient Ambient Soluble in water (50 mM), methanol, ethanol, and DMSO (100 mM) "Wuestenberg A, Kah J, Singethan K, et al. Matrix conditions and KLF2-dependent induction of heme oxygenase-1 modulate inhibition of HCV replication by fluvastatin. PLoS One. 2014 May 6;9(5):e96533. PMID: 24801208.

 

Moraes LA, Vaiyapuri S, Sasikumar P, et al. Antithrombotic actions of statins involve PECAM-1 signaling. Blood. 2013 Oct 31;122(18):3188-96. PMID: 24030383.

 

Vandjelovic N, Zhu H, Misra HP, et al. EPR studies on hydroxyl radical-scavenging activities of pravastatin and fluvastatin. Mol Cell Biochem. 2012 May;364(1-2):71-7. PMID: 22207075.

 

Yaktubay Döndaş N, Sucu N, Coşkun Yilmaz B, et al. Molecular mechanism of vasorelaxant and antiatherogenic effects of the statins in the human saphenous vein graft. Eur J Pharmacol. 2011 Sep;666(1-3):150-7. PMID: 21620829.

 

Dai QM, Lu J, Liu NF. Fluvastatin attenuates myocardial interstitial fibrosis and cardiac dysfunction in diabetic rats by inhibiting over-expression of connective tissue growth factor. Chin Med J (Engl). 2011 Jan;124(1):89-94. PMID: 21362314.

 

Zhang W, Wu J, Zhou L, et al. Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway. Indian J Exp Biol. 2010 Dec;48(12):1167-74. PMID: 21250597.

 

Neuvonen PJ, Backman JT, Niemi M. Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin. Clin Pharmacokinet. 2008;47(7):463-74. PMID: 18563955.

 

Bader T, Fazili J, Madhoun M, et al. Fluvastatin inhibits hepatitis C replication in humans. Am J Gastroenterol. 2008 Jun;103(6):1383-9. PMID: 18410471.

" None Not dangerous goods.

LKT F4482 Fluvastatin Sodium 50 mg 101.9 Statin; HMG-CoA reductase inhibitor, potential RhoA inhibitor. (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methyl- ethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid sodium salt Fluindostatin; XU-62-320; Lescol; Lipaxan; Primexin 93957-55-2 ≥98% 433.45 C24H25FNNaO4 CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)[O-])O)O)C3=CC=C(C=C3)F.[Na+] Ambient Ambient Soluble in water (50 mM), methanol, ethanol, and DMSO (100 mM) "Wuestenberg A, Kah J, Singethan K, et al. Matrix conditions and KLF2-dependent induction of heme oxygenase-1 modulate inhibition of HCV replication by fluvastatin. PLoS One. 2014 May 6;9(5):e96533. PMID: 24801208.

 

Moraes LA, Vaiyapuri S, Sasikumar P, et al. Antithrombotic actions of statins involve PECAM-1 signaling. Blood. 2013 Oct 31;122(18):3188-96. PMID: 24030383.

 

Vandjelovic N, Zhu H, Misra HP, et al. EPR studies on hydroxyl radical-scavenging activities of pravastatin and fluvastatin. Mol Cell Biochem. 2012 May;364(1-2):71-7. PMID: 22207075.

 

Yaktubay Döndaş N, Sucu N, Coşkun Yilmaz B, et al. Molecular mechanism of vasorelaxant and antiatherogenic effects of the statins in the human saphenous vein graft. Eur J Pharmacol. 2011 Sep;666(1-3):150-7. PMID: 21620829.

 

Dai QM, Lu J, Liu NF. Fluvastatin attenuates myocardial interstitial fibrosis and cardiac dysfunction in diabetic rats by inhibiting over-expression of connective tissue growth factor. Chin Med J (Engl). 2011 Jan;124(1):89-94. PMID: 21362314.

 

Zhang W, Wu J, Zhou L, et al. Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway. Indian J Exp Biol. 2010 Dec;48(12):1167-74. PMID: 21250597.

 

Neuvonen PJ, Backman JT, Niemi M. Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin. Clin Pharmacokinet. 2008;47(7):463-74. PMID: 18563955.

 

Bader T, Fazili J, Madhoun M, et al. Fluvastatin inhibits hepatitis C replication in humans. Am J Gastroenterol. 2008 Jun;103(6):1383-9. PMID: 18410471.

" None Not dangerous goods.

LKT F4482 Fluvastatin Sodium 100 mg 163.2 Statin; HMG-CoA reductase inhibitor, potential RhoA inhibitor. (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methyl- ethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid sodium salt Fluindostatin; XU-62-320; Lescol; Lipaxan; Primexin 93957-55-2 ≥98% 433.45 C24H25FNNaO4 CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)[O-])O)O)C3=CC=C(C=C3)F.[Na+] Ambient Ambient Soluble in water (50 mM), methanol, ethanol, and DMSO (100 mM) "Wuestenberg A, Kah J, Singethan K, et al. Matrix conditions and KLF2-dependent induction of heme oxygenase-1 modulate inhibition of HCV replication by fluvastatin. PLoS One. 2014 May 6;9(5):e96533. PMID: 24801208.

 

Moraes LA, Vaiyapuri S, Sasikumar P, et al. Antithrombotic actions of statins involve PECAM-1 signaling. Blood. 2013 Oct 31;122(18):3188-96. PMID: 24030383.

 

Vandjelovic N, Zhu H, Misra HP, et al. EPR studies on hydroxyl radical-scavenging activities of pravastatin and fluvastatin. Mol Cell Biochem. 2012 May;364(1-2):71-7. PMID: 22207075.

 

Yaktubay Döndaş N, Sucu N, Coşkun Yilmaz B, et al. Molecular mechanism of vasorelaxant and antiatherogenic effects of the statins in the human saphenous vein graft. Eur J Pharmacol. 2011 Sep;666(1-3):150-7. PMID: 21620829.

 

Dai QM, Lu J, Liu NF. Fluvastatin attenuates myocardial interstitial fibrosis and cardiac dysfunction in diabetic rats by inhibiting over-expression of connective tissue growth factor. Chin Med J (Engl). 2011 Jan;124(1):89-94. PMID: 21362314.

 

Zhang W, Wu J, Zhou L, et al. Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway. Indian J Exp Biol. 2010 Dec;48(12):1167-74. PMID: 21250597.

 

Neuvonen PJ, Backman JT, Niemi M. Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin. Clin Pharmacokinet. 2008;47(7):463-74. PMID: 18563955.

 

Bader T, Fazili J, Madhoun M, et al. Fluvastatin inhibits hepatitis C replication in humans. Am J Gastroenterol. 2008 Jun;103(6):1383-9. PMID: 18410471.

" None Not dangerous goods.

LKT F4483 Flufenamic Acid 10 g 27.2 NSAID; TREK1 K+ potentiator, voltage-gated Na+ channel blocker, TRPC3 and TRPM2 antagonist, COX-1/2 inhibitor. 2-[[3-(Trifluoromethyl)phenyl]amino]benzoic acid Achless; Ansatin; Arlef; Fullsafe; Parlef; Sastridex; Tecramine 530-78-9 ≥97% 281.23 C14H10F3NO2 C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F Ambient Ambient Soluble in 4 parts of ethanol. Soluble in DMSO to 100 mM and in ethanol to 100 mM "Xie YF, Zhou F. TRPC3 channel mediates excitation of striatal cholinergic interneurons. Neurol Sci. 2014 May 21. [Epub ahead of print]. PMID: 24844791.

 

Veale EL, Al-Moubarak E, Bajaria N, et al. Influence of the N terminus on the biophysical properties and pharmacology of TREK1 potassium channels. Mol Pharmacol. 2014 May;85(5):671-81. PMID: 24509840.

 

Nazıroğlu M, Özgül C, Çelik Ö, et al. Aminoethoxydiphenyl borate and flufenamic acid inhibit Ca2+ influx through TRPM2 channels in rat dorsal root ganglion neurons activated by ADP-ribose and rotenone. J Membr Biol. 2011 May;241(2):69-75. PMID: 21509529.

 

Yau HJ, Baranauskas G, Martina M. Flufenamic acid decreases neuronal excitability through modulation of voltage-gated sodium channel gating. J Physiol. 2010 Oct 15;588(Pt 20):3869-82. PMID: 20724367.

 

Fernández M, Lao-Peregrín C, Martín ED. Flufenamic acid suppresses epileptiform activity in hippocampus by reducing excitatory synaptic transmission and neuronal excitability. Epilepsia. 2010 Mar;51(3):384-90. PMID: 19732136.

" Xn "UN number: 2811     Class: 6.1     Packing Group: III

Proper shipping name: Toxic solid, organic, n.o.s. (Flufenamic Acid)"

LKT F4483 Flufenamic Acid 50 g 67.9 NSAID; TREK1 K+ potentiator, voltage-gated Na+ channel blocker, TRPC3 and TRPM2 antagonist, COX-1/2 inhibitor. 2-[[3-(Trifluoromethyl)phenyl]amino]benzoic acid Achless; Ansatin; Arlef; Fullsafe; Parlef; Sastridex; Tecramine 530-78-9 ≥97% 281.23 C14H10F3NO2 C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F Ambient Ambient Soluble in 4 parts of ethanol. Soluble in DMSO to 100 mM and in ethanol to 100 mM "Xie YF, Zhou F. TRPC3 channel mediates excitation of striatal cholinergic interneurons. Neurol Sci. 2014 May 21. [Epub ahead of print]. PMID: 24844791.

 

Veale EL, Al-Moubarak E, Bajaria N, et al. Influence of the N terminus on the biophysical properties and pharmacology of TREK1 potassium channels. Mol Pharmacol. 2014 May;85(5):671-81. PMID: 24509840.

 

Nazıroğlu M, Özgül C, Çelik Ö, et al. Aminoethoxydiphenyl borate and flufenamic acid inhibit Ca2+ influx through TRPM2 channels in rat dorsal root ganglion neurons activated by ADP-ribose and rotenone. J Membr Biol. 2011 May;241(2):69-75. PMID: 21509529.

 

Yau HJ, Baranauskas G, Martina M. Flufenamic acid decreases neuronal excitability through modulation of voltage-gated sodium channel gating. J Physiol. 2010 Oct 15;588(Pt 20):3869-82. PMID: 20724367.

 

Fernández M, Lao-Peregrín C, Martín ED. Flufenamic acid suppresses epileptiform activity in hippocampus by reducing excitatory synaptic transmission and neuronal excitability. Epilepsia. 2010 Mar;51(3):384-90. PMID: 19732136.

" Xn "UN number: 2811     Class: 6.1     Packing Group: III

Proper shipping name: Toxic solid, organic, n.o.s. (Flufenamic Acid)"

LKT F4501 Flavanone 10 g 40.7 Variety of flavonoid found in various plant sources. 2,3-Dihydroflavone 487-26-3 ≥98% 224.25 C15H12O2 C1C(OC2=CC=CC=C2C1=O)C3=CC=CC=C3 Ambient Ambient "Melliou E, Chinou I. Chemical analysis and antimicrobial activity of Greek propolis. Planta Med. 2004 Jun;70(6):515-9. PMID: 15229802.

 

Fotsis T, Pepper MS, Montesano R, et al. Phytoestrogens and inhibition of angiogenesis. Baillieres Clin Endocrinol Metab. 1998 Dec;12(4):649-66. PMID: 10384818.

" None Not dangerous goods.

LKT F4501 Flavanone 25 g 88.3 Variety of flavonoid found in various plant sources. 2,3-Dihydroflavone 487-26-3 ≥98% 224.25 C15H12O2 C1C(OC2=CC=CC=C2C1=O)C3=CC=CC=C3 Ambient Ambient "Melliou E, Chinou I. Chemical analysis and antimicrobial activity of Greek propolis. Planta Med. 2004 Jun;70(6):515-9. PMID: 15229802.

 

Fotsis T, Pepper MS, Montesano R, et al. Phytoestrogens and inhibition of angiogenesis. Baillieres Clin Endocrinol Metab. 1998 Dec;12(4):649-66. PMID: 10384818.

" None Not dangerous goods.

LKT F4502 Flavokawain A 5 mg 186.6 Chalcone kavalactone found in Piper methysticum (kava plant). 64680-84-8 ≥98% 314.33 C18H18O5 COC1=CC=C(C=C1)C=CC(=O)C2=C(C=C(C=C2OC)OC)O Ambient -20°C DMSO 100 mM. Insoluble in water. Soluble in methanol. "Liu Z, Xu X, Li X, et al. Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model. Cancer Prev Res (Phila). 2013 Dec;6(12):1365-75. PMID: 24121102.

 

Kwon DJ, Ju SM, Youn GS, et al. Suppression of iNOS and COX-2 expression by flavokawain A via blockade of NF-κB and AP-1 activation in RAW 264.7 macrophages. Food Chem Toxicol. 2013 Aug;58:479-86. PMID: 23727179.

 

Folmer F, Blasius R, Morceau F, et al. Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives. Biochem Pharmacol. 2006 Apr 14;71(8):1206-18. PMID: 16464438.

" Not dangerous goods.

LKT F4502 Flavokawain A 10 mg 288.3 Chalcone kavalactone found in Piper methysticum (kava plant). 64680-84-8 ≥98% 314.33 C18H18O5 COC1=CC=C(C=C1)C=CC(=O)C2=C(C=C(C=C2OC)OC)O Ambient -20°C DMSO 100 mM. Insoluble in water. Soluble in methanol. "Liu Z, Xu X, Li X, et al. Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model. Cancer Prev Res (Phila). 2013 Dec;6(12):1365-75. PMID: 24121102.

 

Kwon DJ, Ju SM, Youn GS, et al. Suppression of iNOS and COX-2 expression by flavokawain A via blockade of NF-κB and AP-1 activation in RAW 264.7 macrophages. Food Chem Toxicol. 2013 Aug;58:479-86. PMID: 23727179.

 

Folmer F, Blasius R, Morceau F, et al. Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives. Biochem Pharmacol. 2006 Apr 14;71(8):1206-18. PMID: 16464438.

" Not dangerous goods.

LKT F4503 Flavokawain B 5 mg 186.6 Chalcone kavalactone found in Piper methysticum (kava plant). 1775-97-9 ≥97% 284.31 C17H16O4 COC1=CC(=C(C(=C1)OC)C(=O)C=CC2=CC=CC=C2)O Ambient -20°C DMSO to 35 mM.  Insoluble in water. Soluble in methanol. "Teschke R, Qiu SX, Lebot V. Herbal hepatotoxicity by kava: update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits. Dig Liver Dis. 2011 Sep;43(9):676-81. PMID: 21377431.

 

Folmer F, Blasius R, Morceau F, et al. Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives. Biochem Pharmacol. 2006 Apr 14;71(8):1206-18. PMID: 16464438.

 

Sakai T, Eskander RN, Guo Y, et al. Flavokawain B, a kava chalcone, induces apoptosis in synovial sarcoma cell lines. J Orthop Res. 2012 Jul;30(7):1045-1050. PMID: 22213202.

" Not dangerous goods.

LKT F4503 Flavokawain B 10 mg 288.3 Chalcone kavalactone found in Piper methysticum (kava plant). 1775-97-9 ≥97% 284.31 C17H16O4 COC1=CC(=C(C(=C1)OC)C(=O)C=CC2=CC=CC=C2)O Ambient -20°C DMSO to 35 mM.  Insoluble in water. Soluble in methanol. "Teschke R, Qiu SX, Lebot V. Herbal hepatotoxicity by kava: update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits. Dig Liver Dis. 2011 Sep;43(9):676-81. PMID: 21377431.

 

Folmer F, Blasius R, Morceau F, et al. Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives. Biochem Pharmacol. 2006 Apr 14;71(8):1206-18. PMID: 16464438.

 

Sakai T, Eskander RN, Guo Y, et al. Flavokawain B, a kava chalcone, induces apoptosis in synovial sarcoma cell lines. J Orthop Res. 2012 Jul;30(7):1045-1050. PMID: 22213202.

" Not dangerous goods.

LKT F4556 Florfenicol 1 g 81 Synthetic fluorinated thiamphenicol analog; protein translation inhibitor. 2,2-Dichloro-N-[(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-[4-methylsulfonyl)-phenyl]ethyl]acetamide Fluorothiamphenicol; Aquafen 73231-34-2 ≥98% 358.21 C12H14Cl2FNO4S CS(=O)(=O)C1=CC=C(C=C1)C(C(CF)NC(=O)C(Cl)Cl)O Ambient Ambient Acetone, DMF. Slightly soluble in water (1.3 mg/ml). "Kehrenberg C, Schwarz S, Jacobsen L, et al. A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503. Mol Microbiol. 2005 Aug;57(4):1064-73. PMID: 16091044.

 

Syriopoulou VP, Harding AL, Goldmann DA, et al. In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob Agents Chemother. 1981 Feb;19(2):294-7. PMID: 6957162.

" Xi Not dangerous goods.

LKT F4556 Florfenicol 5 g 231.1 Synthetic fluorinated thiamphenicol analog; protein translation inhibitor. 2,2-Dichloro-N-[(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-[4-methylsulfonyl)-phenyl]ethyl]acetamide Fluorothiamphenicol; Aquafen 73231-34-2 ≥98% 358.21 C12H14Cl2FNO4S CS(=O)(=O)C1=CC=C(C=C1)C(C(CF)NC(=O)C(Cl)Cl)O Ambient Ambient Acetone, DMF. Slightly soluble in water (1.3 mg/ml). "Kehrenberg C, Schwarz S, Jacobsen L, et al. A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503. Mol Microbiol. 2005 Aug;57(4):1064-73. PMID: 16091044.

 

Syriopoulou VP, Harding AL, Goldmann DA, et al. In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob Agents Chemother. 1981 Feb;19(2):294-7. PMID: 6957162.

" Xi Not dangerous goods.

LKT F4556 Florfenicol 10 g 346.5 Synthetic fluorinated thiamphenicol analog; protein translation inhibitor. 2,2-Dichloro-N-[(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-[4-methylsulfonyl)-phenyl]ethyl]acetamide Fluorothiamphenicol; Aquafen 73231-34-2 ≥98% 358.21 C12H14Cl2FNO4S CS(=O)(=O)C1=CC=C(C=C1)C(C(CF)NC(=O)C(Cl)Cl)O Ambient Ambient Acetone, DMF. Slightly soluble in water (1.3 mg/ml). "Kehrenberg C, Schwarz S, Jacobsen L, et al. A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503. Mol Microbiol. 2005 Aug;57(4):1064-73. PMID: 16091044.

 

Syriopoulou VP, Harding AL, Goldmann DA, et al. In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob Agents Chemother. 1981 Feb;19(2):294-7. PMID: 6957162.

" Xi Not dangerous goods.

LKT F4557 Floxuridine 500 mg 223.8 5-Fluorouracil derivative, fluorinated pyrimidine nuceloside analog; thymidylate synthase inhibitor. 2'-Deoxy-5-fluorouridine NSC-27640; FUDR 50-91-9 ≥98% 246.19 C9H11FN2O5 C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O Ambient Ambient Soluble in water. "Fischer MA, Smith JL, Shum D, et al. Flaviviruses are sensitive to inhibition of thymidine synthesis pathways. J Virol. 2013 Sep;87(17):9411-9. PMID: 23824813.

 

Muñoz-Pinedo C, Robledo G, López-Rivas A. Thymidylate synthase inhibition triggers glucose-dependent apoptosis in p53-negative leukemic cells. FEBS Lett. 2004 Jul 16;570(1-3):205-10. PMID: 15251465.

 

Tobias SC, Borch RF. Synthesis and biological studies of novel nucleoside phosphoramidate prodrugs. J Med Chem. 2001 Dec 6;44(25):4475-80. PMID: 11728193.

" Xn "UN number: 2811 Class: 6.1     Packing Group: III

Proper shipping name: Toxic solid, organic, n.o.s. (Floxuridine)"

LKT F4557 Floxuridine 1 g 368.8 5-Fluorouracil derivative, fluorinated pyrimidine nuceloside analog; thymidylate synthase inhibitor. 2'-Deoxy-5-fluorouridine NSC-27640; FUDR 50-91-9 ≥98% 246.19 C9H11FN2O5 C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O Ambient Ambient Soluble in water. "Fischer MA, Smith JL, Shum D, et al. Flaviviruses are sensitive to inhibition of thymidine synthesis pathways. J Virol. 2013 Sep;87(17):9411-9. PMID: 23824813.

 

Muñoz-Pinedo C, Robledo G, López-Rivas A. Thymidylate synthase inhibition triggers glucose-dependent apoptosis in p53-negative leukemic cells. FEBS Lett. 2004 Jul 16;570(1-3):205-10. PMID: 15251465.

 

Tobias SC, Borch RF. Synthesis and biological studies of novel nucleoside phosphoramidate prodrugs. J Med Chem. 2001 Dec 6;44(25):4475-80. PMID: 11728193.

" Xn "UN number: 2811 Class: 6.1     Packing Group: III

Proper shipping name: Toxic solid, organic, n.o.s. (Floxuridine)"

LKT F4580 FluM1 A2 Peptide (58-66) 1 mg 65.8 Peptide, influenza matrix protein M1 epitope. CEF1, Influenza Matrix Protein M1 (58 - 66), 141368-69-6 ≥95% 966.2 C49H75N9O11 Ambient -20°C "Zhou V, Yassai MB, Regunathan J, et al. The functional CD8 T cell memory recall repertoire responding to the influenza A M1(58-66) epitope is polyclonal and shows a complex clonotype distribution. Hum Immunol. 2013 Jul;74(7):809-17. PMID: 23295548.

 

Petrova GV, Naumova EN, Gorski J. The polyclonal CD8 T cell response to influenza M158-66 generates a fully connected network of cross-reactive clonotypes to structurally related peptides: a paradigm for memory repertoire coverage of novel epitopes or escape mutants. J Immunol. 2011 Jun 1;186(11):6390-7. PMID: 21518969.

"

LKT F4580 FluM1 A2 Peptide (58-66) 2 mg 111 Peptide, influenza matrix protein M1 epitope. CEF1, Influenza Matrix Protein M1 (58 - 66), 141368-69-6 ≥95% 966.2 C49H75N9O11 Ambient -20°C "Zhou V, Yassai MB, Regunathan J, et al. The functional CD8 T cell memory recall repertoire responding to the influenza A M1(58-66) epitope is polyclonal and shows a complex clonotype distribution. Hum Immunol. 2013 Jul;74(7):809-17. PMID: 23295548.

 

Petrova GV, Naumova EN, Gorski J. The polyclonal CD8 T cell response to influenza M158-66 generates a fully connected network of cross-reactive clonotypes to structurally related peptides: a paradigm for memory repertoire coverage of novel epitopes or escape mutants. J Immunol. 2011 Jun 1;186(11):6390-7. PMID: 21518969.

"

LKT F4580 FluM1 A2 Peptide (58-66) 5 mg 198.1 Peptide, influenza matrix protein M1 epitope. CEF1, Influenza Matrix Protein M1 (58 - 66), 141368-69-6 ≥95% 966.2 C49H75N9O11 Ambient -20°C "Zhou V, Yassai MB, Regunathan J, et al. The functional CD8 T cell memory recall repertoire responding to the influenza A M1(58-66) epitope is polyclonal and shows a complex clonotype distribution. Hum Immunol. 2013 Jul;74(7):809-17. PMID: 23295548.

 

Petrova GV, Naumova EN, Gorski J. The polyclonal CD8 T cell response to influenza M158-66 generates a fully connected network of cross-reactive clonotypes to structurally related peptides: a paradigm for memory repertoire coverage of novel epitopes or escape mutants. J Immunol. 2011 Jun 1;186(11):6390-7. PMID: 21518969.

"

LKT F4582 Fluocinolone Acetonide 25 mg 33.9 Synthetic hydrocortisone derivative; glucocorticoid agonist. (6α,11β,16α)-6,9-Difluoro-11,21-dihydroxy-16,17- [(91-methylethylidene)bis(oxy)]-pregna-1,4-diene- 3,20-dione Coriphate; Dermalar; Fluonid; Fluvean; Jellin; Synalar; Synemol; Synsac 67-73-2 ≥98% 452.49 C24H30F2O6 CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C Ambient Ambient Slightly soluble in water (<1 mg/mL). Ethanol (22 mg/mL). "Cunha-Vaz J, Ashton P, Iezzi R, et al. Sustained Delivery Fluocinolone Acetonide Vitreous Implants: Long-Term Benefit in Patients with Chronic Diabetic Macular Edema. Ophthalmology. 2014 Jun 13. [Epub ahead of print]. PMID: 24935282.

 

Liu Z, Jiang T, Wang X, et al. Fluocinolone acetonide partially restores the mineralization of LPS-stimulated dental pulp cells through inhibition of NF-κB pathway and activation of AP-1 pathway. Br J Pharmacol. 2013 Nov;170(6):1262-71. PMID: 24024985.

" Xi Not dangerous goods.

LKT F4582 Fluocinolone Acetonide 100 mg 81.6 Synthetic hydrocortisone derivative; glucocorticoid agonist. (6α,11β,16α)-6,9-Difluoro-11,21-dihydroxy-16,17- [(91-methylethylidene)bis(oxy)]-pregna-1,4-diene- 3,20-dione Coriphate; Dermalar; Fluonid; Fluvean; Jellin; Synalar; Synemol; Synsac 67-73-2 ≥98% 452.49 C24H30F2O6 CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C Ambient Ambient Slightly soluble in water (<1 mg/mL). Ethanol (22 mg/mL). "Cunha-Vaz J, Ashton P, Iezzi R, et al. Sustained Delivery Fluocinolone Acetonide Vitreous Implants: Long-Term Benefit in Patients with Chronic Diabetic Macular Edema. Ophthalmology. 2014 Jun 13. [Epub ahead of print]. PMID: 24935282.

 

Liu Z, Jiang T, Wang X, et al. Fluocinolone acetonide partially restores the mineralization of LPS-stimulated dental pulp cells through inhibition of NF-κB pathway and activation of AP-1 pathway. Br J Pharmacol. 2013 Nov;170(6):1262-71. PMID: 24024985.

" Xi Not dangerous goods.

LKT F4582 Fluocinolone Acetonide 250 mg 163.2 Synthetic hydrocortisone derivative; glucocorticoid agonist. (6α,11β,16α)-6,9-Difluoro-11,21-dihydroxy-16,17- [(91-methylethylidene)bis(oxy)]-pregna-1,4-diene- 3,20-dione Coriphate; Dermalar; Fluonid; Fluvean; Jellin; Synalar; Synemol; Synsac 67-73-2 ≥98% 452.49 C24H30F2O6 CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C Ambient Ambient Slightly soluble in water (<1 mg/mL). Ethanol (22 mg/mL). "Cunha-Vaz J, Ashton P, Iezzi R, et al. Sustained Delivery Fluocinolone Acetonide Vitreous Implants: Long-Term Benefit in Patients with Chronic Diabetic Macular Edema. Ophthalmology. 2014 Jun 13. [Epub ahead of print]. PMID: 24935282.

 

Liu Z, Jiang T, Wang X, et al. Fluocinolone acetonide partially restores the mineralization of LPS-stimulated dental pulp cells through inhibition of NF-κB pathway and activation of AP-1 pathway. Br J Pharmacol. 2013 Nov;170(6):1262-71. PMID: 24024985.

" Xi Not dangerous goods.

LKT F4582 Fluocinolone Acetonide 1 g 434.9 Synthetic hydrocortisone derivative; glucocorticoid agonist. (6α,11β,16α)-6,9-Difluoro-11,21-dihydroxy-16,17- [(91-methylethylidene)bis(oxy)]-pregna-1,4-diene- 3,20-dione Coriphate; Dermalar; Fluonid; Fluvean; Jellin; Synalar; Synemol; Synsac 67-73-2 ≥98% 452.49 C24H30F2O6 CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C Ambient Ambient Slightly soluble in water (<1 mg/mL). Ethanol (22 mg/mL). "Cunha-Vaz J, Ashton P, Iezzi R, et al. Sustained Delivery Fluocinolone Acetonide Vitreous Implants: Long-Term Benefit in Patients with Chronic Diabetic Macular Edema. Ophthalmology. 2014 Jun 13. [Epub ahead of print]. PMID: 24935282.

 

Liu Z, Jiang T, Wang X, et al. Fluocinolone acetonide partially restores the mineralization of LPS-stimulated dental pulp cells through inhibition of NF-κB pathway and activation of AP-1 pathway. Br J Pharmacol. 2013 Nov;170(6):1262-71. PMID: 24024985.

" Xi Not dangerous goods.

LKT F4583 Flupirtine Maleate 10 mg 80.4 Kv7 K+ channel activator, NMDA antagonist, GABA-A negative modulator. 75507-68-5 ≥98% 304.32 C15H17FN4O2 C4H4O4 CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N.C(=CC(=O)O)C(=O)O Ambient Ambient "Yadav G, Choupoo S, Das SK, et al. Evaluating the Role of Flupirtine for Postcraniotomy Pain and Compare it With Diclofenac Sodium: A Prospective, Randomized, Double Blind, Placebo-controlled Study. J Neurosurg Anesthesiol. 2013 Jun 11. [Epub ahead of print]. PMID: 23764718.

 

Fleckenstein J, Sittl R, Averbeck B, et al. Activation o axonal Kv7 channels in human peripheral nerve by flupirtine but not placebo - therapeutic potential for peripheral neuropathies: results of a randomised controlled trial. J Transl Med. 2013 Feb 8;11:34. PMID: 23394517.

 

Klinger F, Geier P, Dorostkar MM, et al. Concomitant facilitation of GABAA receptors and KV7 channels by the non-opioid analgesic flupirtine. Br J Pharmacol. 2012 Jul;166(5):1631-42. PMID: 22188423.

 

Harish S, Bhuvana K, Bengalorkar GM, et al. Flupirtine: Clinical pharmacology. J Anaesthesiol Clin Pharmacol. 2012 Apr;28(2):172-7. PMID: 22557738.

 

Devulder J. Flupirtine in pain management: pharmacological properties and clinical use. CNS Drugs. 2010 Oct;24(10):867-81. PMID: 20839897.

 

Morecroft I, Murray A, Nilsen M, et al. Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension. Br J Pharmacol. 2009 Aug;157(7):1241-9. PMID: 19508393.

" None Not dangerous goods.

LKT F4583 Flupirtine Maleate 25 mg 167.4 Kv7 K+ channel activator, NMDA antagonist, GABA-A negative modulator. 75507-68-5 ≥98% 304.32 C15H17FN4O2 C4H4O4 CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N.C(=CC(=O)O)C(=O)O Ambient Ambient "Yadav G, Choupoo S, Das SK, et al. Evaluating the Role of Flupirtine for Postcraniotomy Pain and Compare it With Diclofenac Sodium: A Prospective, Randomized, Double Blind, Placebo-controlled Study. J Neurosurg Anesthesiol. 2013 Jun 11. [Epub ahead of print]. PMID: 23764718.

 

Fleckenstein J, Sittl R, Averbeck B, et al. Activation o axonal Kv7 channels in human peripheral nerve by flupirtine but not placebo - therapeutic potential for peripheral neuropathies: results of a randomised controlled trial. J Transl Med. 2013 Feb 8;11:34. PMID: 23394517.

 

Klinger F, Geier P, Dorostkar MM, et al. Concomitant facilitation of GABAA receptors and KV7 channels by the non-opioid analgesic flupirtine. Br J Pharmacol. 2012 Jul;166(5):1631-42. PMID: 22188423.

 

Harish S, Bhuvana K, Bengalorkar GM, et al. Flupirtine: Clinical pharmacology. J Anaesthesiol Clin Pharmacol. 2012 Apr;28(2):172-7. PMID: 22557738.

 

Devulder J. Flupirtine in pain management: pharmacological properties and clinical use. CNS Drugs. 2010 Oct;24(10):867-81. PMID: 20839897.

 

Morecroft I, Murray A, Nilsen M, et al. Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension. Br J Pharmacol. 2009 Aug;157(7):1241-9. PMID: 19508393.

" None Not dangerous goods.

LKT F4583 Flupirtine Maleate 100 mg 535.7 Kv7 K+ channel activator, NMDA antagonist, GABA-A negative modulator. 75507-68-5 ≥98% 304.32 C15H17FN4O2 C4H4O4 CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N.C(=CC(=O)O)C(=O)O Ambient Ambient "Yadav G, Choupoo S, Das SK, et al. Evaluating the Role of Flupirtine for Postcraniotomy Pain and Compare it With Diclofenac Sodium: A Prospective, Randomized, Double Blind, Placebo-controlled Study. J Neurosurg Anesthesiol. 2013 Jun 11. [Epub ahead of print]. PMID: 23764718.

 

Fleckenstein J, Sittl R, Averbeck B, et al. Activation o axonal Kv7 channels in human peripheral nerve by flupirtine but not placebo - therapeutic potential for peripheral neuropathies: results of a randomised controlled trial. J Transl Med. 2013 Feb 8;11:34. PMID: 23394517.

 

Klinger F, Geier P, Dorostkar MM, et al. Concomitant facilitation of GABAA receptors and KV7 channels by the non-opioid analgesic flupirtine. Br J Pharmacol. 2012 Jul;166(5):1631-42. PMID: 22188423.

 

Harish S, Bhuvana K, Bengalorkar GM, et al. Flupirtine: Clinical pharmacology. J Anaesthesiol Clin Pharmacol. 2012 Apr;28(2):172-7. PMID: 22557738.

 

Devulder J. Flupirtine in pain management: pharmacological properties and clinical use. CNS Drugs. 2010 Oct;24(10):867-81. PMID: 20839897.

 

Morecroft I, Murray A, Nilsen M, et al. Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension. Br J Pharmacol. 2009 Aug;157(7):1241-9. PMID: 19508393.

" None Not dangerous goods.

LKT F4584 Fluphenazine Hydrochloride 1 g 81.6 Piperazine; FIASMA, D2 antagonist, hERG K+ channel blocker. "1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)phenothiazin-

10-yl)propyl)-" Dapotum; Elinol; Fluorfenazine; Fluorophenazine; Pacinol; Moditen. 146-56-5 ≥97% 510.44 C22H26F3N3OS 2HCl C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO.Cl.Cl Ambient Ambient Soluble in water (>100 mg/L), ethanol (149 mg/mL) "Hong HK, Lee BH, Park MH, et al. Block of hERG K+ channel and prolongation of action potential duration by fluphenazine at submicromolar concentration. Eur J Pharmacol. 2013 Feb 28;702(1-3):165-73. PMID: 23395964.

 

Pickar D, Owen RR, Litman RE, et al. Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine. Arch Gen Psychiatry. 1992 May;49(5):345-53. PMID: 1375019.

" Xn "UN number: 2811     Class:  6.1     Packing group:  III

Proper shipping name:  Toxic solids, organic, n.o.s. (Fluphenazine hydrochloride)

Marine pollutant:  No     Poison inhalation hazard:  No"

LKT F4584 Fluphenazine Hydrochloride 5 g 169.9 Piperazine; FIASMA, D2 antagonist, hERG K+ channel blocker. "1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)phenothiazin-

10-yl)propyl)-" Dapotum; Elinol; Fluorfenazine; Fluorophenazine; Pacinol; Moditen. 146-56-5 ≥97% 510.44 C22H26F3N3OS 2HCl C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO.Cl.Cl Ambient Ambient Soluble in water (>100 mg/L), ethanol (149 mg/mL) "Hong HK, Lee BH, Park MH, et al. Block of hERG K+ channel and prolongation of action potential duration by fluphenazine at submicromolar concentration. Eur J Pharmacol. 2013 Feb 28;702(1-3):165-73. PMID: 23395964.

 

Pickar D, Owen RR, Litman RE, et al. Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine. Arch Gen Psychiatry. 1992 May;49(5):345-53. PMID: 1375019.

" Xn "UN number: 2811     Class:  6.1     Packing group:  III

Proper shipping name:  Toxic solids, organic, n.o.s. (Fluphenazine hydrochloride)

Marine pollutant:  No     Poison inhalation hazard:  No"

LKT F4584 Fluphenazine Hydrochloride 25 g 516.4 Piperazine; FIASMA, D2 antagonist, hERG K+ channel blocker. "1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)phenothiazin-

10-yl)propyl)-" Dapotum; Elinol; Fluorfenazine; Fluorophenazine; Pacinol; Moditen. 146-56-5 ≥97% 510.44 C22H26F3N3OS 2HCl C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO.Cl.Cl Ambient Ambient Soluble in water (>100 mg/L), ethanol (149 mg/mL) "Hong HK, Lee BH, Park MH, et al. Block of hERG K+ channel and prolongation of action potential duration by fluphenazine at submicromolar concentration. Eur J Pharmacol. 2013 Feb 28;702(1-3):165-73. PMID: 23395964.

 

Pickar D, Owen RR, Litman RE, et al. Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine. Arch Gen Psychiatry. 1992 May;49(5):345-53. PMID: 1375019.

" Xn "UN number: 2811     Class:  6.1     Packing group:  III

Proper shipping name:  Toxic solids, organic, n.o.s. (Fluphenazine hydrochloride)

Marine pollutant:  No     Poison inhalation hazard:  No"

LKT F4679 Flubendazole 10 g 104.3 Benzimidazole; microtubule polymerization inhibitor. [5-(4-Fluorobenzoyl)-1H-benzimidazole-2-yl]carbamic acid methyl ester Flubenol; Flumoxal; Flumoxane; Fluvermal 31430-15-6 ≥98% 313.28 C16H12FN3O3    COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=C(C=C3)F Ambient Ambient Insoluble in water. "Spagnuolo PA, Hu J, Hurren R, et al. The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma. Blood. 2010 Jun 10;115(23):4824-33. PMID: 20348394.

 

Juliano C, Martinotti MG, Cappuccinelli P. ""In vitro"" effect of microtubule inhibitors on Trichomonas vaginalis. Microbiologica. 1985 Jan;8(1):31-42. PMID: 3871893.

" Xi Not dangerous goods.

LKT F4679 Flubendazole 25 g 226.5 Benzimidazole; microtubule polymerization inhibitor. [5-(4-Fluorobenzoyl)-1H-benzimidazole-2-yl]carbamic acid methyl ester Flubenol; Flumoxal; Flumoxane; Fluvermal 31430-15-6 ≥98% 313.28 C16H12FN3O3    COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=C(C=C3)F Ambient Ambient Insoluble in water. "Spagnuolo PA, Hu J, Hurren R, et al. The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma. Blood. 2010 Jun 10;115(23):4824-33. PMID: 20348394.

 

Juliano C, Martinotti MG, Cappuccinelli P. ""In vitro"" effect of microtubule inhibitors on Trichomonas vaginalis. Microbiologica. 1985 Jan;8(1):31-42. PMID: 3871893.

" Xi Not dangerous goods.

LKT F4679 Flubendazole 100 g 693.2 Benzimidazole; microtubule polymerization inhibitor. [5-(4-Fluorobenzoyl)-1H-benzimidazole-2-yl]carbamic acid methyl ester Flubenol; Flumoxal; Flumoxane; Fluvermal 31430-15-6 ≥98% 313.28 C16H12FN3O3    COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=C(C=C3)F Ambient Ambient Insoluble in water. "Spagnuolo PA, Hu J, Hurren R, et al. The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma. Blood. 2010 Jun 10;115(23):4824-33. PMID: 20348394.

 

Juliano C, Martinotti MG, Cappuccinelli P. ""In vitro"" effect of microtubule inhibitors on Trichomonas vaginalis. Microbiologica. 1985 Jan;8(1):31-42. PMID: 3871893.

" Xi Not dangerous goods.

LKT F4680 Flutamide 1 g 40.7 Non-steroid; AR antagonist. 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]- propanamide Drogenil; Euflex; Flucinom; Fugerel 13311-84-7 ≥98% 276.22 C11H11F3N2O3 CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F Ambient Ambient Insoluble in water. Soluble in DMSO. "Al-Saeedi F. Effects of flutamide on [methyl-(3)h]-choline uptake in human prostate cancer-3 cells: a pilot study. Curr Ther Res Clin Exp. 2007 Jul;68(4):226-41. PMID: 24683213.

 

Shimizu T, Yu HP, Hsieh YC, et al. Flutamide attenuates pro-inflammatory cytokine production and hepatic injury following trauma-hemorrhage via estrogen receptor-related pathway. Ann Surg. 2007 Feb;245(2):297-304. PMID: 17245185.

" Xn Not dangerous goods.

LKT F4680 Flutamide 5 g 136 Non-steroid; AR antagonist. 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]- propanamide Drogenil; Euflex; Flucinom; Fugerel 13311-84-7 ≥98% 276.22 C11H11F3N2O3 CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F Ambient Ambient Insoluble in water. Soluble in DMSO. "Al-Saeedi F. Effects of flutamide on [methyl-(3)h]-choline uptake in human prostate cancer-3 cells: a pilot study. Curr Ther Res Clin Exp. 2007 Jul;68(4):226-41. PMID: 24683213.

 

Shimizu T, Yu HP, Hsieh YC, et al. Flutamide attenuates pro-inflammatory cytokine production and hepatic injury following trauma-hemorrhage via estrogen receptor-related pathway. Ann Surg. 2007 Feb;245(2):297-304. PMID: 17245185.

" Xn Not dangerous goods.

LKT F4681 Flumazenil 25 mg 115.5 GABA-A antagonist. 8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepinne-3-carboxylic acid ethyl ester Anexate; Ro-15-1788; Lanexat; Romazicon 78755-81-4 ≥98% 303.29 C15H14FN3O3 CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C Ambient 4°C Soluble in water (128mg/L). "Rye DB, Bliwise DL, Parker K, et al. Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors. Sci Transl Med. 2012 Nov 21;4(161):161ra151. PMID: 23175709.

 

Lader M. Benzodiazepines revisited--will we ever learn? Addiction. 2011 Dec;106(12):2086-109. PMID: 21714826.

" None Not dangerous goods.

LKT F4681 Flumazenil 100 mg 462.1 GABA-A antagonist. 8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepinne-3-carboxylic acid ethyl ester Anexate; Ro-15-1788; Lanexat; Romazicon 78755-81-4 ≥98% 303.29 C15H14FN3O3 CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C Ambient 4°C Soluble in water (128mg/L). "Rye DB, Bliwise DL, Parker K, et al. Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors. Sci Transl Med. 2012 Nov 21;4(161):161ra151. PMID: 23175709.

 

Lader M. Benzodiazepines revisited--will we ever learn? Addiction. 2011 Dec;106(12):2086-109. PMID: 21714826.

" None Not dangerous goods.

LKT F4683 Fluticasone Propionate 10 mg 93.8 β2-adrenergic agonist. 80474-14-2 ≥98% 500.57 C25H31F3O5S CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF Ambient Ambient 10 mg/ml DMSO "Kan-O K, Matsumoto K, Inoue H, et al. Corticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium. Int Arch Allergy Immunol. 2013;160(1):27-36. PMID: 22948082.

 

Mendes ES, Horvath G, Campos M, et al. Rapid corticosteroid effect on beta(2)-adrenergic airway and airway vascular reactivity in patients with mild asthma. J Allergy Clin Immunol. 2008 Mar;121(3):700-4. PMID: 18086493.

 

Lee SY, Kim JS, Lee JM, et al. Inhaled corticosteroid prevents the thickening of airway smooth muscle in murine model of chronic asthma. Pulm Pharmacol Ther. 2008;21(1):14-9. PMID: 17142077.

 

Edwards MR, Haas J, Panettieri RA Jr, et al. Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct Cis-acting elements. J Biol Chem. 2007 May 25;282(21):15366-75. PMID: 17395587.

 

Booth H, Richmond I, Ward C, et al. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Am J Respir Crit Care Med. 1995 Jul;152(1):45-52. PMID: 7599861.

" Xn, T Not dangerous goods.

LKT F4683 Fluticasone Propionate 25 mg 187.4 β2-adrenergic agonist. 80474-14-2 ≥98% 500.57 C25H31F3O5S CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF Ambient Ambient 10 mg/ml DMSO "Kan-O K, Matsumoto K, Inoue H, et al. Corticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium. Int Arch Allergy Immunol. 2013;160(1):27-36. PMID: 22948082.

 

Mendes ES, Horvath G, Campos M, et al. Rapid corticosteroid effect on beta(2)-adrenergic airway and airway vascular reactivity in patients with mild asthma. J Allergy Clin Immunol. 2008 Mar;121(3):700-4. PMID: 18086493.

 

Lee SY, Kim JS, Lee JM, et al. Inhaled corticosteroid prevents the thickening of airway smooth muscle in murine model of chronic asthma. Pulm Pharmacol Ther. 2008;21(1):14-9. PMID: 17142077.

 

Edwards MR, Haas J, Panettieri RA Jr, et al. Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct Cis-acting elements. J Biol Chem. 2007 May 25;282(21):15366-75. PMID: 17395587.

 

Booth H, Richmond I, Ward C, et al. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Am J Respir Crit Care Med. 1995 Jul;152(1):45-52. PMID: 7599861.

" Xn, T Not dangerous goods.

LKT F4683 Fluticasone Propionate 100 mg 609.5 β2-adrenergic agonist. 80474-14-2 ≥98% 500.57 C25H31F3O5S CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF Ambient Ambient 10 mg/ml DMSO "Kan-O K, Matsumoto K, Inoue H, et al. Corticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium. Int Arch Allergy Immunol. 2013;160(1):27-36. PMID: 22948082.

 

Mendes ES, Horvath G, Campos M, et al. Rapid corticosteroid effect on beta(2)-adrenergic airway and airway vascular reactivity in patients with mild asthma. J Allergy Clin Immunol. 2008 Mar;121(3):700-4. PMID: 18086493.

 

Lee SY, Kim JS, Lee JM, et al. Inhaled corticosteroid prevents the thickening of airway smooth muscle in murine model of chronic asthma. Pulm Pharmacol Ther. 2008;21(1):14-9. PMID: 17142077.

 

Edwards MR, Haas J, Panettieri RA Jr, et al. Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct Cis-acting elements. J Biol Chem. 2007 May 25;282(21):15366-75. PMID: 17395587.

 

Booth H, Richmond I, Ward C, et al. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Am J Respir Crit Care Med. 1995 Jul;152(1):45-52. PMID: 7599861.

" Xn, T Not dangerous goods.

LKT F4781 Fludarabine 5 mg 61.1 Nucleoside (adenosine) analog; DNA chain terminator, ribonucleotide reductase, DNA ligase, DNA primase inhibitor, A1 adenosine antagonist. 2-Fluoroadenine-9-b-D-arabinofuranoside 21679-14-1 ≥98% 285.23 C10H12FN5O4 C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(N=C2N)F Ambient Ambient Slightly soluble in water (3.5 mg/mL).  Soluble in DMSO (100 mM) "Jensen K, Johnson LA, Jacobson PA, et al. Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol. 2012 May;385(5):519-25. PMID: 22249336.

 

Nishioka C, Ikezoe T, Togitani K, et al. Fludarabine induces growth arrest and apoptosis of cytokine- or alloantigen-stimulated peripheral blood mononuclear cells, and decreases production of Th1 cytokines via inhibition of nuclear factor kappaB. Bone Marrow Transplant. 2008 Feb;41(3):303-9. PMID: 17994120.

 

Gandhi V, Plunkett W. Cellular and clinical pharmacology of fludarabine. Clin Pharmacokinet. 2002;41(2):93-103. PMID: 11888330.

" T, Xi Not dangerous goods.

LKT F4781 Fludarabine 10 mg 88.3 Nucleoside (adenosine) analog; DNA chain terminator, ribonucleotide reductase, DNA ligase, DNA primase inhibitor, A1 adenosine antagonist. 2-Fluoroadenine-9-b-D-arabinofuranoside 21679-14-1 ≥98% 285.23 C10H12FN5O4 C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(N=C2N)F Ambient Ambient Slightly soluble in water (3.5 mg/mL).  Soluble in DMSO (100 mM) "Jensen K, Johnson LA, Jacobson PA, et al. Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol. 2012 May;385(5):519-25. PMID: 22249336.

 

Nishioka C, Ikezoe T, Togitani K, et al. Fludarabine induces growth arrest and apoptosis of cytokine- or alloantigen-stimulated peripheral blood mononuclear cells, and decreases production of Th1 cytokines via inhibition of nuclear factor kappaB. Bone Marrow Transplant. 2008 Feb;41(3):303-9. PMID: 17994120.

 

Gandhi V, Plunkett W. Cellular and clinical pharmacology of fludarabine. Clin Pharmacokinet. 2002;41(2):93-103. PMID: 11888330.

" T, Xi Not dangerous goods.

LKT F4781 Fludarabine 25 mg 244.5 Nucleoside (adenosine) analog; DNA chain terminator, ribonucleotide reductase, DNA ligase, DNA primase inhibitor, A1 adenosine antagonist. 2-Fluoroadenine-9-b-D-arabinofuranoside 21679-14-1 ≥98% 285.23 C10H12FN5O4 C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(N=C2N)F Ambient Ambient Slightly soluble in water (3.5 mg/mL).  Soluble in DMSO (100 mM) "Jensen K, Johnson LA, Jacobson PA, et al. Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol. 2012 May;385(5):519-25. PMID: 22249336.

 

Nishioka C, Ikezoe T, Togitani K, et al. Fludarabine induces growth arrest and apoptosis of cytokine- or alloantigen-stimulated peripheral blood mononuclear cells, and decreases production of Th1 cytokines via inhibition of nuclear factor kappaB. Bone Marrow Transplant. 2008 Feb;41(3):303-9. PMID: 17994120.

 

Gandhi V, Plunkett W. Cellular and clinical pharmacology of fludarabine. Clin Pharmacokinet. 2002;41(2):93-103. PMID: 11888330.

" T, Xi Not dangerous goods.

LKT F4782 Fludarabine Phosphate 5 mg 47.6 Nucleoside (adenosine) analog; DNA chain terminator, ribonucleotide reductase, DNA ligase, DNA primase inhibitor, A1 adenosine antagonist. F-ara-A 75607-67-9 ≥98% 365.21 C10H13FN5O7P C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)O)O)O)N=C(N=C2N)F Ambient Ambient Slightly soluble in water (6 mg/mL). Soluble in DMSO (70 mg/mL) "Robak P and Robak T. Older and new purine nucleoside analogs for patients with acute leukemias. Cancer Treat Rev. 2013 Dec;39(8):851-61. PMID: 23566572.

 

Jensen K, Johnson LA, Jacobson PA, et al. Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol. 2012 May;385(5):519-25. PMID: 22249336.

 

Nishioka C, Ikezoe T, Togitani K, et al. Fludarabine induces growth arrest and apoptosis of cytokine- or alloantigen-stimulated peripheral blood mononuclear cells, and decreases production of Th1 cytokines via inhibition of nuclear factor kappaB. Bone Marrow Transplant. 2008 Feb;41(3):303-9. PMID: 17994120.

 

Gandhi V, Plunkett W. Cellular and clinical pharmacology of fludarabine. Clin Pharmacokinet. 2002;41(2):93-103. PMID: 11888330.

 

Yamauchi T, Nowak BJ, Keating MJ, et al. DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine. Clin Cancer Res. 2001 Nov;7(11):3580-9. PMID: 11705880.

 

Catapano CV, Perrino FW, Fernandes DJ. Primer RNA chain termination induced by 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-triphosphate. A mechanism of DNA synthesis inhibition. J Biol Chem. 1993 Apr 5;268(10):7179-85. PMID: 7681821.

" Not dangerous goods.

LKT F4782 Fludarabine Phosphate 10 mg 67.9 Nucleoside (adenosine) analog; DNA chain terminator, ribonucleotide reductase, DNA ligase, DNA primase inhibitor, A1 adenosine antagonist. F-ara-A 75607-67-9 ≥98% 365.21 C10H13FN5O7P C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)O)O)O)N=C(N=C2N)F Ambient Ambient Slightly soluble in water (6 mg/mL). Soluble in DMSO (70 mg/mL) "Robak P and Robak T. Older and new purine nucleoside analogs for patients with acute leukemias. Cancer Treat Rev. 2013 Dec;39(8):851-61. PMID: 23566572.

 

Jensen K, Johnson LA, Jacobson PA, et al. Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol. 2012 May;385(5):519-25. PMID: 22249336.

 

Nishioka C, Ikezoe T, Togitani K, et al. Fludarabine induces growth arrest and apoptosis of cytokine- or alloantigen-stimulated peripheral blood mononuclear cells, and decreases production of Th1 cytokines via inhibition of nuclear factor kappaB. Bone Marrow Transplant. 2008 Feb;41(3):303-9. PMID: 17994120.

 

Gandhi V, Plunkett W. Cellular and clinical pharmacology of fludarabine. Clin Pharmacokinet. 2002;41(2):93-103. PMID: 11888330.

 

Yamauchi T, Nowak BJ, Keating MJ, et al. DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine. Clin Cancer Res. 2001 Nov;7(11):3580-9. PMID: 11705880.

 

Catapano CV, Perrino FW, Fernandes DJ. Primer RNA chain termination induced by 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-triphosphate. A mechanism of DNA synthesis inhibition. J Biol Chem. 1993 Apr 5;268(10):7179-85. PMID: 7681821.

" Not dangerous goods.

LKT F4782 Fludarabine Phosphate 25 mg 163.2 Nucleoside (adenosine) analog; DNA chain terminator, ribonucleotide reductase, DNA ligase, DNA primase inhibitor, A1 adenosine antagonist. F-ara-A 75607-67-9 ≥98% 365.21 C10H13FN5O7P C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)O)O)O)N=C(N=C2N)F Ambient Ambient Slightly soluble in water (6 mg/mL). Soluble in DMSO (70 mg/mL) "Robak P and Robak T. Older and new purine nucleoside analogs for patients with acute leukemias. Cancer Treat Rev. 2013 Dec;39(8):851-61. PMID: 23566572.

 

Jensen K, Johnson LA, Jacobson PA, et al. Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol. 2012 May;385(5):519-25. PMID: 22249336.

 

Nishioka C, Ikezoe T, Togitani K, et al. Fludarabine induces growth arrest and apoptosis of cytokine- or alloantigen-stimulated peripheral blood mononuclear cells, and decreases production of Th1 cytokines via inhibition of nuclear factor kappaB. Bone Marrow Transplant. 2008 Feb;41(3):303-9. PMID: 17994120.

 

Gandhi V, Plunkett W. Cellular and clinical pharmacology of fludarabine. Clin Pharmacokinet. 2002;41(2):93-103. PMID: 11888330.

 

Yamauchi T, Nowak BJ, Keating MJ, et al. DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine. Clin Cancer Res. 2001 Nov;7(11):3580-9. PMID: 11705880.

 

Catapano CV, Perrino FW, Fernandes DJ. Primer RNA chain termination induced by 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-triphosphate. A mechanism of DNA synthesis inhibition. J Biol Chem. 1993 Apr 5;268(10):7179-85. PMID: 7681821.

" Not dangerous goods.

LKT F4783 Fluvoxamine Maleate 25 mg 75.3 FIASMA, 5-HT3 and σ1 agonist, SERT inhibitor. (E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone-O-(2-aminoethyl)oxime maleate 61718-82-9 ≥97% 434.41 C15H21O2N2F3 C4H4O4 COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F.C(=CC(=O)O)C(=O)O Ambient 4°C "Hodge JM, Wang Y, Berk M, et al. Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function. Biol Psychiatry. 2013 Jul 1;74(1):32-9. PMID: 23260229.

 

Fu Y, Yu S, Guo X, et al. Fluvoxamine increased glutamate release by activating both 5-HT(3) and sigma-1 receptors in prelimbic cortex of chronic restraint stress C57BL/6 mice. Biochim Biophys Acta. 2012 Apr;1823(4):826-37. PMID: 22306004.

 

Tynan RJ, Weidenhofer J, Hinwood M, et al. A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun. 2012 Mar;26(3):469-79. PMID: 22251606.

 

Tagashira H, Bhuiyan S, Shioda N, et al. Sigma1-receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice. Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1535-45. PMID: 20802134.

 

Dursun H, Bilici M, Albayrak F, et al. Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue. BMC Gastroenterol. 2009 May 20;9:36. PMID: 19457229.

" Xn Not dangerous goods.

LKT F4783 Fluvoxamine Maleate 100 mg 251.3 FIASMA, 5-HT3 and σ1 agonist, SERT inhibitor. (E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone-O-(2-aminoethyl)oxime maleate 61718-82-9 ≥97% 434.41 C15H21O2N2F3 C4H4O4 COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F.C(=CC(=O)O)C(=O)O Ambient 4°C "Hodge JM, Wang Y, Berk M, et al. Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function. Biol Psychiatry. 2013 Jul 1;74(1):32-9. PMID: 23260229.

 

Fu Y, Yu S, Guo X, et al. Fluvoxamine increased glutamate release by activating both 5-HT(3) and sigma-1 receptors in prelimbic cortex of chronic restraint stress C57BL/6 mice. Biochim Biophys Acta. 2012 Apr;1823(4):826-37. PMID: 22306004.

 

Tynan RJ, Weidenhofer J, Hinwood M, et al. A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun. 2012 Mar;26(3):469-79. PMID: 22251606.

 

Tagashira H, Bhuiyan S, Shioda N, et al. Sigma1-receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice. Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1535-45. PMID: 20802134.

 

Dursun H, Bilici M, Albayrak F, et al. Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue. BMC Gastroenterol. 2009 May 20;9:36. PMID: 19457229.

" Xn Not dangerous goods.

LKT F4783 Fluvoxamine Maleate 500 mg 837.2 FIASMA, 5-HT3 and σ1 agonist, SERT inhibitor. (E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone-O-(2-aminoethyl)oxime maleate 61718-82-9 ≥97% 434.41 C15H21O2N2F3 C4H4O4 COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F.C(=CC(=O)O)C(=O)O Ambient 4°C "Hodge JM, Wang Y, Berk M, et al. Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function. Biol Psychiatry. 2013 Jul 1;74(1):32-9. PMID: 23260229.

 

Fu Y, Yu S, Guo X, et al. Fluvoxamine increased glutamate release by activating both 5-HT(3) and sigma-1 receptors in prelimbic cortex of chronic restraint stress C57BL/6 mice. Biochim Biophys Acta. 2012 Apr;1823(4):826-37. PMID: 22306004.

 

Tynan RJ, Weidenhofer J, Hinwood M, et al. A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun. 2012 Mar;26(3):469-79. PMID: 22251606.

 

Tagashira H, Bhuiyan S, Shioda N, et al. Sigma1-receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice. Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1535-45. PMID: 20802134.

 

Dursun H, Bilici M, Albayrak F, et al. Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue. BMC Gastroenterol. 2009 May 20;9:36. PMID: 19457229.

" Xn Not dangerous goods.

LKT F4856 Fmoc-Lys(Boc)-Leu-Lys(Boc) 1 g 1650.2 Tripeptide used for glycation. ≥98% 809.9 C26H35N8O7S Ambient -20°C Mennella C, Visciano M, Napolitano A, et al. Glycation of lysine-containing dipeptides. J Pept Sci. 2006 Apr;12(4):291-6. PMID: 16180244.

LKT F4857 FMRF Amide 1 mg 90.1 Cardiostimulatory neuropeptide; delayed rectifier K+ channel modulator. ≥95% 598.76 C29H42N8O4S CSCCC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=CC=C1)C(=O)N)NC(=O)C(CC2=CC=CC=C2)N Hygroscopic. Ambient -20°C Soluble in 5% acetic acid. "Di Cristo C. Nervous control of reproduction in Octopus vulgaris: a new model. Invert Neurosci. 2013 Jun;13(1):27-34. PMID: 23558706.

 

Ringstad N, Horvitz HR. FMRFamide neuropeptides and acetylcholine synergistically inhibit egg-laying by C. elegans. Nat Neurosci. 2008 Oct;11(10):1168-76. PMID: 18806786.

 

Ni MM, Luo Y, Liu J, et al. FMRFamide modulates outward potassium currents in mouse olfactory sensory neurons. Clin Exp Pharmacol Physiol. 2008 May;35(5-6):563-7. PMID: 18067588." Not dangerous goods.

LKT F4858 FMRF-like Peptide, snail 1 mg 149.9 Cardiostimulatory neuropeptide  found in Lymnaea; delayed rectifier K+ channel modulator. ≥98% 904.03 C44H62N11O10 Ambient -20°C Soluble in water. "Di Cristo C. Nervous control of reproduction in Octopus vulgaris: a new model. Invert Neurosci. 2013 Jun;13(1):27-34. PMID: 23558706.

 

Ringstad N, Horvitz HR. FMRFamide neuropeptides and acetylcholine synergistically inhibit egg-laying by C. elegans. Nat Neurosci. 2008 Oct;11(10):1168-76. PMID: 18806786.

 

Ni MM, Luo Y, Liu J, et al. FMRFamide modulates outward potassium currents in mouse olfactory sensory neurons. Clin Exp Pharmacol Physiol. 2008 May;35(5-6):563-7. PMID: 18067588.

 

Skingsley DR, Bright K, Santama N, et al. A molecularly defined cardiorespiratory interneuron expressing SDPFLRFamide/GDPFLRFamide in the snail Lymnaea: monosynaptic connections and pharmacology. J Neurophysiol. 1993 Mar;69(3):915-27. PMID: 8096540.

 

Ebberink RH, Price DA, van Loenhout H, et al. The brain of Lymnaea contains a family of FMRFamide-like peptides. Peptides. 1987 May-Jun;8(3):515-22. PMID: 3658814.

" Not dangerous goods.

LKT F4859 FMRF 5 mg 60 Neuropeptide, involved in reproductive behavior. ≥95% 599.76 C29H41N7O5S Ambient -20°C "Di Cristo C. Nervous control of reproduction in Octopus vulgaris: a new model. Invert Neurosci. 2013 Jun;13(1):27-34. PMID: 23558706.

 

Ringstad N, Horvitz HR. FMRFamide neuropeptides and acetylcholine synergistically inhibit egg-laying by C. elegans. Nat Neurosci. 2008 Oct;11(10):1168-76. PMID: 18806786.

 

Ni MM, Luo Y, Liu J, et al. FMRFamide modulates outward potassium currents in mouse olfactory sensory neurons. Clin Exp Pharmacol Physiol. 2008 May;35(5-6):563-7. PMID: 18067588.

" Not dangerous goods.

LKT F4859 FMRF 10 mg 101.9 Neuropeptide, involved in reproductive behavior. ≥95% 599.76 C29H41N7O5S Ambient -20°C "Di Cristo C. Nervous control of reproduction in Octopus vulgaris: a new model. Invert Neurosci. 2013 Jun;13(1):27-34. PMID: 23558706.

 

Ringstad N, Horvitz HR. FMRFamide neuropeptides and acetylcholine synergistically inhibit egg-laying by C. elegans. Nat Neurosci. 2008 Oct;11(10):1168-76. PMID: 18806786.

 

Ni MM, Luo Y, Liu J, et al. FMRFamide modulates outward potassium currents in mouse olfactory sensory neurons. Clin Exp Pharmacol Physiol. 2008 May;35(5-6):563-7. PMID: 18067588.

" Not dangerous goods.

LKT F4859 FMRF 25 mg 180 Neuropeptide, involved in reproductive behavior. ≥95% 599.76 C29H41N7O5S Ambient -20°C "Di Cristo C. Nervous control of reproduction in Octopus vulgaris: a new model. Invert Neurosci. 2013 Jun;13(1):27-34. PMID: 23558706.

 

Ringstad N, Horvitz HR. FMRFamide neuropeptides and acetylcholine synergistically inhibit egg-laying by C. elegans. Nat Neurosci. 2008 Oct;11(10):1168-76. PMID: 18806786.

 

Ni MM, Luo Y, Liu J, et al. FMRFamide modulates outward potassium currents in mouse olfactory sensory neurons. Clin Exp Pharmacol Physiol. 2008 May;35(5-6):563-7. PMID: 18067588.

" Not dangerous goods.

LKT F5668 Forskolin 1 mg 27.2 Labdane diterpene found in Coleus; PP2A and adenylyl cyclase activator. (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-5-(Acetyloxy)-3- ethenyldodecahydro-6,10-10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one Colforsin; Boforsin 66575-29-9 ≥98% 410.5 C22H34O7 CC(=O)OC1C(C2C(CCC(C2(C3(C1(OC(CC3=O)(C)C=C)C)O)C)O)(C)C)O Ambient -20°C Soluble in DMSO (5mg/mL) or ethanol (6 mg/ml). "Rodriguez G, Ross JA, Nagy ZS, et al. Forskolin-inducible cAMP pathway negatively regulates T-cell proliferation by uncoupling the interleukin-2 receptor complex. J Biol Chem. 2013 Mar 8;288(10):7137-46. PMID: 23341462.

 

Makinodan E, Marneros AG. Protein kinase A activation inhibits oncogenic Sonic hedgehog signalling and suppresses basal cell carcinoma of the skin. Exp Dermatol. 2012 Nov;21(11):847-52. PMID: 23163650.

 

Alasbahi RH, Melzig MF. Forskolin and derivatives as tools for studying the role of cAMP. Pharmazie. 2012 Jan;67(1):5-13. PMID: 22393824.

 

Cristóbal I, Garcia-Orti L, Cirauqui C, et al. PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect. Leukemia. 2011 Apr;25(4):606-14. PMID: 21233840.

 

Asai M, Tsukamoto O, Minamino T, et al. PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts. J Mol Cell Cardiol. 2009 Apr;46(4):452-62. PMID: 19059265.

 

Kaur M, Holden NS, Wilson SM, et al. Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. Am J Physiol Lung Cell Mol Physiol. 2008 Sep;295(3):L505-14. PMID: 18586957.

 

Zeng S, Shen B, Wen L, et al. Experimental studies of the effect of Forskolin on the lowering of intraocular pressure. Yan Ke Xue Bao. 1995 Sep;11(3):173-6. PMID: 8758848.

" Xn Not dangerous goods.

LKT F5668 Forskolin 5 mg 61.1 Labdane diterpene found in Coleus; PP2A and adenylyl cyclase activator. (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-5-(Acetyloxy)-3- ethenyldodecahydro-6,10-10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one Colforsin; Boforsin 66575-29-9 ≥98% 410.5 C22H34O7 CC(=O)OC1C(C2C(CCC(C2(C3(C1(OC(CC3=O)(C)C=C)C)O)C)O)(C)C)O Ambient -20°C Soluble in DMSO (5mg/mL) or ethanol (6 mg/ml). "Rodriguez G, Ross JA, Nagy ZS, et al. Forskolin-inducible cAMP pathway negatively regulates T-cell proliferation by uncoupling the interleukin-2 receptor complex. J Biol Chem. 2013 Mar 8;288(10):7137-46. PMID: 23341462.

 

Makinodan E, Marneros AG. Protein kinase A activation inhibits oncogenic Sonic hedgehog signalling and suppresses basal cell carcinoma of the skin. Exp Dermatol. 2012 Nov;21(11):847-52. PMID: 23163650.

 

Alasbahi RH, Melzig MF. Forskolin and derivatives as tools for studying the role of cAMP. Pharmazie. 2012 Jan;67(1):5-13. PMID: 22393824.

 

Cristóbal I, Garcia-Orti L, Cirauqui C, et al. PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect. Leukemia. 2011 Apr;25(4):606-14. PMID: 21233840.

 

Asai M, Tsukamoto O, Minamino T, et al. PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts. J Mol Cell Cardiol. 2009 Apr;46(4):452-62. PMID: 19059265.

 

Kaur M, Holden NS, Wilson SM, et al. Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. Am J Physiol Lung Cell Mol Physiol. 2008 Sep;295(3):L505-14. PMID: 18586957.

 

Zeng S, Shen B, Wen L, et al. Experimental studies of the effect of Forskolin on the lowering of intraocular pressure. Yan Ke Xue Bao. 1995 Sep;11(3):173-6. PMID: 8758848.

" Xn Not dangerous goods.

LKT F5668 Forskolin 10 mg 81.6 Labdane diterpene found in Coleus; PP2A and adenylyl cyclase activator. (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-5-(Acetyloxy)-3- ethenyldodecahydro-6,10-10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-1-one Colforsin; Boforsin 66575-29-9 ≥98% 410.5 C22H34O7 CC(=O)OC1C(C2C(CCC(C2(C3(C1(OC(CC3=O)(C)C=C)C)O)C)O)(C)C)O Ambient -20°C Soluble in DMSO (5mg/mL) or ethanol (6 mg/ml). "Rodriguez G, Ross JA, Nagy ZS, et al. Forskolin-inducible cAMP pathway negatively regulates T-cell proliferation by uncoupling the interleukin-2 receptor complex. J Biol Chem. 2013 Mar 8;288(10):7137-46. PMID: 23341462.

 

Makinodan E, Marneros AG. Protein kinase A activation inhibits oncogenic Sonic hedgehog signalling and suppresses basal cell carcinoma of the skin. Exp Dermatol. 2012 Nov;21(11):847-52. PMID: 23163650.

 

Alasbahi RH, Melzig MF. Forskolin and derivatives as tools for studying the role of cAMP. Pharmazie. 2012 Jan;67(1):5-13. PMID: 22393824.

 

Cristóbal I, Garcia-Orti L, Cirauqui C, et al. PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect. Leukemia. 2011 Apr;25(4):606-14. PMID: 21233840.

 

Asai M, Tsukamoto O, Minamino T, et al. PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts. J Mol Cell Cardiol. 2009 Apr;46(4):452-62. PMID: 19059265.

 

Kaur M, Holden NS, Wilson SM, et al. Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. Am J Physiol Lung Cell Mol Physiol. 2008 Sep;295(3):L505-14. PMID: 18586957.

 

Zeng S, Shen B, Wen L, et al. Experimental studies of the effect of Forskolin on the lowering of intraocular pressure. Yan Ke Xue Bao. 1995 Sep;11(3):173-6. PMID: 8758848.

" Xn Not dangerous goods.

LKT "F5745

" Folic Acid 10 g 33.9 Non-endogenous essential vitamin (B9), found in leafy vegetables, required for synthesis and repair of DNA. N-[4-[[(2-Amino-1,4-dihydrox-4-oxo-6-pteridinyl)- methyl]amino]benzoyl]-L-glutamic acid PGA; Vitamin M; Folacin; Foliamin; Folipac; Folsan; Millafol 59-30-3 ≥96% 441.4 C19H19N7O6 C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N Ambient 4°C Soluble in hot dil HCl or H2SO4. Slightly soluble in methanol, acetic acid, phenol, or pyridine. Insoluble in acetone, chloroform, ether, water, or benzene. "Reynolds EH. The neurology of folic acid deficiency. Handb Clin Neurol. 2014;120:927-43. PMID: 24365361.

 

Czeizel AE, Dudás I, Vereczkey A, et al. Folate deficiency and folic acid supplementation: the prevention of neural-tube defects and congenital heart defects. Nutrients. 2013 Nov 21;5(11):4760-75. PMID: 24284617.

 

Ebisch IM, Thomas CM, Peters WH, et al. The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Hum Reprod Update. 2007 Mar-Apr;13(2):163-74. PMID: 17099205.

 

Coppen A, Bolander-Gouaille C. Treatment of depression: time to consider folic acid and vitamin B12. J Psychopharmacol. 2005 Jan;19(1):59-65. PMID: 15671130.

" None Not dangerous goods.

LKT "F5745

" Folic Acid 50 g 95.1 Non-endogenous essential vitamin (B9), found in leafy vegetables, required for synthesis and repair of DNA. N-[4-[[(2-Amino-1,4-dihydrox-4-oxo-6-pteridinyl)- methyl]amino]benzoyl]-L-glutamic acid PGA; Vitamin M; Folacin; Foliamin; Folipac; Folsan; Millafol 59-30-3 ≥96% 441.4 C19H19N7O6 C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N Ambient 4°C Soluble in hot dil HCl or H2SO4. Slightly soluble in methanol, acetic acid, phenol, or pyridine. Insoluble in acetone, chloroform, ether, water, or benzene. "Reynolds EH. The neurology of folic acid deficiency. Handb Clin Neurol. 2014;120:927-43. PMID: 24365361.

 

Czeizel AE, Dudás I, Vereczkey A, et al. Folate deficiency and folic acid supplementation: the prevention of neural-tube defects and congenital heart defects. Nutrients. 2013 Nov 21;5(11):4760-75. PMID: 24284617.

 

Ebisch IM, Thomas CM, Peters WH, et al. The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Hum Reprod Update. 2007 Mar-Apr;13(2):163-74. PMID: 17099205.

 

Coppen A, Bolander-Gouaille C. Treatment of depression: time to consider folic acid and vitamin B12. J Psychopharmacol. 2005 Jan;19(1):59-65. PMID: 15671130.

" None Not dangerous goods.

LKT F5766 Forchlorfenuron 500 mg 101 Synthetic cytokinin, plant growth regulator; filament polymerization inhibitor. N-(2-chloro-4-pyridinyl)-N'-phenyl-Urea KT-30 68157-60-8 ≥98% 247.68 C12H10ClN3O C1=CC=C(C=C1)NC(=O)NC2=CC(=NC=C2)Cl Ambient Ambient Soluble in water (39mg/L) at pH6.4. "Zeraik AE, Galkin VE, Rinaldi G, et al. Reversible paralysis of Schistosoma mansoni by forchlorfenuron, a phenylurea cytokinin that affects septins. Int J Parasitol. 2014 Apr 21. [Epub ahead of print]. PMID: 24768753.

 

Vardi-Oknin D, Golan M, Mabjeesh NJ. Forchlorfenuron disrupts SEPT9_i1 filaments and inhibits HIF-1. PLoS One. 2013 Aug 19;8(8):e73179. PMID: 23977378.

 

Hu Q, Nelson WJ, Spiliotis ET. Forchlorfenuron alters mammalian septin assembly, organization, and dynamics. J Biol Chem. 2008 Oct 24;283(43):29563-71. PMID: 18713753.

" Xn, N "UN number: 3077     Class: 9     Packing Group: III

Proper shipping name: Environmentally hazardous substance, solid, n.o.s. (Forchlorfenuron)"

LKT F5766 Forchlorfenuron 1 g 163.9 Synthetic cytokinin, plant growth regulator; filament polymerization inhibitor. N-(2-chloro-4-pyridinyl)-N'-phenyl-Urea KT-30 68157-60-8 ≥98% 247.68 C12H10ClN3O C1=CC=C(C=C1)NC(=O)NC2=CC(=NC=C2)Cl Ambient Ambient Soluble in water (39mg/L) at pH6.4. "Zeraik AE, Galkin VE, Rinaldi G, et al. Reversible paralysis of Schistosoma mansoni by forchlorfenuron, a phenylurea cytokinin that affects septins. Int J Parasitol. 2014 Apr 21. [Epub ahead of print]. PMID: 24768753.

 

Vardi-Oknin D, Golan M, Mabjeesh NJ. Forchlorfenuron disrupts SEPT9_i1 filaments and inhibits HIF-1. PLoS One. 2013 Aug 19;8(8):e73179. PMID: 23977378.

 

Hu Q, Nelson WJ, Spiliotis ET. Forchlorfenuron alters mammalian septin assembly, organization, and dynamics. J Biol Chem. 2008 Oct 24;283(43):29563-71. PMID: 18713753.

" Xn, N "UN number: 3077     Class: 9     Packing Group: III

Proper shipping name: Environmentally hazardous substance, solid, n.o.s. (Forchlorfenuron)"

LKT F5766 Forchlorfenuron 5 g 630.1 Synthetic cytokinin, plant growth regulator; filament polymerization inhibitor. N-(2-chloro-4-pyridinyl)-N'-phenyl-Urea KT-30 68157-60-8 ≥98% 247.68 C12H10ClN3O C1=CC=C(C=C1)NC(=O)NC2=CC(=NC=C2)Cl Ambient Ambient Soluble in water (39mg/L) at pH6.4. "Zeraik AE, Galkin VE, Rinaldi G, et al. Reversible paralysis of Schistosoma mansoni by forchlorfenuron, a phenylurea cytokinin that affects septins. Int J Parasitol. 2014 Apr 21. [Epub ahead of print]. PMID: 24768753.

 

Vardi-Oknin D, Golan M, Mabjeesh NJ. Forchlorfenuron disrupts SEPT9_i1 filaments and inhibits HIF-1. PLoS One. 2013 Aug 19;8(8):e73179. PMID: 23977378.

 

Hu Q, Nelson WJ, Spiliotis ET. Forchlorfenuron alters mammalian septin assembly, organization, and dynamics. J Biol Chem. 2008 Oct 24;283(43):29563-71. PMID: 18713753.

" Xn, N "UN number: 3077     Class: 9     Packing Group: III

Proper shipping name: Environmentally hazardous substance, solid, n.o.s. (Forchlorfenuron)"

LKT F5769 Formestane 100 mg 40.7 Steroid; aromatase inhibitor. 4-Hydroxyandrost-4-ene-3,17-dione 4-OHA; Lentaron 566-48-3 ≥98% 302.41 C19H26O3 CC12CCC(=O)C(=C1CCC3C2CCC4(C3CCC4=O)C)O Ambient Ambient Soluble in methanol. "Miller WR. Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer. Semin Oncol. 2003 Aug;30(4 Suppl 14):3-11. PMID: 14513432.

 

Dowsett M. Aromatase inhibition: basic concepts, and the pharmacodynamics of formestane. Ann Oncol. 1994;5 Suppl 7:S3-5. PMID: 7873460." T Not dangerous goods.

LKT F5769 Formestane 500 mg 88.3 Steroid; aromatase inhibitor. 4-Hydroxyandrost-4-ene-3,17-dione 4-OHA; Lentaron 566-48-3 ≥98% 302.41 C19H26O3 CC12CCC(=O)C(=C1CCC3C2CCC4(C3CCC4=O)C)O Ambient Ambient Soluble in methanol. "Miller WR. Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer. Semin Oncol. 2003 Aug;30(4 Suppl 14):3-11. PMID: 14513432.

 

Dowsett M. Aromatase inhibition: basic concepts, and the pharmacodynamics of formestane. Ann Oncol. 1994;5 Suppl 7:S3-5. PMID: 7873460." T Not dangerous goods.

LKT F5770 Formononetin 100 mg 67.9 Isoflavone found in legumes such as soy. 7-Hydroxy-3-(4-methoxyphenyl)-4H-1-benzopyran-4-one Biochanin B; Formononetol; Neochanin 485-72-3 ≥90% 268.26 C16H12O4 COC1=CC=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)O Store in a cool, dry place. Keep away from light. Ambient Ambient Soluble in DMSO (200mg/mL) or methanol (2mg/mL). "Li Z, Dong X, Zhang J, et al. Formononetin protects TBI rats against neurological lesions and the underlying mechanism. J Neurol Sci. 2014 Mar 15;338(1-2):112-7. PMID: 24411660.

 

Huang WJ, Bi LY, Li ZZ, et al. Formononetin induces the mitochondrial apoptosis pathway in prostate cancer cells via downregulation of the IGF-1/IGF-1R signaling pathway. Pharm Biol. 2013 Dec 20. [Epub ahead of print]. PMID: 24359236.

 

Sun T, Wang J, Huang LH, et al. Antihypertensive effect of formononetin through regulating the expressions of eNOS, 5-HT2A/1B receptors and α1-adrenoceptors in spontaneously rat arteries. Eur J Pharmacol. 2013 Jan 15;699(1-3):241-9. PMID: 23123056.

 

Lauwaet T, Andersen Y, Van de Ven L, et al. Rapid detachment of Giardia lamblia trophozoites as a mechanism of antimicrobial action of the isoflavone formononetin. J Antimicrob Chemother. 2010 Mar;65(3):531-4. PMID: 20067984.

 

Huh JE, Kwon NH, Baek YH, et al. Formononetin promotes early fracture healing through stimulating angiogenesis by up-regulating VEGFR-2/Flk-1 in a rat fracture model. Int Immunopharmacol. 2009 Nov;9(12):1357-65. PMID: 19695348.

" Xi Not dangerous goods.

LKT F5770 Formononetin 500 mg 203.8 Isoflavone found in legumes such as soy. 7-Hydroxy-3-(4-methoxyphenyl)-4H-1-benzopyran-4-one Biochanin B; Formononetol; Neochanin 485-72-3 ≥90% 268.26 C16H12O4 COC1=CC=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)O Store in a cool, dry place. Keep away from light. Ambient Ambient Soluble in DMSO (200mg/mL) or methanol (2mg/mL). "Li Z, Dong X, Zhang J, et al. Formononetin protects TBI rats against neurological lesions and the underlying mechanism. J Neurol Sci. 2014 Mar 15;338(1-2):112-7. PMID: 24411660.

 

Huang WJ, Bi LY, Li ZZ, et al. Formononetin induces the mitochondrial apoptosis pathway in prostate cancer cells via downregulation of the IGF-1/IGF-1R signaling pathway. Pharm Biol. 2013 Dec 20. [Epub ahead of print]. PMID: 24359236.

 

Sun T, Wang J, Huang LH, et al. Antihypertensive effect of formononetin through regulating the expressions of eNOS, 5-HT2A/1B receptors and α1-adrenoceptors in spontaneously rat arteries. Eur J Pharmacol. 2013 Jan 15;699(1-3):241-9. PMID: 23123056.

 

Lauwaet T, Andersen Y, Van de Ven L, et al. Rapid detachment of Giardia lamblia trophozoites as a mechanism of antimicrobial action of the isoflavone formononetin. J Antimicrob Chemother. 2010 Mar;65(3):531-4. PMID: 20067984.

 

Huh JE, Kwon NH, Baek YH, et al. Formononetin promotes early fracture healing through stimulating angiogenesis by up-regulating VEGFR-2/Flk-1 in a rat fracture model. Int Immunopharmacol. 2009 Nov;9(12):1357-65. PMID: 19695348.

" Xi Not dangerous goods.

LKT F5770 Formononetin 1 g 339.8 Isoflavone found in legumes such as soy. 7-Hydroxy-3-(4-methoxyphenyl)-4H-1-benzopyran-4-one Biochanin B; Formononetol; Neochanin 485-72-3 ≥90% 268.26 C16H12O4 COC1=CC=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)O Store in a cool, dry place. Keep away from light. Ambient Ambient Soluble in DMSO (200mg/mL) or methanol (2mg/mL). "Li Z, Dong X, Zhang J, et al. Formononetin protects TBI rats against neurological lesions and the underlying mechanism. J Neurol Sci. 2014 Mar 15;338(1-2):112-7. PMID: 24411660.

 

Huang WJ, Bi LY, Li ZZ, et al. Formononetin induces the mitochondrial apoptosis pathway in prostate cancer cells via downregulation of the IGF-1/IGF-1R signaling pathway. Pharm Biol. 2013 Dec 20. [Epub ahead of print]. PMID: 24359236.

 

Sun T, Wang J, Huang LH, et al. Antihypertensive effect of formononetin through regulating the expressions of eNOS, 5-HT2A/1B receptors and α1-adrenoceptors in spontaneously rat arteries. Eur J Pharmacol. 2013 Jan 15;699(1-3):241-9. PMID: 23123056.

 

Lauwaet T, Andersen Y, Van de Ven L, et al. Rapid detachment of Giardia lamblia trophozoites as a mechanism of antimicrobial action of the isoflavone formononetin. J Antimicrob Chemother. 2010 Mar;65(3):531-4. PMID: 20067984.

 

Huh JE, Kwon NH, Baek YH, et al. Formononetin promotes early fracture healing through stimulating angiogenesis by up-regulating VEGFR-2/Flk-1 in a rat fracture model. Int Immunopharmacol. 2009 Nov;9(12):1357-65. PMID: 19695348.

" Xi Not dangerous goods.

LKT F5773 Fosinopril Sodium 25 mg 65.6 ACE inhibitor. "Dynacil; Eliten; Fosinil; Fosinopril sodium; Fosinorm; Fosipres; Fositen; Fositens; Foziretic; Fucithalmic; Hiperlex; Monopril; Newace; Sapril; Staril; Tenso Stop; Tensogard 

 

" 88889-14-9 ≥98% 585.64 C30H45NNaO7P CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3.[Na+] Ambient -20°C "Yang S, Li R, Tang L, et al. TLR4-mediated anti-atherosclerosis mechanisms of angiotensin-converting enzyme inhibitor--fosinopril. Cell Immunol. 2013 Sep-Oct;285(1-2):38-41. PMID: 24044965.

 

Huang K, Dai G. The effect and mechanism of forsinopril on ventricular hypertrophy of SHR and left ventricular pressure overloading rat. J Huazhong Univ Sci Technolog Med Sci. 2002;22(1):17-20. PMID: 12658773.

" Xn Not dangerous goods.

LKT F5773 Fosinopril Sodium 100 mg 225 ACE inhibitor. "Dynacil; Eliten; Fosinil; Fosinopril sodium; Fosinorm; Fosipres; Fositen; Fositens; Foziretic; Fucithalmic; Hiperlex; Monopril; Newace; Sapril; Staril; Tenso Stop; Tensogard 

 

" 88889-14-9 ≥98% 585.64 C30H45NNaO7P CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3.[Na+] Ambient -20°C "Yang S, Li R, Tang L, et al. TLR4-mediated anti-atherosclerosis mechanisms of angiotensin-converting enzyme inhibitor--fosinopril. Cell Immunol. 2013 Sep-Oct;285(1-2):38-41. PMID: 24044965.

 

Huang K, Dai G. The effect and mechanism of forsinopril on ventricular hypertrophy of SHR and left ventricular pressure overloading rat. J Huazhong Univ Sci Technolog Med Sci. 2002;22(1):17-20. PMID: 12658773.

" Xn Not dangerous goods.

LKT F5773 Fosinopril Sodium 250 mg 450 ACE inhibitor. "Dynacil; Eliten; Fosinil; Fosinopril sodium; Fosinorm; Fosipres; Fositen; Fositens; Foziretic; Fucithalmic; Hiperlex; Monopril; Newace; Sapril; Staril; Tenso Stop; Tensogard 

 

" 88889-14-9 ≥98% 585.64 C30H45NNaO7P CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3.[Na+] Ambient -20°C "Yang S, Li R, Tang L, et al. TLR4-mediated anti-atherosclerosis mechanisms of angiotensin-converting enzyme inhibitor--fosinopril. Cell Immunol. 2013 Sep-Oct;285(1-2):38-41. PMID: 24044965.

 

Huang K, Dai G. The effect and mechanism of forsinopril on ventricular hypertrophy of SHR and left ventricular pressure overloading rat. J Huazhong Univ Sci Technolog Med Sci. 2002;22(1):17-20. PMID: 12658773.

" Xn Not dangerous goods.

LKT F5868 Formoterol Fumarate Dihydrate 10 mg 156.2 β2-adrenergic agonist. rel-N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4- methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]- formamide fumarate dihydrate Formoterol Fumarate Dihydrate; Atock; Foradil; Oxeze 43229-80-7 ≥98% 840.91 (C19H24N2O4)2C4H4O4 2H2O CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O.C(=CC(=O)O)C(=O)O Ambient -20°C "Lee P, Day RO, Greenfield JR, et al. Formoterol, a highly β2-selective agonist, increases energy expenditure and fat utilisation in men. Int J Obes (Lond). 2013 Apr;37(4):593-7. PMID: 22641064.

 

Wills LP, Trager RE, Beeson GC, et al. The β2-adrenoceptor agonist formoterol stimulates mitochondrial biogenesis. J Pharmacol Exp Ther. 2012 Jul;342(1):106-18. PMID: 22490378.

 

Rider CF, King EM, Holden NS, et al. Inflammatory stimuli inhibit glucocorticoid-dependent transactivation in human pulmonary epithelial cells: rescue by long-acting beta2-adrenoceptor agonists. J Pharmacol Exp Ther. 2011 Sep;338(3):860-9. PMID: 21622733.

" None Not dangerous goods.

LKT F5868 Formoterol Fumarate Dihydrate 50 mg 577.6 β2-adrenergic agonist. rel-N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4- methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]- formamide fumarate dihydrate Formoterol Fumarate Dihydrate; Atock; Foradil; Oxeze 43229-80-7 ≥98% 840.91 (C19H24N2O4)2C4H4O4 2H2O CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O.C(=CC(=O)O)C(=O)O Ambient -20°C "Lee P, Day RO, Greenfield JR, et al. Formoterol, a highly β2-selective agonist, increases energy expenditure and fat utilisation in men. Int J Obes (Lond). 2013 Apr;37(4):593-7. PMID: 22641064.

 

Wills LP, Trager RE, Beeson GC, et al. The β2-adrenoceptor agonist formoterol stimulates mitochondrial biogenesis. J Pharmacol Exp Ther. 2012 Jul;342(1):106-18. PMID: 22490378.

 

Rider CF, King EM, Holden NS, et al. Inflammatory stimuli inhibit glucocorticoid-dependent transactivation in human pulmonary epithelial cells: rescue by long-acting beta2-adrenoceptor agonists. J Pharmacol Exp Ther. 2011 Sep;338(3):860-9. PMID: 21622733.

" None Not dangerous goods.

LKT F5869 N-formyl-Met-Ala-Ser 1 mg 60 Peptide, involved in neutrophil activation; FPR1 agonist. N-formyl-Met-Ala-Ser 17351-32-5 ≥95% 335.38 C12H21N3O6S CC(C(=O)NC(CO)C(=O)O)NC(=O)C(CCSC)NC=O Ambient -20°C He HQ, Troksa EL, Caltabiano G, et al. Structural determinants for the interaction of formyl Peptide receptor 2 with Peptide ligands. J Biol Chem. 2014 Jan 24;289(4):2295-306. PMID: 24285541.

LKT F5869 N-formyl-Met-Ala-Ser 2 mg 101.9 Peptide, involved in neutrophil activation; FPR1 agonist. N-formyl-Met-Ala-Ser 17351-32-5 ≥95% 335.38 C12H21N3O6S CC(C(=O)NC(CO)C(=O)O)NC(=O)C(CCSC)NC=O Ambient -20°C He HQ, Troksa EL, Caltabiano G, et al. Structural determinants for the interaction of formyl Peptide receptor 2 with Peptide ligands. J Biol Chem. 2014 Jan 24;289(4):2295-306. PMID: 24285541.

LKT F5869 N-formyl-Met-Ala-Ser 5 mg 180 Peptide, involved in neutrophil activation; FPR1 agonist. N-formyl-Met-Ala-Ser 17351-32-5 ≥95% 335.38 C12H21N3O6S CC(C(=O)NC(CO)C(=O)O)NC(=O)C(CCSC)NC=O Ambient -20°C He HQ, Troksa EL, Caltabiano G, et al. Structural determinants for the interaction of formyl Peptide receptor 2 with Peptide ligands. J Biol Chem. 2014 Jan 24;289(4):2295-306. PMID: 24285541.

LKT F5870 N-formyl-Met-Leu-Phe 25 mg 144 Peptide, involved in neutrophil activation; FPR1 agonist. N-Formylmethionine leucyl-phenylalanine; L-Phenylalanine, N-(N-(N-formyl-L-methionyl)-L-leucyl)-; Tyramine HCl; N-Formyl-Met-Leu-Phe 59880-97-6 ≥95% 437.6 C21H31N3O5S CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C(CCSC)NC=O Ambient -20°C "Hurtado-Nedelec M, Makni-Maalej K, Gougerot-Pocidalo MA, et al. Assessment of priming of the human neutrophil respiratory burst. Methods Mol Biol. 2014;1124:405-12. PMID: 24504964.

 

Andréasson E, Önnheim K, Forsman H. The subcellular localization of the receptor for platelet-activating factor in neutrophils affects signaling and activation characteristics. Clin Dev Immunol. 2013;2013:456407. PMID: 24069041.

 

Sengeløv H, Boulay F, Kjeldsen L, et al. Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils. Biochem J. 1994 Apr 15;299 ( Pt 2):473-9. PMID: 8172608.

" Xi Not dangerous goods.

LKT F5870 N-formyl-Met-Leu-Phe 10 mg 81 Peptide, involved in neutrophil activation; FPR1 agonist. N-Formylmethionine leucyl-phenylalanine; L-Phenylalanine, N-(N-(N-formyl-L-methionyl)-L-leucyl)-; Tyramine HCl; N-Formyl-Met-Leu-Phe 59880-97-6 ≥95% 437.6 C21H31N3O5S CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C(CCSC)NC=O Ambient -20°C "Hurtado-Nedelec M, Makni-Maalej K, Gougerot-Pocidalo MA, et al. Assessment of priming of the human neutrophil respiratory burst. Methods Mol Biol. 2014;1124:405-12. PMID: 24504964.

 

Andréasson E, Önnheim K, Forsman H. The subcellular localization of the receptor for platelet-activating factor in neutrophils affects signaling and activation characteristics. Clin Dev Immunol. 2013;2013:456407. PMID: 24069041.

 

Sengeløv H, Boulay F, Kjeldsen L, et al. Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils. Biochem J. 1994 Apr 15;299 ( Pt 2):473-9. PMID: 8172608.

" Xi Not dangerous goods.

LKT F5870 N-formyl-Met-Leu-Phe 5 mg 48 Peptide, involved in neutrophil activation; FPR1 agonist. N-Formylmethionine leucyl-phenylalanine; L-Phenylalanine, N-(N-(N-formyl-L-methionyl)-L-leucyl)-; Tyramine HCl; N-Formyl-Met-Leu-Phe 59880-97-6 ≥95% 437.6 C21H31N3O5S CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C(CCSC)NC=O Ambient -20°C "Hurtado-Nedelec M, Makni-Maalej K, Gougerot-Pocidalo MA, et al. Assessment of priming of the human neutrophil respiratory burst. Methods Mol Biol. 2014;1124:405-12. PMID: 24504964.

 

Andréasson E, Önnheim K, Forsman H. The subcellular localization of the receptor for platelet-activating factor in neutrophils affects signaling and activation characteristics. Clin Dev Immunol. 2013;2013:456407. PMID: 24069041.

 

Sengeløv H, Boulay F, Kjeldsen L, et al. Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils. Biochem J. 1994 Apr 15;299 ( Pt 2):473-9. PMID: 8172608.

" Xi Not dangerous goods.

LKT F5871 N-formyl-Met-Leu-Phe-Lys 5 mg 48 Peptide, involved in neutrophil activation; FPR1 agonist. Chemotactic peptide; N-Formyl-Met-Leu-Phe-Lys 104180-18-9 ≥95% 565.74 C27H43N3O6S CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCSC)NC=O Ambient -20°C He HQ, Troksa EL, Caltabiano G, et al. Structural determinants for the interaction of formyl Peptide receptor 2 with Peptide ligands. J Biol Chem. 2014 Jan 24;289(4):2295-306. PMID: 24285541.

LKT F5871 N-formyl-Met-Leu-Phe-Lys 10 mg 81 Peptide, involved in neutrophil activation; FPR1 agonist. Chemotactic peptide; N-Formyl-Met-Leu-Phe-Lys 104180-18-9 ≥95% 565.74 C27H43N3O6S CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCSC)NC=O Ambient -20°C He HQ, Troksa EL, Caltabiano G, et al. Structural determinants for the interaction of formyl Peptide receptor 2 with Peptide ligands. J Biol Chem. 2014 Jan 24;289(4):2295-306. PMID: 24285541.

LKT F5871 N-formyl-Met-Leu-Phe-Lys 25 mg 144 Peptide, involved in neutrophil activation; FPR1 agonist. Chemotactic peptide; N-Formyl-Met-Leu-Phe-Lys 104180-18-9 ≥95% 565.74 C27H43N3O6S CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCSC)NC=O Ambient -20°C He HQ, Troksa EL, Caltabiano G, et al. Structural determinants for the interaction of formyl Peptide receptor 2 with Peptide ligands. J Biol Chem. 2014 Jan 24;289(4):2295-306. PMID: 24285541.

LKT F5872 N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys 25 mg 287.9 Peptide, involved in neutrophil activation; FPR1 agonist. F-Chemotactic peptide, F-Peptide; N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys 71901-21-8 ≥95% 824.04 C43H65O7N9 CCCCC(C(=O)NC(CC(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCCC)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCCN)C(=O)O)NC=O Ambient -20°C Allen RA, Erickson RW, Jesaitis AJ. Identification of a human neutrophil protein of Mr 24 000 that binds N-formyl peptides: co-sedimentation with specific granules. Biochim Biophys Acta. 1989 Apr 25;991(1):123-33. PMID: 2653446. Not dangerous goods.

LKT F5872 N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys 10 mg 162 Peptide, involved in neutrophil activation; FPR1 agonist. F-Chemotactic peptide, F-Peptide; N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys 71901-21-8 ≥95% 824.04 C43H65O7N9 CCCCC(C(=O)NC(CC(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCCC)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCCN)C(=O)O)NC=O Ambient -20°C Allen RA, Erickson RW, Jesaitis AJ. Identification of a human neutrophil protein of Mr 24 000 that binds N-formyl peptides: co-sedimentation with specific granules. Biochim Biophys Acta. 1989 Apr 25;991(1):123-33. PMID: 2653446. Not dangerous goods.

LKT F5872 N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys 5 mg 96 Peptide, involved in neutrophil activation; FPR1 agonist. F-Chemotactic peptide, F-Peptide; N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys 71901-21-8 ≥95% 824.04 C43H65O7N9 CCCCC(C(=O)NC(CC(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCCC)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCCN)C(=O)O)NC=O Ambient -20°C Allen RA, Erickson RW, Jesaitis AJ. Identification of a human neutrophil protein of Mr 24 000 that binds N-formyl peptides: co-sedimentation with specific granules. Biochim Biophys Acta. 1989 Apr 25;991(1):123-33. PMID: 2653446. Not dangerous goods.

LKT F5873 Foscarnet Sodium 1 g 84.3 Metal ion chelator, viral DNA polymerase inhibitor, reverse transcriptase inhibitor, type II Pi transporter inhibitor phosphonoformic acid 63585-09-1 ≥98% 191.95 CNa3O5P C(=O)([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+] Ambient Ambient "Zahn KE, Tchesnokov EP, Götte M, et al. Phosphonoformic acid inhibits viral replication by trapping the closed form of the DNA polymerase. J Biol Chem. 2011 Jul 15;286(28):25246-55. PMID: 21566148.

 

Villa-Bellosta R, Sorribas V. Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition. Arterioscler Thromb Vasc Biol. 2009 May;29(5):761-6. PMID: 19213941.

 

Marchand B, Tchesnokov EP, Götte M. The pyrophosphate analogue foscarnet traps the pre-translocational state of HIV-1 reverse transcriptase in a Brownian ratchet model of polymerase translocation. J Biol Chem. 2007 Feb 2;282(5):3337-46. PMID: 17145704.

 

Morfin F, Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J Clin Virol. 2003 Jan;26(1):29-37. PMID: 12589832.

 

Hardy WD. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial. Am J Med. 1992 Feb 14;92(2A):30S-35S. PMID: 1531285.

" Not dangerous goods.

LKT F5873 Foscarnet Sodium 5 g 328.1 Metal ion chelator, viral DNA polymerase inhibitor, reverse transcriptase inhibitor, type II Pi transporter inhibitor phosphonoformic acid 63585-09-1 ≥98% 191.95 CNa3O5P C(=O)([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+] Ambient Ambient "Zahn KE, Tchesnokov EP, Götte M, et al. Phosphonoformic acid inhibits viral replication by trapping the closed form of the DNA polymerase. J Biol Chem. 2011 Jul 15;286(28):25246-55. PMID: 21566148.

 

Villa-Bellosta R, Sorribas V. Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition. Arterioscler Thromb Vasc Biol. 2009 May;29(5):761-6. PMID: 19213941.

 

Marchand B, Tchesnokov EP, Götte M. The pyrophosphate analogue foscarnet traps the pre-translocational state of HIV-1 reverse transcriptase in a Brownian ratchet model of polymerase translocation. J Biol Chem. 2007 Feb 2;282(5):3337-46. PMID: 17145704.

 

Morfin F, Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J Clin Virol. 2003 Jan;26(1):29-37. PMID: 12589832.

 

Hardy WD. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial. Am J Med. 1992 Feb 14;92(2A):30S-35S. PMID: 1531285.

" Not dangerous goods.

LKT F5873 Foscarnet Sodium 10 g 562.5 Metal ion chelator, viral DNA polymerase inhibitor, reverse transcriptase inhibitor, type II Pi transporter inhibitor phosphonoformic acid 63585-09-1 ≥98% 191.95 CNa3O5P C(=O)([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+] Ambient Ambient "Zahn KE, Tchesnokov EP, Götte M, et al. Phosphonoformic acid inhibits viral replication by trapping the closed form of the DNA polymerase. J Biol Chem. 2011 Jul 15;286(28):25246-55. PMID: 21566148.

 

Villa-Bellosta R, Sorribas V. Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition. Arterioscler Thromb Vasc Biol. 2009 May;29(5):761-6. PMID: 19213941.

 

Marchand B, Tchesnokov EP, Götte M. The pyrophosphate analogue foscarnet traps the pre-translocational state of HIV-1 reverse transcriptase in a Brownian ratchet model of polymerase translocation. J Biol Chem. 2007 Feb 2;282(5):3337-46. PMID: 17145704.

 

Morfin F, Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J Clin Virol. 2003 Jan;26(1):29-37. PMID: 12589832.

 

Hardy WD. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial. Am J Med. 1992 Feb 14;92(2A):30S-35S. PMID: 1531285.

" Not dangerous goods.

LKT F5874 Fosfomycin Calcium 5 g 93.8 MurA and isopentenyl mevalonate kinase inhibitor. 26016-98-8 ≥97% 176.12 C3H5CaO4P CC1C(O1)P(=O)([O-])[O-].[Ca+2] Ambient Ambient "Olesen SH, Ingles DJ, Yang Y, et al. Differential antibacterial properties of the MurA inhibitors terreic acid and fosfomycin. J Basic Microbiol. 2013 May 20. [Epub ahead of print]. PMID: 23686727.

 

Mabanglo MF, Serohijos AW, Poulter CD. The Streptomyces-produced antibiotic fosfomycin is a promiscuous substrate for archaeal isopentenyl phosphate kinase. Biochemistry. 2012 Jan 31;51(4):917-25. PMID: 22148590.

 

Yanagida C, Ito K, Komiya I, et al. Protective effect of fosfomycin on gentamicin-induced lipid peroxidation of rat renal tissue. Chem Biol Interact. 2004 Jul 20;148(3):139-47. PMID: 15276870.

 

Borrmann S, Adegnika AA, Matsiegui PB, et al. Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children. J Infect Dis. 2004 Mar 1;189(5):901-8. PMID: 14976608.

 

Matsumoto T, Tateda K, Miyazaki S, et al. Immunomodulating effect of fosfomycin on gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob Agents Chemother. 1997 Feb;41(2):308-13. PMID: 9021184.

" None Not dangerous goods.

LKT F5874 Fosfomycin Calcium 25 g 375.1 MurA and isopentenyl mevalonate kinase inhibitor. 26016-98-8 ≥97% 176.12 C3H5CaO4P CC1C(O1)P(=O)([O-])[O-].[Ca+2] Ambient Ambient "Olesen SH, Ingles DJ, Yang Y, et al. Differential antibacterial properties of the MurA inhibitors terreic acid and fosfomycin. J Basic Microbiol. 2013 May 20. [Epub ahead of print]. PMID: 23686727.

 

Mabanglo MF, Serohijos AW, Poulter CD. The Streptomyces-produced antibiotic fosfomycin is a promiscuous substrate for archaeal isopentenyl phosphate kinase. Biochemistry. 2012 Jan 31;51(4):917-25. PMID: 22148590.

 

Yanagida C, Ito K, Komiya I, et al. Protective effect of fosfomycin on gentamicin-induced lipid peroxidation of rat renal tissue. Chem Biol Interact. 2004 Jul 20;148(3):139-47. PMID: 15276870.

 

Borrmann S, Adegnika AA, Matsiegui PB, et al. Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children. J Infect Dis. 2004 Mar 1;189(5):901-8. PMID: 14976608.

 

Matsumoto T, Tateda K, Miyazaki S, et al. Immunomodulating effect of fosfomycin on gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob Agents Chemother. 1997 Feb;41(2):308-13. PMID: 9021184.

" None Not dangerous goods.

LKT F5976 Fotemustine 5 mg 58.7 Chloroethylnitrosourea, DNA alkylator and cross-linker. 92118-27-9 ≥98% 315.69 C9H19ClN3O5P CCOP(=O)(C(C)NC(=O)N(CCCl)N=O)OCC Ambient 4°C "Hayes MT, Bartley J, Parsons PG. In vitro evaluation of fotemustine as a potential agent for limb perfusion in melanoma. Melanoma Res. 1998 Feb;8(1):67-75. PMID: 9508380.

 

Hayes MT, Bartley J, Parsons PG, et al. Mechanism of action of fotemustine, a new chloroethylnitrosourea anticancer agent: evidence for the formation of two DNA-reactive intermediates contributing to cytotoxicity. Biochemistry. 1997 Sep 2;36(35):10646-54. PMID: 9271495.

 

Schallreuter KU, Gleason FK, Wood JM. The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase. Biochim Biophys Acta. 1990 Aug 13;1054(1):14-20. PMID: 2200526.

" Xn Not dangerous goods.

LKT F5976 Fotemustine 25 mg 133.9 Chloroethylnitrosourea, DNA alkylator and cross-linker. 92118-27-9 ≥98% 315.69 C9H19ClN3O5P CCOP(=O)(C(C)NC(=O)N(CCCl)N=O)OCC Ambient 4°C "Hayes MT, Bartley J, Parsons PG. In vitro evaluation of fotemustine as a potential agent for limb perfusion in melanoma. Melanoma Res. 1998 Feb;8(1):67-75. PMID: 9508380.

 

Hayes MT, Bartley J, Parsons PG, et al. Mechanism of action of fotemustine, a new chloroethylnitrosourea anticancer agent: evidence for the formation of two DNA-reactive intermediates contributing to cytotoxicity. Biochemistry. 1997 Sep 2;36(35):10646-54. PMID: 9271495.

 

Schallreuter KU, Gleason FK, Wood JM. The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase. Biochim Biophys Acta. 1990 Aug 13;1054(1):14-20. PMID: 2200526.

" Xn Not dangerous goods.

LKT F5976 Fotemustine 100 mg 335 Chloroethylnitrosourea, DNA alkylator and cross-linker. 92118-27-9 ≥98% 315.69 C9H19ClN3O5P CCOP(=O)(C(C)NC(=O)N(CCCl)N=O)OCC Ambient 4°C "Hayes MT, Bartley J, Parsons PG. In vitro evaluation of fotemustine as a potential agent for limb perfusion in melanoma. Melanoma Res. 1998 Feb;8(1):67-75. PMID: 9508380.

 

Hayes MT, Bartley J, Parsons PG, et al. Mechanism of action of fotemustine, a new chloroethylnitrosourea anticancer agent: evidence for the formation of two DNA-reactive intermediates contributing to cytotoxicity. Biochemistry. 1997 Sep 2;36(35):10646-54. PMID: 9271495.

 

Schallreuter KU, Gleason FK, Wood JM. The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase. Biochim Biophys Acta. 1990 Aug 13;1054(1):14-20. PMID: 2200526.

" Xn Not dangerous goods.

LKT F8048 Fumagillin 1 mg 56.6 Produced by Aspergillus; type 2 methionine aminopeptidase inhibitor. [3R-[3α,4α(2R*,3R*),5β,6β(all-E)]]-2,4,6,8-Decatetra- enedioic acid, mono[5-methoxy-4-[2-methyl-3-(3- methyl- 2-butenyl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl] ester Amebacilin; Fugillin; Fumadil B: Fumidil 23110-15-8 ≥98% 458.54 C26H34O7 CC(=CCC1C(O1)(C)C2C(C(CCC23CO3)OC(=O)C=CC=CC=CC=CC(=O)O)OC)C Stored under argon Ambient 4°C Soluble in most organic solvents. Practically insoluble in water, dilute acids and saturated hydrocarbons. "Kass DJ, Rattigan E, Kahloon R, et al. Early treatment with fumagillin, an inhibitor of methionine aminopeptidase-2, prevents Pulmonary Hypertension in monocrotaline-injured rats. PLoS One. 2012;7(4):e35388. PMID: 22509410.

 

Champion L, Durrbach A, Lang P, et al. Fumagillin for treatment of intestinal microsporidiosis in renal transplant recipients. Am J Transplant. 2010 Aug;10(8):1925-30. PMID: 20636462.

 

Arico-Muendel C, Centrella PA, Contonio BD, et al. Antiparasitic activities of novel, orally available fumagillin analogs. Bioorg Med Chem Lett. 2009 Sep 1;19(17):5128-31. PMID: 19648008.

 

Hou L, Mori D, Takase Y, et al. Fumagillin inhibits colorectal cancer growth and metastasis in mice: in vivo and in vitro study of anti-angiogenesis. Pathol Int. 2009 Jul;59(7):448-61. PMID: 19563408.

 

Chen X, Xie S, Bhat S, et al. Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo. Chem Biol. 2009 Feb 27;16(2):193-202. PMID: 19246010.

" Xn Not dangerous goods.

LKT F8048 Fumagillin 5 mg 188.8 Produced by Aspergillus; type 2 methionine aminopeptidase inhibitor. [3R-[3α,4α(2R*,3R*),5β,6β(all-E)]]-2,4,6,8-Decatetra- enedioic acid, mono[5-methoxy-4-[2-methyl-3-(3- methyl- 2-butenyl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl] ester Amebacilin; Fugillin; Fumadil B: Fumidil 23110-15-8 ≥98% 458.54 C26H34O7 CC(=CCC1C(O1)(C)C2C(C(CCC23CO3)OC(=O)C=CC=CC=CC=CC(=O)O)OC)C Stored under argon Ambient 4°C Soluble in most organic solvents. Practically insoluble in water, dilute acids and saturated hydrocarbons. "Kass DJ, Rattigan E, Kahloon R, et al. Early treatment with fumagillin, an inhibitor of methionine aminopeptidase-2, prevents Pulmonary Hypertension in monocrotaline-injured rats. PLoS One. 2012;7(4):e35388. PMID: 22509410.

 

Champion L, Durrbach A, Lang P, et al. Fumagillin for treatment of intestinal microsporidiosis in renal transplant recipients. Am J Transplant. 2010 Aug;10(8):1925-30. PMID: 20636462.

 

Arico-Muendel C, Centrella PA, Contonio BD, et al. Antiparasitic activities of novel, orally available fumagillin analogs. Bioorg Med Chem Lett. 2009 Sep 1;19(17):5128-31. PMID: 19648008.

 

Hou L, Mori D, Takase Y, et al. Fumagillin inhibits colorectal cancer growth and metastasis in mice: in vivo and in vitro study of anti-angiogenesis. Pathol Int. 2009 Jul;59(7):448-61. PMID: 19563408.

 

Chen X, Xie S, Bhat S, et al. Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo. Chem Biol. 2009 Feb 27;16(2):193-202. PMID: 19246010.

" Xn Not dangerous goods.

LKT F8270 Furosemide 5 g 57.8 Loop diuretic; NKCC symporter inhibitor, CFTR Cl- channel blocker, GABA-A antagonist. 5-(Aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)- amino]benzoic acid Fursemide; Beronald; Discoid; Durafurid; Eutensin; Fulsix; Furosedon; Impugan; Katlex; Lasix; Macasirrol; Nicorol; Odemase; Rosemide; Urex 54-31-9 ≥97% 330.74 C12H11ClN2O5S C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl Keep dry and away from light. Ambient Ambient Soluble in acetone, DMF, and methanol. Slightly soluble in water, chloroform and ether. "Ju M, Scott-Ward TS, Liu J, et al. Loop diuretics are open-channel blockers of the cystic fibrosis transmembrane conductance regulator with distinct kinetics. Br J Pharmacol. 2014 Jan;171(1):265-78. PMID: 24117047.

 

Krystal AD, Sutherland J, Hochman DW. Loop diuretics have anxiolytic effects in rat models of conditioned anxiety. PLoS One. 2012;7(4):e35417. PMID: 22514741.

 

Somasekharan S, Tanis J, Forbush B. Loop diuretic and ion-binding residues revealed by scanning mutagenesis of transmembrane helix 3 (TM3) of Na-K-Cl cotransporter (NKCC1). J Biol Chem. 2012 May 18;287(21):17308-17. PMID: 22437837.

 

Korpi ER, Kuner T, Seeburg PH, et al. Selective antagonist for the cerebellar granule cell-specific gamma-aminobutyric acid type A receptor. Mol Pharmacol. 1995 Feb;47(2):283-9. PMID: 7870036.

" Repr., T, F Not dangerous goods.

LKT F8270 Furosemide 10 g 97.2 Loop diuretic; NKCC symporter inhibitor, CFTR Cl- channel blocker, GABA-A antagonist. 5-(Aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)- amino]benzoic acid Fursemide; Beronald; Discoid; Durafurid; Eutensin; Fulsix; Furosedon; Impugan; Katlex; Lasix; Macasirrol; Nicorol; Odemase; Rosemide; Urex 54-31-9 ≥97% 330.74 C12H11ClN2O5S C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl Keep dry and away from light. Ambient Ambient Soluble in acetone, DMF, and methanol. Slightly soluble in water, chloroform and ether. "Ju M, Scott-Ward TS, Liu J, et al. Loop diuretics are open-channel blockers of the cystic fibrosis transmembrane conductance regulator with distinct kinetics. Br J Pharmacol. 2014 Jan;171(1):265-78. PMID: 24117047.

 

Krystal AD, Sutherland J, Hochman DW. Loop diuretics have anxiolytic effects in rat models of conditioned anxiety. PLoS One. 2012;7(4):e35417. PMID: 22514741.

 

Somasekharan S, Tanis J, Forbush B. Loop diuretic and ion-binding residues revealed by scanning mutagenesis of transmembrane helix 3 (TM3) of Na-K-Cl cotransporter (NKCC1). J Biol Chem. 2012 May 18;287(21):17308-17. PMID: 22437837.

 

Korpi ER, Kuner T, Seeburg PH, et al. Selective antagonist for the cerebellar granule cell-specific gamma-aminobutyric acid type A receptor. Mol Pharmacol. 1995 Feb;47(2):283-9. PMID: 7870036.

" Repr., T, F Not dangerous goods.

LKT F8270 Furosemide 25 g 184.8 Loop diuretic; NKCC symporter inhibitor, CFTR Cl- channel blocker, GABA-A antagonist. 5-(Aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)- amino]benzoic acid Fursemide; Beronald; Discoid; Durafurid; Eutensin; Fulsix; Furosedon; Impugan; Katlex; Lasix; Macasirrol; Nicorol; Odemase; Rosemide; Urex 54-31-9 ≥97% 330.74 C12H11ClN2O5S C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl Keep dry and away from light. Ambient Ambient Soluble in acetone, DMF, and methanol. Slightly soluble in water, chloroform and ether. "Ju M, Scott-Ward TS, Liu J, et al. Loop diuretics are open-channel blockers of the cystic fibrosis transmembrane conductance regulator with distinct kinetics. Br J Pharmacol. 2014 Jan;171(1):265-78. PMID: 24117047.

 

Krystal AD, Sutherland J, Hochman DW. Loop diuretics have anxiolytic effects in rat models of conditioned anxiety. PLoS One. 2012;7(4):e35417. PMID: 22514741.

 

Somasekharan S, Tanis J, Forbush B. Loop diuretic and ion-binding residues revealed by scanning mutagenesis of transmembrane helix 3 (TM3) of Na-K-Cl cotransporter (NKCC1). J Biol Chem. 2012 May 18;287(21):17308-17. PMID: 22437837.

 

Korpi ER, Kuner T, Seeburg PH, et al. Selective antagonist for the cerebellar granule cell-specific gamma-aminobutyric acid type A receptor. Mol Pharmacol. 1995 Feb;47(2):283-9. PMID: 7870036.

" Repr., T, F Not dangerous goods.

LKT G0000 G250.A2 Peptide 1 mg 65.8 Peptide, carbonic anhydrase G250 epitope. ≥95% 1001.16 C45H72N14O12 Ambient -20°C Socie G, Blazar BR. Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation. Elsevier, 2012. Web.

LKT G0000 G250.A2 Peptide 2 mg 111 Peptide, carbonic anhydrase G250 epitope. ≥95% 1001.16 C45H72N14O12 Ambient -20°C Socie G, Blazar BR. Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation. Elsevier, 2012. Web.

LKT G0000 G250.A2 Peptide 5 mg 198.1 Peptide, carbonic anhydrase G250 epitope. ≥95% 1001.16 C45H72N14O12 Ambient -20°C Socie G, Blazar BR. Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation. Elsevier, 2012. Web.

LKT G0044 Galantide 0.5 mg 228 Peptide; galanin antagonist. M15 138579-66-5 ≥95% 2199.58 C104H151N25O26S CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C3CCCN3C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)CN Ambient -20°C "Sun YG, Yu LC. Interactions of galanin and opioids in nociceptive modulation in the arcuate nucleus of hypothalamus in rats. Regul Pept. 2005 Jan 15;124(1-3):37-43. PMID: 15544839.

 

Korolkiewicz RP, Konstanski Z, Rekowski P, et al. Mechanism of the contractile effects of galantide and Galanin(1-14) [alpha-aminobutyric acid]scyliorhinin-I in rat isolated fundus strips. Med Sci Monit. 2002 Jan;8(1):BR19-23. PMID: 11782668.

 

Arletti R, Benelli A, Cavazzuti E, et al. Galantide improves social memory in rats. Pharmacol Res. 1997 Apr;35(4):317-9. PMID: 9264048.

" Not dangerous goods.

LKT G0044 Galantide 1 mg 387 Peptide; galanin antagonist. M15 138579-66-5 ≥95% 2199.58 C104H151N25O26S CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C3CCCN3C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)CN Ambient -20°C "Sun YG, Yu LC. Interactions of galanin and opioids in nociceptive modulation in the arcuate nucleus of hypothalamus in rats. Regul Pept. 2005 Jan 15;124(1-3):37-43. PMID: 15544839.

 

Korolkiewicz RP, Konstanski Z, Rekowski P, et al. Mechanism of the contractile effects of galantide and Galanin(1-14) [alpha-aminobutyric acid]scyliorhinin-I in rat isolated fundus strips. Med Sci Monit. 2002 Jan;8(1):BR19-23. PMID: 11782668.

 

Arletti R, Benelli A, Cavazzuti E, et al. Galantide improves social memory in rats. Pharmacol Res. 1997 Apr;35(4):317-9. PMID: 9264048.

" Not dangerous goods.

LKT G0044 Galantide 2.5 mg 684.1 Peptide; galanin antagonist. M15 138579-66-5 ≥95% 2199.58 C104H151N25O26S CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C3CCCN3C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)CN Ambient -20°C "Sun YG, Yu LC. Interactions of galanin and opioids in nociceptive modulation in the arcuate nucleus of hypothalamus in rats. Regul Pept. 2005 Jan 15;124(1-3):37-43. PMID: 15544839.

 

Korolkiewicz RP, Konstanski Z, Rekowski P, et al. Mechanism of the contractile effects of galantide and Galanin(1-14) [alpha-aminobutyric acid]scyliorhinin-I in rat isolated fundus strips. Med Sci Monit. 2002 Jan;8(1):BR19-23. PMID: 11782668.

 

Arletti R, Benelli A, Cavazzuti E, et al. Galantide improves social memory in rats. Pharmacol Res. 1997 Apr;35(4):317-9. PMID: 9264048.

" Not dangerous goods.

LKT G0048 γ-Amino Butyric Acid 10 g 27.6 Endogenous neurotransmitter; GABA agonist. 4-Aminobutanoic acid γ-Aminobutyric acid; Gammalon; GABA; gamma-amino butyric acid 56-12-2 ≥98% 103.12 C4H9NO2 C(CC(=O)O)CN Ambient Ambient Soluble in water. Practically insoluble in other solvents. "Li K, Xu E. The role and the mechanism of gamma-aminobutyric acid during central nervous system development. Neurosci Bull. 2008 Jun;24(3):195-200. PMID: 18500393.

 

Abdou AM, Higashiguchi S, Horie K, et al. Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. Biofactors. 2006;26(3):201-8. PMID: 16971751.

 

Foster AC, Kemp JA. Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2006 Feb;6(1):7-17. PMID: 16377242.

" Xi Not dangerous goods.

LKT G0048 γ-Amino Butyric Acid 25 g 41.3 Endogenous neurotransmitter; GABA agonist. 4-Aminobutanoic acid γ-Aminobutyric acid; Gammalon; GABA; gamma-amino butyric acid 56-12-2 ≥98% 103.12 C4H9NO2 C(CC(=O)O)CN Ambient Ambient Soluble in water. Practically insoluble in other solvents. "Li K, Xu E. The role and the mechanism of gamma-aminobutyric acid during central nervous system development. Neurosci Bull. 2008 Jun;24(3):195-200. PMID: 18500393.

 

Abdou AM, Higashiguchi S, Horie K, et al. Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. Biofactors. 2006;26(3):201-8. PMID: 16971751.

 

Foster AC, Kemp JA. Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2006 Feb;6(1):7-17. PMID: 16377242.

" Xi Not dangerous goods.

LKT G0048 γ-Amino Butyric Acid 100 g 68.8 Endogenous neurotransmitter; GABA agonist. 4-Aminobutanoic acid γ-Aminobutyric acid; Gammalon; GABA; gamma-amino butyric acid 56-12-2 ≥98% 103.12 C4H9NO2 C(CC(=O)O)CN Ambient Ambient Soluble in water. Practically insoluble in other solvents. "Li K, Xu E. The role and the mechanism of gamma-aminobutyric acid during central nervous system development. Neurosci Bull. 2008 Jun;24(3):195-200. PMID: 18500393.

 

Abdou AM, Higashiguchi S, Horie K, et al. Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. Biofactors. 2006;26(3):201-8. PMID: 16971751.

 

Foster AC, Kemp JA. Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2006 Feb;6(1):7-17. PMID: 16377242.

" Xi Not dangerous goods.

LKT G0096 GAY 5 mg 72.1 Tripeptide, used to tag proteins. Tyrosyl-alanyl-glycine, Tag peptide; G-A-Y 69537-64-0 ≥95% 309.18 C14H19N3O5 CC(C(=O)NCC(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N Ambient -20°C

LKT G0096 GAY 10 mg 123.1 Tripeptide, used to tag proteins. Tyrosyl-alanyl-glycine, Tag peptide; G-A-Y 69537-64-0 ≥95% 309.18 C14H19N3O5 CC(C(=O)NCC(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N Ambient -20°C

LKT G0096 GAY 25 mg 216.1 Tripeptide, used to tag proteins. Tyrosyl-alanyl-glycine, Tag peptide; G-A-Y 69537-64-0 ≥95% 309.18 C14H19N3O5 CC(C(=O)NCC(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N Ambient -20°C

LKT G0106 Gabapentin 10 mg 47.6 GABA analog; GABA potentiator, adenosine A1 agonist, voltage-gated α2δ Ca2+ channel blocker, NMDA modulator. 1-(Aminomethyl)-cyclohexaneacetic acid GOE-3450; Neurontin 60142-96-3 ≥98% 171.24 C9H17NO2 C1CCC(CC1)(CC(=O)O)CN Ambient Ambient Soluble in water (pH 7.4). "Kukkar A, Bali A, Singh N, et al. Implications and mechanism of action of gabapentin in neuropathic pain. Arch Pharm Res. 2013 Mar;36(3):237-51. PMID: 23435945.

 

Davies A, Hendrich J, Van Minh AT, et al. Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels. Trends Pharmacol Sci. 2007 May;28(5):220-8. PMID: 17403543.

 

Johannessen SI, Ben-Menachem E. Management of focal-onset seizures: an update on drug treatment. Drugs. 2006;66(13):1701-25. PMID: 16978035.

 

Ho KY, Gan TJ, Habib AS. Gabapentin and postoperative pain--a systematic review of randomized controlled trials. Pain. 2006 Dec 15;126(1-3):91-101. PMID: 16846695.

" T Not dangerous goods.

LKT G0106 Gabapentin 50 mg 169.9 GABA analog; GABA potentiator, adenosine A1 agonist, voltage-gated α2δ Ca2+ channel blocker, NMDA modulator. 1-(Aminomethyl)-cyclohexaneacetic acid GOE-3450; Neurontin 60142-96-3 ≥98% 171.24 C9H17NO2 C1CCC(CC1)(CC(=O)O)CN Ambient Ambient Soluble in water (pH 7.4). "Kukkar A, Bali A, Singh N, et al. Implications and mechanism of action of gabapentin in neuropathic pain. Arch Pharm Res. 2013 Mar;36(3):237-51. PMID: 23435945.

 

Davies A, Hendrich J, Van Minh AT, et al. Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels. Trends Pharmacol Sci. 2007 May;28(5):220-8. PMID: 17403543.

 

Johannessen SI, Ben-Menachem E. Management of focal-onset seizures: an update on drug treatment. Drugs. 2006;66(13):1701-25. PMID: 16978035.

 

Ho KY, Gan TJ, Habib AS. Gabapentin and postoperative pain--a systematic review of randomized controlled trials. Pain. 2006 Dec 15;126(1-3):91-101. PMID: 16846695.

" T Not dangerous goods.

LKT G0106 Gabapentin 250 mg 407.7 GABA analog; GABA potentiator, adenosine A1 agonist, voltage-gated α2δ Ca2+ channel blocker, NMDA modulator. 1-(Aminomethyl)-cyclohexaneacetic acid GOE-3450; Neurontin 60142-96-3 ≥98% 171.24 C9H17NO2 C1CCC(CC1)(CC(=O)O)CN Ambient Ambient Soluble in water (pH 7.4). "Kukkar A, Bali A, Singh N, et al. Implications and mechanism of action of gabapentin in neuropathic pain. Arch Pharm Res. 2013 Mar;36(3):237-51. PMID: 23435945.

 

Davies A, Hendrich J, Van Minh AT, et al. Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels. Trends Pharmacol Sci. 2007 May;28(5):220-8. PMID: 17403543.

 

Johannessen SI, Ben-Menachem E. Management of focal-onset seizures: an update on drug treatment. Drugs. 2006;66(13):1701-25. PMID: 16978035.

 

Ho KY, Gan TJ, Habib AS. Gabapentin and postoperative pain--a systematic review of randomized controlled trials. Pain. 2006 Dec 15;126(1-3):91-101. PMID: 16846695.

" T Not dangerous goods.

LKT G0144 Galactosamine Hydrochloride 500 mg 61.1 Galactose-derived hexosamine sugar, component of FSH and LH. 2-Amino-2-deoxy-D-galactose Chondrosamine; GalN 1772-03-8 ≥98% 215.63 C6H13NO5 HCl C(C1C(C(C(C(O1)O)N)O)O)O.Cl Ambient Ambient Soluble in water. Capini CJ, Bertin-Maghit SM, Bessis N, et al. Active immunization against murine TNFalpha peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection. Vaccine. 2004 Aug 13;22(23-24):3144-53. PMID: 15297067. None Not dangerous goods.

LKT G0144 Galactosamine Hydrochloride 1 g 81.6 Galactose-derived hexosamine sugar, component of FSH and LH. 2-Amino-2-deoxy-D-galactose Chondrosamine; GalN 1772-03-8 ≥98% 215.63 C6H13NO5 HCl C(C1C(C(C(C(O1)O)N)O)O)O.Cl Ambient Ambient Soluble in water. Capini CJ, Bertin-Maghit SM, Bessis N, et al. Active immunization against murine TNFalpha peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection. Vaccine. 2004 Aug 13;22(23-24):3144-53. PMID: 15297067. None Not dangerous goods.

LKT G0144 Galactosamine Hydrochloride 5 g 339.8 Galactose-derived hexosamine sugar, component of FSH and LH. 2-Amino-2-deoxy-D-galactose Chondrosamine; GalN 1772-03-8 ≥98% 215.63 C6H13NO5 HCl C(C1C(C(C(C(O1)O)N)O)O)O.Cl Ambient Ambient Soluble in water. Capini CJ, Bertin-Maghit SM, Bessis N, et al. Active immunization against murine TNFalpha peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection. Vaccine. 2004 Aug 13;22(23-24):3144-53. PMID: 15297067. None Not dangerous goods.

LKT G0146 Galanin, human 1 mg 600.1 Endogenous neuropeptide, involved in nociception, sleep regulation, feeding behavior; GAL agonist. 119418-04-1 ≥98% 3157.44 C139H210N42O43 CC(C)CC(C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)O)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC2=CNC=N2)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC3=CNC=N3)NC(=O)C4CCCN4C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC6=CNC7=CC=CC=C76)NC(=O)CN Ambient -20°C Soluble in 5% acetic acid. "Mitsukawa K, Lu X, Bartfai T. Galanin, galanin receptors and drug targets. Cell Mol Life Sci. 2008 Jun;65(12):1796-805. PMID: 18500647.

 

Counts SE, Perez SE, Mufson EJ. Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective? Cell Mol Life Sci. 2008 Jun;65(12):1842-53. PMID: 18500641.

 

Lang R, Gundlach AL, Kofler B. The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol Ther. 2007 Aug;115(2):177-207. PMID: 17604107.

 

Mazarati A, Lu X, Shinmei S, et al. Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice. Neuroscience. 2004;128(2):431-41. PMID: 15350653.

" Not dangerous goods.

LKT G0147 Galanin, pig 1 mg 600.1 Endogenous neuropeptide, involved in nociception, sleep regulation, feeding behavior; GAL agonist. 88813-36-9 ≥98% 3210.55 C146H213N43O40 CCC(C)C(C(=O)NC(CC(=O)O)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CNC=N1)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC3=CN=CN3)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(C)C(=O)N)NC(=O)C(C)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCCN6C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC7=CC=C(C=C7)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)CN Ambient -20°C Soluble in 5% acetic acid. "Mitsukawa K, Lu X, Bartfai T. Galanin, galanin receptors and drug targets. Cell Mol Life Sci. 2008 Jun;65(12):1796-805. PMID: 18500647.

 

Counts SE, Perez SE, Mufson EJ. Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective? Cell Mol Life Sci. 2008 Jun;65(12):1842-53. PMID: 18500641.

 

Lang R, Gundlach AL, Kofler B. The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol Ther. 2007 Aug;115(2):177-207. PMID: 17604107.

 

Mazarati A, Lu X, Shinmei S, et al. Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice. Neuroscience. 2004;128(2):431-41. PMID: 15350653.

" Not dangerous goods.

LKT G0148 Galanin, rat 1 mg 672.2 Endogenous neuropeptide, involved in nociception, sleep regulation, feeding behavior; GAL agonist. 114547-31-8 ≥98% 3164.48 C141H211N43O41 CCC(C)C(C(=O)NC(CC(=O)O)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CNC=N1)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CO)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC3=CNC=N3)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)N)NC(=O)C(C)NC(=O)C(CC4=CNC=N4)NC(=O)C5CCCN5C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC7=CNC8=CC=CC=C87)NC(=O)CN Ambient -20°C Soluble in 5% acetic acid. "Mitsukawa K, Lu X, Bartfai T. Galanin, galanin receptors and drug targets. Cell Mol Life Sci. 2008 Jun;65(12):1796-805. PMID: 18500647.

 

Counts SE, Perez SE, Mufson EJ. Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective? Cell Mol Life Sci. 2008 Jun;65(12):1842-53. PMID: 18500641.

 

Lang R, Gundlach AL, Kofler B. The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol Ther. 2007 Aug;115(2):177-207. PMID: 17604107.

 

Mazarati A, Lu X, Shinmei S, et al. Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice. Neuroscience. 2004;128(2):431-41. PMID: 15350653.

" Not dangerous goods.

LKT G0152 Ganciclovir 50 mg 95.1 Nucleoside (guanosine) analog; DNA chain terminator, viral DNA polymerase inhibitor. 2-Amino-1,9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]- methyl]-6H-purin-6-one DHPG; 2'NDG; BIOLF 82410-32-0 ≥98% 255.23 C9H13N5O4 C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N Ambient Ambient Soluble in water. "Prichard MN, Kern ER. The search for new therapies for human cytomegalovirus infections. Virus Res. 2011 May;157(2):212-21. PMID: 21095209.

 

Abate-Daga D, Garcia-Rodríguez L, Sumoy L, et al. Cell cycle control pathways act as conditioning factors for TK/GCV sensitivity in pancreatic cancer cells. Biochim Biophys Acta. 2010 Oct;1803(10):1175-85. PMID: 20599444.

 

De Clercq E, Neyts J. Antiviral agents acting as DNA or RNA chain terminators. Handb Exp Pharmacol. 2009;(189):53-84. PMID: 19048197.

" T Not dangerous goods.

LKT G0152 Ganciclovir 100 mg 176.6 Nucleoside (guanosine) analog; DNA chain terminator, viral DNA polymerase inhibitor. 2-Amino-1,9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]- methyl]-6H-purin-6-one DHPG; 2'NDG; BIOLF 82410-32-0 ≥98% 255.23 C9H13N5O4 C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N Ambient Ambient Soluble in water. "Prichard MN, Kern ER. The search for new therapies for human cytomegalovirus infections. Virus Res. 2011 May;157(2):212-21. PMID: 21095209.

 

Abate-Daga D, Garcia-Rodríguez L, Sumoy L, et al. Cell cycle control pathways act as conditioning factors for TK/GCV sensitivity in pancreatic cancer cells. Biochim Biophys Acta. 2010 Oct;1803(10):1175-85. PMID: 20599444.

 

De Clercq E, Neyts J. Antiviral agents acting as DNA or RNA chain terminators. Handb Exp Pharmacol. 2009;(189):53-84. PMID: 19048197.

" T Not dangerous goods.

LKT G0175 Gastric Inhibitory Peptide, human 0.5 mg 228 Endogenous peptide hormone, somatostatin analog; GIP-R agonist. GIP 100040-31-1 ≥95% 4983.64 C226H338N60O66S Ambient -20°C "Mohammad S, Ramos LS, Buck J, et al. Gastric inhibitory peptide controls adipose insulin sensitivity via activation of cAMP-response element-binding protein and p110β isoform of phosphatidylinositol 3-kinase. J Biol Chem. 2011 Dec 16;286(50):43062-70. PMID: 22027830.

 

Adrian TE, Barnes AJ, Long RG, et al. The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J Clin Endocrinol Metab. 1981 Oct;53(4):675-81. PMID: 6116721.

" Not dangerous.

LKT G0175 Gastric Inhibitory Peptide, human 1 mg 387 Endogenous peptide hormone, somatostatin analog; GIP-R agonist. GIP 100040-31-1 ≥95% 4983.64 C226H338N60O66S Ambient -20°C "Mohammad S, Ramos LS, Buck J, et al. Gastric inhibitory peptide controls adipose insulin sensitivity via activation of cAMP-response element-binding protein and p110β isoform of phosphatidylinositol 3-kinase. J Biol Chem. 2011 Dec 16;286(50):43062-70. PMID: 22027830.

 

Adrian TE, Barnes AJ, Long RG, et al. The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J Clin Endocrinol Metab. 1981 Oct;53(4):675-81. PMID: 6116721.

" Not dangerous.

LKT G0175 Gastric Inhibitory Peptide, human 2.5 mg 684.1 Endogenous peptide hormone, somatostatin analog; GIP-R agonist. GIP 100040-31-1 ≥95% 4983.64 C226H338N60O66S Ambient -20°C "Mohammad S, Ramos LS, Buck J, et al. Gastric inhibitory peptide controls adipose insulin sensitivity via activation of cAMP-response element-binding protein and p110β isoform of phosphatidylinositol 3-kinase. J Biol Chem. 2011 Dec 16;286(50):43062-70. PMID: 22027830.

 

Adrian TE, Barnes AJ, Long RG, et al. The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J Clin Endocrinol Metab. 1981 Oct;53(4):675-81. PMID: 6116721.

" Not dangerous.

LKT G0178 Gastrin, chicken 0.5 mg 396.1 Endogenous peptide hormone; CCK2 agonist, indirect H+/K+ ATPase activator. ≥95% 4055.58 C190H265N47O51S1 Ambient -20°C "Furuse M, Ao R, Bungo T, et al. Central gastrin inhibits feeding behavior and food passage in neonatal chicks. Life Sci. 1999;65(3):305-11. PMID: 10447216.

 

Zimmerhackl B, Wünsch E, Classen M, et al. In man histamine and muscarinergic mechanisms are essential mediators of acid secretion in response to synthetic human gastrin (1-17). Regul Pept. 1993 Jul 23;46(3):583-92. PMID: 8105512.

 

Rattan S, Coln D, Goyal RK. The mechanism of action of gastrin on the lower esophageal sphincter. Gastroenterology. 1976 May;70(5 PT.1):828-31. PMID: 1261781.

" Not dangerous goods.

LKT G0178 Gastrin, chicken 1 mg 672.2 Endogenous peptide hormone; CCK2 agonist, indirect H+/K+ ATPase activator. ≥95% 4055.58 C190H265N47O51S1 Ambient -20°C "Furuse M, Ao R, Bungo T, et al. Central gastrin inhibits feeding behavior and food passage in neonatal chicks. Life Sci. 1999;65(3):305-11. PMID: 10447216.

 

Zimmerhackl B, Wünsch E, Classen M, et al. In man histamine and muscarinergic mechanisms are essential mediators of acid secretion in response to synthetic human gastrin (1-17). Regul Pept. 1993 Jul 23;46(3):583-92. PMID: 8105512.

 

Rattan S, Coln D, Goyal RK. The mechanism of action of gastrin on the lower esophageal sphincter. Gastroenterology. 1976 May;70(5 PT.1):828-31. PMID: 1261781.

" Not dangerous goods.

LKT G0178 Gastrin, chicken 2.5 mg 1188.1 Endogenous peptide hormone; CCK2 agonist, indirect H+/K+ ATPase activator. ≥95% 4055.58 C190H265N47O51S1 Ambient -20°C "Furuse M, Ao R, Bungo T, et al. Central gastrin inhibits feeding behavior and food passage in neonatal chicks. Life Sci. 1999;65(3):305-11. PMID: 10447216.

 

Zimmerhackl B, Wünsch E, Classen M, et al. In man histamine and muscarinergic mechanisms are essential mediators of acid secretion in response to synthetic human gastrin (1-17). Regul Pept. 1993 Jul 23;46(3):583-92. PMID: 8105512.

 

Rattan S, Coln D, Goyal RK. The mechanism of action of gastrin on the lower esophageal sphincter. Gastroenterology. 1976 May;70(5 PT.1):828-31. PMID: 1261781.

" Not dangerous goods.

LKT G0179 Gastrin-1, rat 0.5 mg 228 Endogenous peptide hormone; CCK2 agonist, indirect H+/K+ ATPase activator. 81123-06-0 ≥95% 2126.32 C94H128N22O31S2 Ambient -20°C "Furuse M, Ao R, Bungo T, et al. Central gastrin inhibits feeding behavior and food passage in neonatal chicks. Life Sci. 1999;65(3):305-11. PMID: 10447216.

 

Zimmerhackl B, Wünsch E, Classen M, et al. In man histamine and muscarinergic mechanisms are essential mediators of acid secretion in response to synthetic human gastrin (1-17). Regul Pept. 1993 Jul 23;46(3):583-92. PMID: 8105512.

 

Rattan S, Coln D, Goyal RK. The mechanism of action of gastrin on the lower esophageal sphincter. Gastroenterology. 1976 May;70(5 PT.1):828-31. PMID: 1261781.

" Not dangerous goods.

LKT G0179 Gastrin-1, rat 1 mg 387 Endogenous peptide hormone; CCK2 agonist, indirect H+/K+ ATPase activator. 81123-06-0 ≥95% 2126.32 C94H128N22O31S2 Ambient -20°C "Furuse M, Ao R, Bungo T, et al. Central gastrin inhibits feeding behavior and food passage in neonatal chicks. Life Sci. 1999;65(3):305-11. PMID: 10447216.

 

Zimmerhackl B, Wünsch E, Classen M, et al. In man histamine and muscarinergic mechanisms are essential mediators of acid secretion in response to synthetic human gastrin (1-17). Regul Pept. 1993 Jul 23;46(3):583-92. PMID: 8105512.

 

Rattan S, Coln D, Goyal RK. The mechanism of action of gastrin on the lower esophageal sphincter. Gastroenterology. 1976 May;70(5 PT.1):828-31. PMID: 1261781.

" Not dangerous goods.

LKT G0179 Gastrin-1, rat 2.5 mg 684.1 Endogenous peptide hormone; CCK2 agonist, indirect H+/K+ ATPase activator. 81123-06-0 ≥95% 2126.32 C94H128N22O31S2 Ambient -20°C "Furuse M, Ao R, Bungo T, et al. Central gastrin inhibits feeding behavior and food passage in neonatal chicks. Life Sci. 1999;65(3):305-11. PMID: 10447216.

 

Zimmerhackl B, Wünsch E, Classen M, et al. In man histamine and muscarinergic mechanisms are essential mediators of acid secretion in response to synthetic human gastrin (1-17). Regul Pept. 1993 Jul 23;46(3):583-92. PMID: 8105512.

 

Rattan S, Coln D, Goyal RK. The mechanism of action of gastrin on the lower esophageal sphincter. Gastroenterology. 1976 May;70(5 PT.1):828-31. PMID: 1261781.

" Not dangerous goods.

LKT G0180 Gastrin I, human 5 mg 684.1 Endogenous peptide hormone involved in feeding behavior and enteric movement; CCK2 agonist, indirect H+/K+ TPase activator. 18-Pyroglutamic acid; big gastrin I-(18-34)-peptide amide, human; [pGlu18]-Big gastrin I fragment 18-34 amide; Gastrin I, heptadecapeptide; HG-17; Little gastrin I; Little gastrin 10047-33-3 ≥98% 2098.22 C130H204N38O31S CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NCC(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC4=CC=CC=C4)C(=O)N)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C7CCCN7C(=O)CNC(=O)C8CCC(=O)N8 Ambient -20°C "Furuse M, Ao R, Bungo T, et al. Central gastrin inhibits feeding behavior and food passage in neonatal chicks. Life Sci. 1999;65(3):305-11. PMID: 10447216.

 

Zimmerhackl B, Wünsch E, Classen M, et al. In man histamine and muscarinergic mechanisms are essential mediators of acid secretion in response to synthetic human gastrin (1-17). Regul Pept. 1993 Jul 23;46(3):583-92. PMID: 8105512.

 

Rattan S, Coln D, Goyal RK. The mechanism of action of gastrin on the lower esophageal sphincter. Gastroenterology. 1976 May;70(5 PT.1):828-31. PMID: 1261781.

" Not dangerous goods.

LKT G0180 Gastrin I, human 2 mg 387 Endogenous peptide hormone involved in feeding behavior and enteric movement; CCK2 agonist, indirect H+/K+ TPase activator. 18-Pyroglutamic acid; big gastrin I-(18-34)-peptide amide, human; [pGlu18]-Big gastrin I fragment 18-34 amide; Gastrin I, heptadecapeptide; HG-17; Little gastrin I; Little gastrin 10047-33-3 ≥98% 2098.22 C130H204N38O31S CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NCC(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC4=CC=CC=C4)C(=O)N)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C7CCCN7C(=O)CNC(=O)C8CCC(=O)N8 Ambient -20°C "Furuse M, Ao R, Bungo T, et al. Central gastrin inhibits feeding behavior and food passage in neonatal chicks. Life Sci. 1999;65(3):305-11. PMID: 10447216.

 

Zimmerhackl B, Wünsch E, Classen M, et al. In man histamine and muscarinergic mechanisms are essential mediators of acid secretion in response to synthetic human gastrin (1-17). Regul Pept. 1993 Jul 23;46(3):583-92. PMID: 8105512.

 

Rattan S, Coln D, Goyal RK. The mechanism of action of gastrin on the lower esophageal sphincter. Gastroenterology. 1976 May;70(5 PT.1):828-31. PMID: 1261781.

" Not dangerous goods.

LKT G0180 Gastrin I, human 1 mg 228 Endogenous peptide hormone involved in feeding behavior and enteric movement; CCK2 agonist, indirect H+/K+ TPase activator. 18-Pyroglutamic acid; big gastrin I-(18-34)-peptide amide, human; [pGlu18]-Big gastrin I fragment 18-34 amide; Gastrin I, heptadecapeptide; HG-17; Little gastrin I; Little gastrin 10047-33-3 ≥98% 2098.22 C130H204N38O31S CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NCC(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC4=CC=CC=C4)C(=O)N)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C7CCCN7C(=O)CNC(=O)C8CCC(=O)N8 Ambient -20°C "Furuse M, Ao R, Bungo T, et al. Central gastrin inhibits feeding behavior and food passage in neonatal chicks. Life Sci. 1999;65(3):305-11. PMID: 10447216.

 

Zimmerhackl B, Wünsch E, Classen M, et al. In man histamine and muscarinergic mechanisms are essential mediators of acid secretion in response to synthetic human gastrin (1-17). Regul Pept. 1993 Jul 23;46(3):583-92. PMID: 8105512.

 

Rattan S, Coln D, Goyal RK. The mechanism of action of gastrin on the lower esophageal sphincter. Gastroenterology. 1976 May;70(5 PT.1):828-31. PMID: 1261781.

" Not dangerous goods.

LKT G0181 Gastrin Releasing Peptide, human 1 mg 450 Endogenous bombesin-like peptide, involved in feeding behavior, stress signaling, circadian rhythms; GRP agonist. GRP 93755-85-2 ≥95% 2859.4 C130H204N38O31S2 CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)C(CC1=CNC=N1)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CNC=N4)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C5CCCN5C(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CCSC)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(C(C)O)NC(=O)CNC(=O)CNC(=O)CNC(=O)C(C)NC(=O)C7CCCN7C(=O)C(CC(C)C)NC(=O)C8CCCN8C(=O)C(C(C)C)N Ambient -20°C Soluble in water. "Kallingal GJ, Mintz EM. Site-specific effects of gastrin-releasing peptide in the suprachiasmatic nucleus. Eur J Neurosci. 2014 Feb;39(4):630-9. PMID: 24528136.

 

Lee KH, Koh SA, Kim JR. Hepatocyte growth factor-mediated gastrin-releasing peptide induces IL-8 expression through Ets-1 in gastric cancer cells. Oncol Res. 2013;20(9):393-402. PMID: 23924923.

 

Sukhtankar DD, Ko MC. Physiological function of gastrin-releasing peptide and neuromedin B receptors in regulating itch scratching behavior in the spinal cord of mice. PLoS One. 2013 Jun 24;8(6):e67422. PMID: 23826298.

 

Merali Z, McIntosh J, Anisman H. Role of bombesin-related peptides in the control of food intake. Neuropeptides. 1999 Oct;33(5):376-86. PMID: 10657515.

" Not dangerous goods.

LKT G0182 Gastrin Releasing Peptide, pig 1 mg 450 Endogenous bombesin-like peptide, involved in feeding behavior, stress signaling, circadian rhythms; GRP agonist. GRP 74815-57-9 ≥98% 2805.4 C126H198N38O31S2 CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)C(CC1=CN=CN1)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CN=CN4)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C5CCCN5C(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CCSC)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(C(C)O)NC(=O)CNC(=O)CNC(=O)CNC(=O)C(C(C)C)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C7CCCN7C(=O)C(C)N Ambient -20°C Soluble in water. "Kallingal GJ, Mintz EM. Site-specific effects of gastrin-releasing peptide in the suprachiasmatic nucleus. Eur J Neurosci. 2014 Feb;39(4):630-9. PMID: 24528136.

 

Lee KH, Koh SA, Kim JR. Hepatocyte growth factor-mediated gastrin-releasing peptide induces IL-8 expression through Ets-1 in gastric cancer cells. Oncol Res. 2013;20(9):393-402. PMID: 23924923.

 

Sukhtankar DD, Ko MC. Physiological function of gastrin-releasing peptide and neuromedin B receptors in regulating itch scratching behavior in the spinal cord of mice. PLoS One. 2013 Jun 24;8(6):e67422. PMID: 23826298.

 

Merali Z, McIntosh J, Anisman H. Role of bombesin-related peptides in the control of food intake. Neuropeptides. 1999 Oct;33(5):376-86. PMID: 10657515.

" Not dangerous goods.

LKT G0246 Galantamine Hydrobromide 5 mg 40.7 Alkaloid found in Galanthus, Narcissus, Leucojum, and Lycoris; AChE inhibitor, α7 nAChR agonist, mAChR agonist. (4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy- 11-methyl-6H-benzofuronyl Nivalin, Galanthamine Hydrobromide 1953-04-4 ≥98% 368.27 C17H21NO3 HBr CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O.Br Ambient -20°C Soluble in water. "Kita Y, Ago Y, Higashino K, et al. Galantamine promotes adult hippocampal neurogenesis via M1 muscarinic and α7 nicotinic receptors in mice. Int J Neuropsychopharmacol. 2014 Dec;17(12):1957-68. PMID: 24818616.

 

Tsvetkova D, Obreshkova D, Zheleva-Dimitrova D, et al. Antioxidant activity of galantamine and some of its derivatives. Curr Med Chem. 2013;20(36):4595-608. PMID: 23834167.

 

Ago Y, Koda K, Takuma K, et al. Pharmacological aspects of the acetylcholinesterase inhigalantamine. J Pharmacol Sci. 2011;116(1):6-17. PMID: 21498956.

 

Woodruff-Pak DS, Vogel RW 3rd, Wenk GL. Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning. Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):2089-94. PMID: 11172080.

" T "UN number: 2811     Class: 6.1     Packing Group: III

Proper shipping name: Toxic solid, organic, n.o.s. (Galantamine Hydrobromide)"

LKT G0246 Galantamine Hydrobromide 25 mg 81.6 Alkaloid found in Galanthus, Narcissus, Leucojum, and Lycoris; AChE inhibitor, α7 nAChR agonist, mAChR agonist. (4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy- 11-methyl-6H-benzofuronyl Nivalin, Galanthamine Hydrobromide 1953-04-4 ≥98% 368.27 C17H21NO3 HBr CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O.Br Ambient -20°C Soluble in water. "Kita Y, Ago Y, Higashino K, et al. Galantamine promotes adult hippocampal neurogenesis via M1 muscarinic and α7 nicotinic receptors in mice. Int J Neuropsychopharmacol. 2014 Dec;17(12):1957-68. PMID: 24818616.

 

Tsvetkova D, Obreshkova D, Zheleva-Dimitrova D, et al. Antioxidant activity of galantamine and some of its derivatives. Curr Med Chem. 2013;20(36):4595-608. PMID: 23834167.

 

Ago Y, Koda K, Takuma K, et al. Pharmacological aspects of the acetylcholinesterase inhib galantamine. J Pharmacol Sci. 2011;116(1):6-17. PMID: 21498956.

 

Woodruff-Pak DS, Vogel RW 3rd, Wenk GL. Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning. Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):2089-94. PMID: 11172080.

" T "UN number: 2811     Class: 6.1     Packing Group: III

Proper shipping name: Toxic solid, organic, n.o.s. (Galantamine Hydrobromide)"

LKT G0246 Galantamine Hydrobromide 100 mg 136 Alkaloid found in Galanthus, Narcissus, Leucojum, and Lycoris; AChE inhibitor, α7 nAChR agonist, mAChR agonist. (4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy- 11-methyl-6H-benzofuronyl Nivalin, Galanthamine Hydrobromide 1953-04-4 ≥98% 368.27 C17H21NO3 HBr CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O.Br Ambient -20°C Soluble in water. "Kita Y, Ago Y, Higashino K, et al. Galantamine promotes adult hippocampal neurogenesis via M1 muscarinic and α7 nicotinic receptors in mice. Int J Neuropsychopharmacol. 2014 Dec;17(12):1957-68. PMID: 24818616.

 

Tsvetkova D, Obreshkova D, Zheleva-Dimitrova D, et al. Antioxidant activity of galantamine and some of its derivatives. Curr Med Chem. 2013;20(36):4595-608. PMID: 23834167.

 

Ago Y, Koda K, Takuma K, et al. Pharmacological aspects of the acetylcholinesterase inhigalantamine. J Pharmacol Sci. 2011;116(1):6-17. PMID: 21498956.

 

Woodruff-Pak DS, Vogel RW 3rd, Wenk GL. Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning. Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):2089-94. PMID: 11172080.

" T "UN number: 2811     Class: 6.1     Packing Group: III

Proper shipping name: Toxic solid, organic, n.o.s. (Galantamine Hydrobromide)"

LKT G1650 Geniposide 10 mg 95.1 Iridoid glycoside found in Gardenia. 24512-63-8 ≥98% 388.37 C17H24O10 COC(=O)C1=COC(C2C1CC=C2CO)OC3C(C(C(C(O3)CO)O)O)O Ambient Ambient Soluble in water, methanol and ethanol. 24512-63-8 "Guo LX, Liu JH, Yin F. Regulation of insulin secretion by geniposide: possible involvement of phosphatidylinositol 3-phosphate kinase. Eur Rev Med Pharmacol Sci. 2014;18(9):1287-94. PMID: 24867506.

 

Song X, Zhang W, Wang T, et al. Geniposide Plays an Anti-inflammatory Role via Regulating TLR4 and Downstream Signaling Pathways in Lipopolysaccharide-Induced Mastitis in Mice. Inflammation. 2014 Apr 27. [Epub ahead of print]. PMID: 24771071.

 

Liu J, Guo L, Yin F, et al. Geniposide regulates glucose-stimulated insulin secretion possibly through controlling glucose metabolism in INS-1 cells. PLoS One. 2013 Oct 22;8(10):e78315. Erratum in: PLoS One. 2014;9(1). PMID: 24167617.

 

Liu J, Zhang Y, Deng X, et al. Geniposide decreases the level of Aβ1-42 in the hippocampus of streptozotocin-induced diabetic rats.

 cta Biochim Biophys Sin (Shanghai). 2013 Sep;45(9):787-91. PMID: 23803411.

 

Suzuki Y, Kondo K, Ikeda Y, et al. Antithrombotic effect of geniposide and genipin in the mouse thrombosis model. Planta Med. 2001 Dec;67(9):807-10. PMID: 11745015.

 

Tseng T, Chu C, Wang C. Comparison of geniposide and its acetylated derivative for the inhibition of aflatoxin b1-induced DNA-repair synthesis in rat primary hepatocyte. Oncol Rep. 1994 Jan;1(1):165-8. PMID: 21607329.

" None Not dangerous goods.

LKT G1650 Geniposide 25 mg 122.3 Iridoid glycoside found in Gardenia. 24512-63-8 ≥98% 388.37 C17H24O10 COC(=O)C1=COC(C2C1CC=C2CO)OC3C(C(C(C(O3)CO)O)O)O Ambient Ambient Soluble in water, methanol and ethanol. 24512-63-8 "Guo LX, Liu JH, Yin F. Regulation of insulin secretion by geniposide: possible involvement of phosphatidylinositol 3-phosphate kinase. Eur Rev Med Pharmacol Sci. 2014;18(9):1287-94. PMID: 24867506.

 

Song X, Zhang W, Wang T, et al. Geniposide Plays an Anti-inflammatory Role via Regulating TLR4 and Downstream Signaling Pathways in Lipopolysaccharide-Induced Mastitis in Mice. Inflammation. 2014 Apr 27. [Epub ahead of print]. PMID: 24771071.

 

Liu J, Guo L, Yin F, et al. Geniposide regulates glucose-stimulated insulin secretion possibly through controlling glucose metabolism in INS-1 cells. PLoS One. 2013 Oct 22;8(10):e78315. Erratum in: PLoS One. 2014;9(1). PMID: 24167617.

 

Liu J, Zhang Y, Deng X, et al. Geniposide decreases the level of Aβ1-42 in the hippocampus of streptozotocin-induced diabetic rats.

 cta Biochim Biophys Sin (Shanghai). 2013 Sep;45(9):787-91. PMID: 23803411.

 

Suzuki Y, Kondo K, Ikeda Y, et al. Antithrombotic effect of geniposide and genipin in the mouse thrombosis model. Planta Med. 2001 Dec;67(9):807-10. PMID: 11745015.

 

Tseng T, Chu C, Wang C. Comparison of geniposide and its acetylated derivative for the inhibition of aflatoxin b1-induced DNA-repair synthesis in rat primary hepatocyte. Oncol Rep. 1994 Jan;1(1):165-8. PMID: 21607329.

" None Not dangerous goods.

LKT G1650 Geniposide 100 mg 339.8 Iridoid glycoside found in Gardenia. 24512-63-8 ≥98% 388.37 C17H24O10 COC(=O)C1=COC(C2C1CC=C2CO)OC3C(C(C(C(O3)CO)O)O)O Ambient Ambient Soluble in water, methanol and ethanol. 24512-63-8 "Guo LX, Liu JH, Yin F. Regulation of insulin secretion by geniposide: possible involvement of phosphatidylinositol 3-phosphate kinase. Eur Rev Med Pharmacol Sci. 2014;18(9):1287-94. PMID: 24867506.

 

Song X, Zhang W, Wang T, et al. Geniposide Plays an Anti-inflammatory Role via Regulating TLR4 and Downstream Signaling Pathways in Lipopolysaccharide-Induced Mastitis in Mice. Inflammation. 2014 Apr 27. [Epub ahead of print]. PMID: 24771071.

 

Liu J, Guo L, Yin F, et al. Geniposide regulates glucose-stimulated insulin secretion possibly through controlling glucose metabolism in INS-1 cells. PLoS One. 2013 Oct 22;8(10):e78315. Erratum in: PLoS One. 2014;9(1). PMID: 24167617.

 

Liu J, Zhang Y, Deng X, et al. Geniposide decreases the level of Aβ1-42 in the hippocampus of streptozotocin-induced diabetic rats.

 cta Biochim Biophys Sin (Shanghai). 2013 Sep;45(9):787-91. PMID: 23803411.

 

Suzuki Y, Kondo K, Ikeda Y, et al. Antithrombotic effect of geniposide and genipin in the mouse thrombosis model. Planta Med. 2001 Dec;67(9):807-10. PMID: 11745015.

 

Tseng T, Chu C, Wang C. Comparison of geniposide and its acetylated derivative for the inhibition of aflatoxin b1-induced DNA-repair synthesis in rat primary hepatocyte. Oncol Rep. 1994 Jan;1(1):165-8. PMID: 21607329.

" None Not dangerous goods.

LKT G1653 Genistin 1 mg 65.6 Isoflavone found in soy; SERM. Genistoside, Isoflavone; 4',5,7-trihydroxy-, 7-D-glucoside; GENISTEIN-7-O-GLUCOSIDE 529-59-9 ≥98% 432.38 C21H20O10 C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)OC4C(C(C(C(O4)CO)O)O)O)O Ambient Ambient "Xiong YJ, Chen DP, Lv BC, et al. The characteristics of genistin-induced inhibitory effects on intestinal motility. Arch Pharm Res. 2013 Mar;36(3):345-52. PMID: 23435915.

 

Choi EJ, Kim T, Lee MS. Pro-apoptotic effect and cytotoxicity of genistein and genistin in human ovarian cancer SK-OV-3 cells. Life Sci. 2007 Mar 20;80(15):1403-8. PMID: 17291540.

 

Hwang CS, Kwak HS, Lim HJ, et al. Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol. 2006 Nov;101(4-5):246-53. PMID: 16965913.

 

Ishida H, Uesugi T, Hirai K, et al. Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol Pharm Bull. 1998 Jan;21(1):62-6. PMID: 9477170.

" None Not dangerous goods.

LKT G1653 Genistin 5 mg 225 Isoflavone found in soy; SERM. Genistoside, Isoflavone; 4',5,7-trihydroxy-, 7-D-glucoside; GENISTEIN-7-O-GLUCOSIDE 529-59-9 ≥98% 432.38 C21H20O10 C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)OC4C(C(C(C(O4)CO)O)O)O)O Ambient Ambient "Xiong YJ, Chen DP, Lv BC, et al. The characteristics of genistin-induced inhibitory effects on intestinal motility. Arch Pharm Res. 2013 Mar;36(3):345-52. PMID: 23435915.

 

Choi EJ, Kim T, Lee MS. Pro-apoptotic effect and cytotoxicity of genistein and genistin in human ovarian cancer SK-OV-3 cells. Life Sci. 2007 Mar 20;80(15):1403-8. PMID: 17291540.

 

Hwang CS, Kwak HS, Lim HJ, et al. Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol. 2006 Nov;101(4-5):246-53. PMID: 16965913.

 

Ishida H, Uesugi T, Hirai K, et al. Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol Pharm Bull. 1998 Jan;21(1):62-6. PMID: 9477170.

" None Not dangerous goods.

LKT G1658 Gentamycin Sulfate 500 mg 47.6 Aminoglycoside; protein translation inhibitor. Gentamicin C complex sulfate; Alcomicin; Garamycin; Gentacin; Lugacin; Ophtagram; Pangram; Sulmycin 1405-41-0 ≥98% 551.73 CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC.OS(=O)(=O)O Hygroscopic. Ambient Ambient Soluble in ethylene glycol and formamide. "Cavallo G, Martinetto P. The mechanism of action of aminoglycosides. G Batteriol Virol Immunol. 1981 Jul-Dec;74(7-12):335-46. PMID: 6182050.

 

Hahn FE, Sarre SG. Mechanism of action of gentamicin. J Infect Dis. 1969 Apr-May;119(4):364-9. PMID: 4892389.

" Xn Not dangerous goods.

LKT G1658 Gentamycin Sulfate 1 g 67.9 Aminoglycoside; protein translation inhibitor. Gentamicin C complex sulfate; Alcomicin; Garamycin; Gentacin; Lugacin; Ophtagram; Pangram; Sulmycin 1405-41-0 ≥98% 551.73 CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC.OS(=O)(=O)O Hygroscopic. Ambient Ambient Soluble in ethylene glycol and formamide. "Cavallo G, Martinetto P. The mechanism of action of aminoglycosides. G Batteriol Virol Immunol. 1981 Jul-Dec;74(7-12):335-46. PMID: 6182050.

 

Hahn FE, Sarre SG. Mechanism of action of gentamicin. J Infect Dis. 1969 Apr-May;119(4):364-9. PMID: 4892389.

" Xn Not dangerous goods.

LKT G1658 Gentamycin Sulfate 5 g 244.5 Aminoglycoside; protein translation inhibitor. Gentamicin C complex sulfate; Alcomicin; Garamycin; Gentacin; Lugacin; Ophtagram; Pangram; Sulmycin 1405-41-0 ≥98% 551.73 CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC.OS(=O)(=O)O Hygroscopic. Ambient Ambient Soluble in ethylene glycol and formamide. "Cavallo G, Martinetto P. The mechanism of action of aminoglycosides. G Batteriol Virol Immunol. 1981 Jul-Dec;74(7-12):335-46. PMID: 6182050.

 

Hahn FE, Sarre SG. Mechanism of action of gentamicin. J Infect Dis. 1969 Apr-May;119(4):364-9. PMID: 4892389.

" Xn Not dangerous goods.

LKT G1658 Gentamycin Sulfate 10 g 407.7 Aminoglycoside; protein translation inhibitor. Gentamicin C complex sulfate; Alcomicin; Garamycin; Gentacin; Lugacin; Ophtagram; Pangram; Sulmycin 1405-41-0 ≥98% 551.73 CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC.OS(=O)(=O)O Hygroscopic. Ambient Ambient Soluble in ethylene glycol and formamide. "Cavallo G, Martinetto P. The mechanism of action of aminoglycosides. G Batteriol Virol Immunol. 1981 Jul-Dec;74(7-12):335-46. PMID: 6182050.

 

Hahn FE, Sarre SG. Mechanism of action of gentamicin. J Infect Dis. 1969 Apr-May;119(4):364-9. PMID: 4892389.

" Xn Not dangerous goods.

LKT G1721 Gefitinib 100 mg 113.9 EGFR inhibitor. N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine 184475-35-2 ≥98% 446.9 C22H24ClFN4O3 COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4 Ambient Ambient DMSO (20 mg/ml), DMF (20 mg/ml) "Mansure JJ, Nassim R, Chevalier S, et al. A novel mechanism of PPAR gamma induction via EGFR signalling constitutes rational for combination therapy in bladder cancer. PLoS One. 2013;8(2):e55997. doi: 10.1371/journal.pone.0055997. Erratum in: PLoS One. 2013; 8(5).  PMID: 23409107.

 

Yoshida T, Yamada K, Azuma K, et al. Comparison of adverse events and efficacy between gefitinib and erlotinib in patients with non-small-cell lung cancer: a retrospective analysis. Med Oncol. 2013 Mar;30(1):349. PMID: 23263831.

 

Wan S, Wright DW, Coveney PV. Mechanism of drug efficacy within the EGF receptor revealed by microsecond molecular dynamics simulation. Mol Cancer Ther. 2012 Nov;11(11):2394-400. PMID: 22863610.

 

Namba T, Tanaka K, Hoshino T, et al. Suppression of expression of heat shock protein 70 by gefitinib and its contribution to pulmonary fibrosis. PLoS One. 2011;6(11):e27296. PMID: 22096546.

 

Lu PH, Kuo TC, Chang KC, et al. Gefitinib-induced epidermal growth factor receptor-independent keratinocyte apoptosis is mediated by the JNK activation pathway. Br J Dermatol. 2011 Jan;164(1):38-46. PMID: 20846305.

 

Stegmaier K, Corsello SM, Ross KN, et al. Gefitinib induces myeloid differentiation of acute myeloid leukemia. Blood. 2005 Oct 15;106(8):2841-8. PMID: 15998836.

 

Tracy S, Mukohara T, Hansen M, et al. Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255. Cancer Res. 2004 Oct 15;64(20):7241-4. PMID: 15492241.

" "UN number: 3077     Class:  9     Packing group:  III 

Proper shipping name:  Environmentally hazardous substance, solid, n.o.s. (Gefitinib)

Marine Pollutant: Yes     Poison inhalation hazard: No"

LKT G1721 Gefitinib 250 mg 200.8 EGFR inhibitor. N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine 184475-35-2 ≥98% 446.9 C22H24ClFN4O3 COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4 Ambient Ambient DMSO (20 mg/ml), DMF (20 mg/ml) "Mansure JJ, Nassim R, Chevalier S, et al. A novel mechanism of PPAR gamma induction via EGFR signalling constitutes rational for combination therapy in bladder cancer. PLoS One. 2013;8(2):e55997. doi: 10.1371/journal.pone.0055997. Erratum in: PLoS One. 2013; 8(5).  PMID: 23409107.

 

Yoshida T, Yamada K, Azuma K, et al. Comparison of adverse events and efficacy between gefitinib and erlotinib in patients with non-small-cell lung cancer: a retrospective analysis. Med Oncol. 2013 Mar;30(1):349. PMID: 23263831.

 

Wan S, Wright DW, Coveney PV. Mechanism of drug efficacy within the EGF receptor revealed by microsecond molecular dynamics simulation. Mol Cancer Ther. 2012 Nov;11(11):2394-400. PMID: 22863610.

 

Namba T, Tanaka K, Hoshino T, et al. Suppression of expression of heat shock protein 70 by gefitinib and its contribution to pulmonary fibrosis. PLoS One. 2011;6(11):e27296. PMID: 22096546.

 

Lu PH, Kuo TC, Chang KC, et al. Gefitinib-induced epidermal growth factor receptor-independent keratinocyte apoptosis is mediated by the JNK activation pathway. Br J Dermatol. 2011 Jan;164(1):38-46. PMID: 20846305.

 

Stegmaier K, Corsello SM, Ross KN, et al. Gefitinib induces myeloid differentiation of acute myeloid leukemia. Blood. 2005 Oct 15;106(8):2841-8. PMID: 15998836.

 

Tracy S, Mukohara T, Hansen M, et al. Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255. Cancer Res. 2004 Oct 15;64(20):7241-4. PMID: 15492241.

" "UN number: 3077     Class:  9     Packing group:  III 

Proper shipping name:  Environmentally hazardous substance, solid, n.o.s. (Gefitinib)

Marine Pollutant: Yes     Poison inhalation hazard: No"

LKT G1721 Gefitinib 1 g 585.9 EGFR inhibitor. N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine 184475-35-2 ≥98% 446.9 C22H24ClFN4O3 COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4 Ambient Ambient DMSO (20 mg/ml), DMF (20 mg/ml) "Mansure JJ, Nassim R, Chevalier S, et al. A novel mechanism of PPAR gamma induction via EGFR signalling constitutes rational for combination therapy in bladder cancer. PLoS One. 2013;8(2):e55997. doi: 10.1371/journal.pone.0055997. Erratum in: PLoS One. 2013; 8(5).  PMID: 23409107.

 

Yoshida T, Yamada K, Azuma K, et al. Comparison of adverse events and efficacy between gefitinib and erlotinib in patients with non-small-cell lung cancer: a retrospective analysis. Med Oncol. 2013 Mar;30(1):349. PMID: 23263831.

 

Wan S, Wright DW, Coveney PV. Mechanism of drug efficacy within the EGF receptor revealed by microsecond molecular dynamics simulation. Mol Cancer Ther. 2012 Nov;11(11):2394-400. PMID: 22863610.

 

Namba T, Tanaka K, Hoshino T, et al. Suppression of expression of heat shock protein 70 by gefitinib and its contribution to pulmonary fibrosis. PLoS One. 2011;6(11):e27296. PMID: 22096546.

 

Lu PH, Kuo TC, Chang KC, et al. Gefitinib-induced epidermal growth factor receptor-independent keratinocyte apoptosis is mediated by the JNK activation pathway. Br J Dermatol. 2011 Jan;164(1):38-46. PMID: 20846305.

 

Stegmaier K, Corsello SM, Ross KN, et al. Gefitinib induces myeloid differentiation of acute myeloid leukemia. Blood. 2005 Oct 15;106(8):2841-8. PMID: 15998836.

 

Tracy S, Mukohara T, Hansen M, et al. Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255. Cancer Res. 2004 Oct 15;64(20):7241-4. PMID: 15492241.

" "UN number: 3077     Class:  9     Packing group:  III 

Proper shipping name:  Environmentally hazardous substance, solid, n.o.s. (Gefitinib)

Marine Pollutant: Yes     Poison inhalation hazard: No"

LKT G1749 Gemfibrozil 5 g 76.3 Fibrate; PPARα agonist, enoyl-CoA reductase inhibitor. 5-(2,5-Dimethylphenoxy)-2,2-dimethylpentanoic acid Decrelip; Genlip; Lipozid; Lipur; Lopid 25812-30-0 ≥98% 250.33 C15H22O3 CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O Ambient Ambient Soluble in water and acid (0.0019%). Soluble in dilute base (>1%). "Reich-Slotky R, Kabbash CA, Della-Latta P, et al. Gemfibrozil inhibits Legionella pneumophila and Mycobacterium tuberculosis enoyl coenzyme A reductases and blocks intracellular growth of these bacteria in macrophages. J Bacteriol. 2009 Aug;191(16):5262-71. PMID: 19429621.

 

Sirtori CR, Franceschini G, Gianfranceschi G, et al. Activity profile of gemfibrozil on the major plasma lipoprotein parameters. Eur J Epidemiol. 1992 May;8 Suppl 1:120-4. PMID: 1505648.

" Xn Not dangerous goods.

LKT G1749 Gemfibrozil 25 g 254.3 Fibrate; PPARα agonist, enoyl-CoA reductase inhibitor. 5-(2,5-Dimethylphenoxy)-2,2-dimethylpentanoic acid Decrelip; Genlip; Lipozid; Lipur; Lopid 25812-30-0 ≥98% 250.33 C15H22O3 CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O Ambient Ambient Soluble in water and acid (0.0019%). Soluble in dilute base (>1%). "Reich-Slotky R, Kabbash CA, Della-Latta P, et al. Gemfibrozil inhibits Legionella pneumophila and Mycobacterium tuberculosis enoyl coenzyme A reductases and blocks intracellular growth of these bacteria in macrophages. J Bacteriol. 2009 Aug;191(16):5262-71. PMID: 19429621.

 

Sirtori CR, Franceschini G, Gianfranceschi G, et al. Activity profile of gemfibrozil on the major plasma lipoprotein parameters. Eur J Epidemiol. 1992 May;8 Suppl 1:120-4. PMID: 1505648.

" Xn Not dangerous goods.

LKT G1869 Geranylgeraniol 25 mg 140.7 Diterpene alcohol, geranylgeranyl pyrophosphate analog, used in synthesis of vitamins E and K. 3,7,11,15-Tetramethyl-2,6,10,14-hexadecatraen-1-ol all trans-3,7,11-15-Tetramethyl-2,6,10,14-hexadecatetraen- 1-ol 24034-73-9 ≥95% 290.49 C20H34O CC(=CCCC(=CCCC(=CCCC(=CCO)C)C)C)C Blue Ice -20°C Soluble in chloroform, alcohols, acetone, or ethyl acetate. "Campia I, Lussiana C, Pescarmona G, et al. Geranylgeraniol prevents the cytotoxic effects of mevastatin in THP-1 cells, without decreasing the beneficial effects on cholesterol synthesis. Br J Pharmacol. 2009 Dec;158(7):1777-86. PMID: 19888963.

 

Vik A, James A, Gundersen LL. Screening of terpenes and derivatives for antimycobacterial activity; identification of geranylgeraniol and geranylgeranyl acetate as potent inhibitors of Mycobacterium tuberculosis in vitro. Planta Med. 2007 Oct;73(13):1410-2. PMID: 17924309.

 

Shibayama-Imazu T, Sakairi S, Watanabe A, et al. Vitamin K(2) selectively induced apoptosis in ovarian TYK-nu and pancreatic MIA PaCa-2 cells out of eight solid tumor cell lines through a mechanism different from geranylgeraniol. J Cancer Res Clin Oncol. 2003 Jan;129(1):1-11. PMID: 12618894.

" Xi Not dangerous goods.

LKT G1869 Geranylgeraniol 100 mg 402.2 Diterpene alcohol, geranylgeranyl pyrophosphate analog, used in synthesis of vitamins E and K. 3,7,11,15-Tetramethyl-2,6,10,14-hexadecatraen-1-ol all trans-3,7,11-15-Tetramethyl-2,6,10,14-hexadecatetraen- 1-ol 24034-73-9 ≥95% 290.49 C20H34O CC(=CCCC(=CCCC(=CCCC(=CCO)C)C)C)C Blue Ice -20°C Soluble in chloroform, alcohols, acetone, or ethyl acetate. "Campia I, Lussiana C, Pescarmona G, et al. Geranylgeraniol prevents the cytotoxic effects of mevastatin in THP-1 cells, without decreasing the beneficial effects on cholesterol synthesis. Br J Pharmacol. 2009 Dec;158(7):1777-86. PMID: 19888963.

 

Vik A, James A, Gundersen LL. Screening of terpenes and derivatives for antimycobacterial activity; identification of geranylgeraniol and geranylgeranyl acetate as potent inhibitors of Mycobacterium tuberculosis in vitro. Planta Med. 2007 Oct;73(13):1410-2. PMID: 17924309.

 

Shibayama-Imazu T, Sakairi S, Watanabe A, et al. Vitamin K(2) selectively induced apoptosis in ovarian TYK-nu and pancreatic MIA PaCa-2 cells out of eight solid tumor cell lines through a mechanism different from geranylgeraniol. J Cancer Res Clin Oncol. 2003 Jan;129(1):1-11. PMID: 12618894.

" Xi Not dangerous goods.

LKT G1975 Gestrinone 25 mg 61.1 Synthetic steroid hormone; AR agonist, ER and PR antagonist. (17a)-13-Ethyl-17-hydroxy-18,19-dinorpregna-4,9,11-trien-20-yn-3-one 13b-ethyl-17a-ethynyl-17b-hydroxy-4,9,11-gonatrien-3-one; 13b-ethyl-17a-ethynyl-D4,9,11-gonatriene-17b-ol-3-one; ethylnorgestrienone 16320-04-0 ≥98% 308.41 C21H24O2 CCC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2(C#C)O Ambient Ambient "Zhu Y, Zhang T, Xie S, et al. Gestrinone inhibits growth of human uterine leiomyoma may relate to activity regulation of ERα, Src and P38 MAPK. Biomed Pharmacother. 2012 Dec;66(8):569-77. PMID: 23102719.

 

Wu S, Dong J, Cong J, et al. Gestrinone compared with mifepristone for emergency contraception: a randomized controlled trial. Obstet Gynecol. 2010 Apr;115(4):740-4. PMID: 20308833.

 

Ohno Y, Kitagawa I, Tamura H, et al. Antiestrogenic effect of gestrinone as an inhibitor of [3H]-estradiol binding to nuclear type II sites. Gynecol Obstet Invest. 1991;31(2):97-101. PMID: 2037266.

 

Venturini PL, Bertolini S, Brunenghi MC, et al. Endocrine, metabolic, and clinical effects of gestrinone in women with endometriosis. Fertil Steril. 1989 Oct;52(4):589-95. PMID: 2806598.

 

Tamaya T, Fujimoto J, Watanabe Y, et al. Gestrinone (R2323) binding to steroid receptors in human uterine endometrial cytosol. Acta Obstet Gynecol Scand. 1986;65(5):439-41. PMID: 3490730.

 

Kauppila A, Isomaa V, Rönnberg L, et al. Effect of gestrinone in endometriosis tissue and endometrium. Fertil Steril. 1985 Oct;44(4):466-70. PMID: 2996949.

" Not dangerous goods.

LKT G1975 Gestrinone 100 mg 129 Synthetic steroid hormone; AR agonist, ER and PR antagonist. (17a)-13-Ethyl-17-hydroxy-18,19-dinorpregna-4,9,11-trien-20-yn-3-one 13b-ethyl-17a-ethynyl-17b-hydroxy-4,9,11-gonatrien-3-one; 13b-ethyl-17a-ethynyl-D4,9,11-gonatriene-17b-ol-3-one; ethylnorgestrienone 16320-04-0 ≥98% 308.41 C21H24O2 CCC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2(C#C)O Ambient Ambient "Zhu Y, Zhang T, Xie S, et al. Gestrinone inhibits growth of human uterine leiomyoma may relate to activity regulation of ERα, Src and P38 MAPK. Biomed Pharmacother. 2012 Dec;66(8):569-77. PMID: 23102719.

 

Wu S, Dong J, Cong J, et al. Gestrinone compared with mifepristone for emergency contraception: a randomized controlled trial. Obstet Gynecol. 2010 Apr;115(4):740-4. PMID: 20308833.

 

Ohno Y, Kitagawa I, Tamura H, et al. Antiestrogenic effect of gestrinone as an inhibitor of [3H]-estradiol binding to nuclear type II sites. Gynecol Obstet Invest. 1991;31(2):97-101. PMID: 2037266.

 

Venturini PL, Bertolini S, Brunenghi MC, et al. Endocrine, metabolic, and clinical effects of gestrinone in women with endometriosis. Fertil Steril. 1989 Oct;52(4):589-95. PMID: 2806598.

 

Tamaya T, Fujimoto J, Watanabe Y, et al. Gestrinone (R2323) binding to steroid receptors in human uterine endometrial cytosol. Acta Obstet Gynecol Scand. 1986;65(5):439-41. PMID: 3490730.

 

Kauppila A, Isomaa V, Rönnberg L, et al. Effect of gestrinone in endometriosis tissue and endometrium. Fertil Steril. 1985 Oct;44(4):466-70. PMID: 2996949.

" Not dangerous goods.

LKT G1975 Gestrinone 500 mg 543.6 Synthetic steroid hormone; AR agonist, ER and PR antagonist. (17a)-13-Ethyl-17-hydroxy-18,19-dinorpregna-4,9,11-trien-20-yn-3-one 13b-ethyl-17a-ethynyl-17b-hydroxy-4,9,11-gonatrien-3-one; 13b-ethyl-17a-ethynyl-D4,9,11-gonatriene-17b-ol-3-one; ethylnorgestrienone 16320-04-0 ≥98% 308.41 C21H24O2 CCC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2(C#C)O Ambient Ambient "Zhu Y, Zhang T, Xie S, et al. Gestrinone inhibits growth of human uterine leiomyoma may relate to activity regulation of ERα, Src and P38 MAPK. Biomed Pharmacother. 2012 Dec;66(8):569-77. PMID: 23102719.

 

Wu S, Dong J, Cong J, et al. Gestrinone compared with mifepristone for emergency contraception: a randomized controlled trial. Obstet Gynecol. 2010 Apr;115(4):740-4. PMID: 20308833.

 

Ohno Y, Kitagawa I, Tamura H, et al. Antiestrogenic effect of gestrinone as an inhibitor of [3H]-estradiol binding to nuclear type II sites. Gynecol Obstet Invest. 1991;31(2):97-101. PMID: 2037266.

 

Venturini PL, Bertolini S, Brunenghi MC, et al. Endocrine, metabolic, and clinical effects of gestrinone in women with endometriosis. Fertil Steril. 1989 Oct;52(4):589-95. PMID: 2806598.

 

Tamaya T, Fujimoto J, Watanabe Y, et al. Gestrinone (R2323) binding to steroid receptors in human uterine endometrial cytosol. Acta Obstet Gynecol Scand. 1986;65(5):439-41. PMID: 3490730.

 

Kauppila A, Isomaa V, Rönnberg L, et al. Effect of gestrinone in endometriosis tissue and endometrium. Fertil Steril. 1985 Oct;44(4):466-70. PMID: 2996949.

" Not dangerous goods.

LKT G2368 GFR 5 mg 72.1 Peptide hormone found in crustaceans. ≥95% 378.4 C17H26N6O4 Ambient -20°C Pettis RJ, Erickson BW, Forward RB, et al. Superpotent synthetic tripeptide mimics of the mud-crab pumping pheromone. Int J Pept Protein Res. 1993 Oct;42(4):312-9. PMID: 8244626. Not dangerous goods.

LKT G2368 GFR 10 mg 123.1 Peptide hormone found in crustaceans. ≥95% 378.4 C17H26N6O4 Ambient -20°C Pettis RJ, Erickson BW, Forward RB, et al. Superpotent synthetic tripeptide mimics of the mud-crab pumping pheromone. Int J Pept Protein Res. 1993 Oct;42(4):312-9. PMID: 8244626. Not dangerous goods.

LKT G2368 GFR 25 mg 216.1 Peptide hormone found in crustaceans. ≥95% 378.4 C17H26N6O4 Ambient -20°C Pettis RJ, Erickson BW, Forward RB, et al. Superpotent synthetic tripeptide mimics of the mud-crab pumping pheromone. Int J Pept Protein Res. 1993 Oct;42(4):312-9. PMID: 8244626. Not dangerous goods.

LKT G2868 Ghrelin, human 1 mg 420.1 Endogenous peptide hormone, involved in feeding behavior and energy homeostasis; ghrelin agonist. 258279-04-8 ≥98% 3370.9 C149H249N47O42 CCCCCCCC(=O)N(C(CO)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)N2CCCC2C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC=N3)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)N6CCCC6C(=O)NC(CCCNC(=N)N)C(=O)O)C(=O)C(CO)NC(=O)CN Ambient -20°C Soluble in 1% acetic acid (1mg/mL). "Meyer RM, Burgos-Robles A, Liu E, et al. A ghrelin-growth hormone axis drives stress-induced vulnerability to enhanced fear. Mol Psychiatry. 2013 Oct 15. [Epub ahead of print]. PMID: 24126924.

 

Xu X, Jhun BS, Ha CH, Jin ZG. Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. Endocrinology. 2008 Aug;149(8):4183-92. PMID: 18450953.

 

Diano S, Farr SA, Benoit SC, et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci. 2006 Mar;9(3):381-8. PMID: 16491079.

 

Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000 Oct 19;407(6806):908-13. PMID: 11057670.

" Not dangerous goods.

LKT G2868 Ghrelin, human 5 mg 1440.2 Endogenous peptide hormone, involved in feeding behavior and energy homeostasis; ghrelin agonist. 258279-04-8 ≥98% 3370.9 C149H249N47O42 CCCCCCCC(=O)N(C(CO)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)N2CCCC2C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC=N3)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)N6CCCC6C(=O)NC(CCCNC(=N)N)C(=O)O)C(=O)C(CO)NC(=O)CN Ambient -20°C Soluble in 1% acetic acid (1mg/mL). "Meyer RM, Burgos-Robles A, Liu E, et al. A ghrelin-growth hormone axis drives stress-induced vulnerability to enhanced fear. Mol Psychiatry. 2013 Oct 15. [Epub ahead of print]. PMID: 24126924.

 

Xu X, Jhun BS, Ha CH, Jin ZG. Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. Endocrinology. 2008 Aug;149(8):4183-92. PMID: 18450953.

 

Diano S, Farr SA, Benoit SC, et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci. 2006 Mar;9(3):381-8. PMID: 16491079.

 

Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000 Oct 19;407(6806):908-13. PMID: 11057670.

" Not dangerous goods.

LKT G2869 Ghrelin, rat 1 mg 420.1 Endogenous peptide hormone, involved in feeding behavior and energy homeostasis; ghrelin agonist. ≥95% 3314.8 C147H245N45O42 CCCCCCCC(=O)N(C(CO)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)N2CCCC2C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC=N3)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)N6CCCC6C(=O)NC(CCCNC(=N)N)C(=O)O)C(=O)C(CO)NC(=O)CN Ambient -20°C Soluble in 1% acetic acid (1mg/mL). "Meyer RM, Burgos-Robles A, Liu E, et al. A ghrelin-growth hormone axis drives stress-induced vulnerability to enhanced fear. Mol Psychiatry. 2013 Oct 15. [Epub ahead of print]. PMID: 24126924.

 

Xu X, Jhun BS, Ha CH, Jin ZG. Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. Endocrinology. 2008 Aug;149(8):4183-92. PMID: 18450953.

 

Diano S, Farr SA, Benoit SC, et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci. 2006 Mar;9(3):381-8. PMID: 16491079.

 

Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000 Oct 19;407(6806):908-13. PMID: 11057670.

" Not dangerous goods.

LKT G2869 Ghrelin, rat 5 mg 1440.2 Endogenous peptide hormone, involved in feeding behavior and energy homeostasis; ghrelin agonist. ≥95% 3314.8 C147H245N45O42 CCCCCCCC(=O)N(C(CO)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)N2CCCC2C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC=N3)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)N6CCCC6C(=O)NC(CCCNC(=N)N)C(=O)O)C(=O)C(CO)NC(=O)CN Ambient -20°C Soluble in 1% acetic acid (1mg/mL). "Meyer RM, Burgos-Robles A, Liu E, et al. A ghrelin-growth hormone axis drives stress-induced vulnerability to enhanced fear. Mol Psychiatry. 2013 Oct 15. [Epub ahead of print]. PMID: 24126924.

 

Xu X, Jhun BS, Ha CH, Jin ZG. Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. Endocrinology. 2008 Aug;149(8):4183-92. PMID: 18450953.

 

Diano S, Farr SA, Benoit SC, et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci. 2006 Mar;9(3):381-8. PMID: 16491079.

 

Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000 Oct 19;407(6806):908-13. PMID: 11057670.

" Not dangerous goods.

LKT G2870 Growth Hormone Releasing Factor (1-44), human 0.5 mg 348 Endogenous peptide hormone, involved in growth hormone secretion; GHRH agonist. Somatorelin, Somatoliberin (humanpancreatic islet); GHRF; GHRH 83930-13-6 ≥95% 5039.7 C215H358N72O66S1 CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)N)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(CC3=CC=C(C=C3)O)N Ambient -20°C "Obál F Jr, Krueger JM. The somatotropic axis and sleep. Rev Neurol (Paris). 2001 Nov;157(11 Pt 2):S12-5. PMID: 11924022.

 

Liesman JS, McNamara JP, Capuco AV, et al. Comparison of growth hormone-releasing factor and somatotropin: lipid and glucose metabolism in dairy cows. J Dairy Sci. 1995 Oct;78(10):2159-66. PMID: 8598400.

 

Karakji EG, Tsang BK. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Mol Cell Endocrinol. 1995 Jan;107(1):105-12. PMID: 7796929.

 

Alvarez XA, Cacabelos R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides. 1993 Jul-Aug;14(4):707-12. PMID: 8234013.

" Not dangerous goods.

LKT G2870 Growth Hormone Releasing Factor (1-44), human 1 mg 591 Endogenous peptide hormone, involved in growth hormone secretion; GHRH agonist. Somatorelin, Somatoliberin (humanpancreatic islet); GHRF; GHRH 83930-13-6 ≥95% 5039.7 C215H358N72O66S1 CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)N)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(CC3=CC=C(C=C3)O)N Ambient -20°C "Obál F Jr, Krueger JM. The somatotropic axis and sleep. Rev Neurol (Paris). 2001 Nov;157(11 Pt 2):S12-5. PMID: 11924022.

 

Liesman JS, McNamara JP, Capuco AV, et al. Comparison of growth hormone-releasing factor and somatotropin: lipid and glucose metabolism in dairy cows. J Dairy Sci. 1995 Oct;78(10):2159-66. PMID: 8598400.

 

Karakji EG, Tsang BK. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Mol Cell Endocrinol. 1995 Jan;107(1):105-12. PMID: 7796929.

 

Alvarez XA, Cacabelos R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides. 1993 Jul-Aug;14(4):707-12. PMID: 8234013.

" Not dangerous goods.

LKT G2870 Growth Hormone Releasing Factor (1-44), human 2.5 mg 1043.9 Endogenous peptide hormone, involved in growth hormone secretion; GHRH agonist. Somatorelin, Somatoliberin (humanpancreatic islet); GHRF; GHRH 83930-13-6 ≥95% 5039.7 C215H358N72O66S1 CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)N)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(CC3=CC=C(C=C3)O)N Ambient -20°C "Obál F Jr, Krueger JM. The somatotropic axis and sleep. Rev Neurol (Paris). 2001 Nov;157(11 Pt 2):S12-5. PMID: 11924022.

 

Liesman JS, McNamara JP, Capuco AV, et al. Comparison of growth hormone-releasing factor and somatotropin: lipid and glucose metabolism in dairy cows. J Dairy Sci. 1995 Oct;78(10):2159-66. PMID: 8598400.

 

Karakji EG, Tsang BK. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Mol Cell Endocrinol. 1995 Jan;107(1):105-12. PMID: 7796929.

 

Alvarez XA, Cacabelos R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides. 1993 Jul-Aug;14(4):707-12. PMID: 8234013.

" Not dangerous goods.

LKT G2871 Growth Hormone Releasing Factor, cow 0.5 mg 396.1 Endogenous peptide hormone, involved in growth hormone secretion; GHRH agonist. GHRF; GHRH 88894-91-1 ≥95% 5107.88 C220H366N72O66S1 Ambient -20°C "Obál F Jr, Krueger JM. The somatotropic axis and sleep. Rev Neurol (Paris). 2001 Nov;157(11 Pt 2):S12-5. PMID: 11924022.

 

Liesman JS, McNamara JP, Capuco AV, et al. Comparison of growth hormone-releasing factor and somatotropin: lipid and glucose metabolism in dairy cows. J Dairy Sci. 1995 Oct;78(10):2159-66. PMID: 8598400.

 

Karakji EG, Tsang BK. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Mol Cell Endocrinol. 1995 Jan;107(1):105-12. PMID: 7796929.

 

Alvarez XA, Cacabelos R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides. 1993 Jul-Aug;14(4):707-12. PMID: 8234013.

" Not dangerous goods.

LKT G2871 Growth Hormone Releasing Factor, cow 1 mg 672.2 Endogenous peptide hormone, involved in growth hormone secretion; GHRH agonist. GHRF; GHRH 88894-91-1 ≥95% 5107.88 C220H366N72O66S1 Ambient -20°C "Obál F Jr, Krueger JM. The somatotropic axis and sleep. Rev Neurol (Paris). 2001 Nov;157(11 Pt 2):S12-5. PMID: 11924022.

 

Liesman JS, McNamara JP, Capuco AV, et al. Comparison of growth hormone-releasing factor and somatotropin: lipid and glucose metabolism in dairy cows. J Dairy Sci. 1995 Oct;78(10):2159-66. PMID: 8598400.

 

Karakji EG, Tsang BK. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Mol Cell Endocrinol. 1995 Jan;107(1):105-12. PMID: 7796929.

 

Alvarez XA, Cacabelos R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides. 1993 Jul-Aug;14(4):707-12. PMID: 8234013.

" Not dangerous goods.

LKT G2871 Growth Hormone Releasing Factor, cow 2.5 mg 1188.1 Endogenous peptide hormone, involved in growth hormone secretion; GHRH agonist. GHRF; GHRH 88894-91-1 ≥95% 5107.88 C220H366N72O66S1 Ambient -20°C "Obál F Jr, Krueger JM. The somatotropic axis and sleep. Rev Neurol (Paris). 2001 Nov;157(11 Pt 2):S12-5. PMID: 11924022.

 

Liesman JS, McNamara JP, Capuco AV, et al. Comparison of growth hormone-releasing factor and somatotropin: lipid and glucose metabolism in dairy cows. J Dairy Sci. 1995 Oct;78(10):2159-66. PMID: 8598400.

 

Karakji EG, Tsang BK. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Mol Cell Endocrinol. 1995 Jan;107(1):105-12. PMID: 7796929.

 

Alvarez XA, Cacabelos R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides. 1993 Jul-Aug;14(4):707-12. PMID: 8234013.

" Not dangerous goods.

LKT G2872 Growth Hormone Releasing Factor, mouse 2.5 mg 1188.1 Endogenous peptide hormone, involved in growth hormone secretion; GHRH agonist. GHRF; GHRH ≥95% 5032.85 C220H365N69O64S1 Ambient -20°C "Obál F Jr, Krueger JM. The somatotropic axis and sleep. Rev Neurol (Paris). 2001 Nov;157(11 Pt 2):S12-5. PMID: 11924022.

 

Liesman JS, McNamara JP, Capuco AV, et al. Comparison of growth hormone-releasing factor and somatotropin: lipid and glucose metabolism in dairy cows. J Dairy Sci. 1995 Oct;78(10):2159-66. PMID: 8598400.

 

Karakji EG, Tsang BK. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Mol Cell Endocrinol. 1995 Jan;107(1):105-12. PMID: 7796929.

 

Alvarez XA, Cacabelos R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides. 1993 Jul-Aug;14(4):707-12. PMID: 8234013.

" Not dangerous goods.

LKT G2872 Growth Hormone Releasing Factor, mouse 1 mg 672.2 Endogenous peptide hormone, involved in growth hormone secretion; GHRH agonist. GHRF; GHRH ≥95% 5032.85 C220H365N69O64S1 Ambient -20°C "Obál F Jr, Krueger JM. The somatotropic axis and sleep. Rev Neurol (Paris). 2001 Nov;157(11 Pt 2):S12-5. PMID: 11924022.

 

Liesman JS, McNamara JP, Capuco AV, et al. Comparison of growth hormone-releasing factor and somatotropin: lipid and glucose metabolism in dairy cows. J Dairy Sci. 1995 Oct;78(10):2159-66. PMID: 8598400.

 

Karakji EG, Tsang BK. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Mol Cell Endocrinol. 1995 Jan;107(1):105-12. PMID: 7796929.

 

Alvarez XA, Cacabelos R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides. 1993 Jul-Aug;14(4):707-12. PMID: 8234013.

" Not dangerous goods.

LKT G2872 Growth Hormone Releasing Factor, mouse 0.5 mg 396.1 Endogenous peptide hormone, involved in growth hormone secretion; GHRH agonist. GHRF; GHRH ≥95% 5032.85 C220H365N69O64S1 Ambient -20°C "Obál F Jr, Krueger JM. The somatotropic axis and sleep. Rev Neurol (Paris). 2001 Nov;157(11 Pt 2):S12-5. PMID: 11924022.

 

Liesman JS, McNamara JP, Capuco AV, et al. Comparison of growth hormone-releasing factor and somatotropin: lipid and glucose metabolism in dairy cows. J Dairy Sci. 1995 Oct;78(10):2159-66. PMID: 8598400.

 

Karakji EG, Tsang BK. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Mol Cell Endocrinol. 1995 Jan;107(1):105-12. PMID: 7796929.

 

Alvarez XA, Cacabelos R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides. 1993 Jul-Aug;14(4):707-12. PMID: 8234013.

" Not dangerous goods.

LKT G2873 Growth Hormone Releasing Factor, sheep 0.5 mg 276.2 Endogenous peptide hormone, involved in growth hormone secretion; GHRH agonist. GHRF; GHRH 94948-82-0 ≥95% 5121.9 C221H368N72O66S1 Ambient -20°C "Obál F Jr, Krueger JM. The somatotropic axis and sleep. Rev Neurol (Paris). 2001 Nov;157(11 Pt 2):S12-5. PMID: 11924022.

 

Liesman JS, McNamara JP, Capuco AV, et al. Comparison of growth hormone-releasing factor and somatotropin: lipid and glucose metabolism in dairy cows. J Dairy Sci. 1995 Oct;78(10):2159-66. PMID: 8598400.

 

Karakji EG, Tsang BK. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Mol Cell Endocrinol. 1995 Jan;107(1):105-12. PMID: 7796929.

 

Alvarez XA, Cacabelos R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides. 1993 Jul-Aug;14(4):707-12. PMID: 8234013.

" Not dangerous goods.

LKT G2873 Growth Hormone Releasing Factor, sheep 1 mg 468.2 Endogenous peptide hormone, involved in growth hormone secretion; GHRH agonist. GHRF; GHRH 94948-82-0 ≥95% 5121.9 C221H368N72O66S1 Ambient -20°C "Obál F Jr, Krueger JM. The somatotropic axis and sleep. Rev Neurol (Paris). 2001 Nov;157(11 Pt 2):S12-5. PMID: 11924022.

 

Liesman JS, McNamara JP, Capuco AV, et al. Comparison of growth hormone-releasing factor and somatotropin: lipid and glucose metabolism in dairy cows. J Dairy Sci. 1995 Oct;78(10):2159-66. PMID: 8598400.

 

Karakji EG, Tsang BK. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Mol Cell Endocrinol. 1995 Jan;107(1):105-12. PMID: 7796929.

 

Alvarez XA, Cacabelos R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides. 1993 Jul-Aug;14(4):707-12. PMID: 8234013.

" Not dangerous goods.

LKT G2873 Growth Hormone Releasing Factor, sheep 2.5 mg 828.1 Endogenous peptide hormone, involved in growth hormone secretion; GHRH agonist. GHRF; GHRH 94948-82-0 ≥95% 5121.9 C221H368N72O66S1 Ambient -20°C "Obál F Jr, Krueger JM. The somatotropic axis and sleep. Rev Neurol (Paris). 2001 Nov;157(11 Pt 2):S12-5. PMID: 11924022.

 

Liesman JS, McNamara JP, Capuco AV, et al. Comparison of growth hormone-releasing factor and somatotropin: lipid and glucose metabolism in dairy cows. J Dairy Sci. 1995 Oct;78(10):2159-66. PMID: 8598400.

 

Karakji EG, Tsang BK. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Mol Cell Endocrinol. 1995 Jan;107(1):105-12. PMID: 7796929.

 

Alvarez XA, Cacabelos R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides. 1993 Jul-Aug;14(4):707-12. PMID: 8234013.

" Not dangerous goods.

LKT G2874 Growth Hormone Releasing Factor, rat 2.5 mg 1188.1 Endogenous peptide hormone, involved in growth hormone secretion; GHRH agonist. Somatotropin releasing hormone (1-43), Growth hormone releasing factor 43, Somatoliberin (rathypothalamus) (9CI); GHRF; GHRH 86472-71-1 ≥95% 5232.93 C225H361N77O66S "CCC(C)C(C(=O)NC(Cc1ccccc1)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(Cc2ccc(cc2)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)CC)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(Cc3ccc(cc3)O)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(Cc4cnc[nH]4)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(Cc5ccccc5)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(Cc6cnc[nH]6)N

" Ambient -20°C "Obál F Jr, Krueger JM. The somatotropic axis and sleep. Rev Neurol (Paris). 2001 Nov;157(11 Pt 2):S12-5. PMID: 11924022.

 

Liesman JS, McNamara JP, Capuco AV, et al. Comparison of growth hormone-releasing factor and somatotropin: lipid and glucose metabolism in dairy cows. J Dairy Sci. 1995 Oct;78(10):2159-66. PMID: 8598400.

 

Karakji EG, Tsang BK. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Mol Cell Endocrinol. 1995 Jan;107(1):105-12. PMID: 7796929.

 

Alvarez XA, Cacabelos R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides. 1993 Jul-Aug;14(4):707-12. PMID: 8234013.

" Not dangerous goods.

LKT G2874 Growth Hormone Releasing Factor, rat 1 mg 672.2 Endogenous peptide hormone, involved in growth hormone secretion; GHRH agonist. Somatotropin releasing hormone (1-43), Growth hormone releasing factor 43, Somatoliberin (rathypothalamus) (9CI); GHRF; GHRH 86472-71-1 ≥95% 5232.93 C225H361N77O66S "CCC(C)C(C(=O)NC(Cc1ccccc1)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(Cc2ccc(cc2)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)CC)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(Cc3ccc(cc3)O)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(Cc4cnc[nH]4)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(Cc5ccccc5)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(Cc6cnc[nH]6)N

" Ambient -20°C "Obál F Jr, Krueger JM. The somatotropic axis and sleep. Rev Neurol (Paris). 2001 Nov;157(11 Pt 2):S12-5. PMID: 11924022.

 

Liesman JS, McNamara JP, Capuco AV, et al. Comparison of growth hormone-releasing factor and somatotropin: lipid and glucose metabolism in dairy cows. J Dairy Sci. 1995 Oct;78(10):2159-66. PMID: 8598400.

 

Karakji EG, Tsang BK. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Mol Cell Endocrinol. 1995 Jan;107(1):105-12. PMID: 7796929.

 

Alvarez XA, Cacabelos R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides. 1993 Jul-Aug;14(4):707-12. PMID: 8234013.

" Not dangerous goods.

LKT G2874 Growth Hormone Releasing Factor, rat 0.5 mg 396.1 Endogenous peptide hormone, involved in growth hormone secretion; GHRH agonist. Somatotropin releasing hormone (1-43), Growth hormone releasing factor 43, Somatoliberin (rathypothalamus) (9CI); GHRF; GHRH 86472-71-1 ≥95% 5232.93 C225H361N77O66S "CCC(C)C(C(=O)NC(Cc1ccccc1)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(Cc2ccc(cc2)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)CC)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(Cc3ccc(cc3)O)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(Cc4cnc[nH]4)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(Cc5ccccc5)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(Cc6cnc[nH]6)N

" Ambient -20°C "Obál F Jr, Krueger JM. The somatotropic axis and sleep. Rev Neurol (Paris). 2001 Nov;157(11 Pt 2):S12-5. PMID: 11924022.

 

Liesman JS, McNamara JP, Capuco AV, et al. Comparison of growth hormone-releasing factor and somatotropin: lipid and glucose metabolism in dairy cows. J Dairy Sci. 1995 Oct;78(10):2159-66. PMID: 8598400.

 

Karakji EG, Tsang BK. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Mol Cell Endocrinol. 1995 Jan;107(1):105-12. PMID: 7796929.

 

Alvarez XA, Cacabelos R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides. 1993 Jul-Aug;14(4):707-12. PMID: 8234013.

" Not dangerous goods.

LKT G2968 Growth Hormone Releasing Peptide 2 0.5 mg 107.8 Endogenous peptide hormone, involved in growth hormone secretion; ghrelin agonist. Pralmorelin, KP 102; GHRP-2 158861-67-7 ≥95% 818 C45H54O6N9 CC(C(=O)NC(=O)C(CCCCN)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(C)NC(=O)C(CC4=CC5=CC=CC=C5C=C4)N)N Ambient -20°C "Zeng P, Chen JX, Yang B, et al. Attenuation of systemic morphine-induced analgesia by central administration of ghrelin and related peptides in mice. Peptides. 2013 Dec;50:42-9. PMID: 24113541.

 

Peroni CN, Hayashida CY, Nascimento N, et al. Growth hormone response to growth hormone-releasing peptide-2 in growth hormone-deficient little mice. Clinics (Sao Paulo). 2012;67(3):265-72. PMID: 22473409.

 

Tsukamoto N, Otsuka F, Miyoshi T, et al. Functional interaction of bone morphogenetic protein and growth hormone releasing peptide in adrenocorticotropin regulation by corticotrope cells. Mol Cell Endocrinol. 2011 Sep 15;344(1-2):41-50. PMID: 21742013.

 

Li G, Li J, Zhou Q, et al. Growth hormone releasing peptide-2, a ghrelin agonist, attenuates lipopolysaccharide-induced acute lung injury in rats. Tohoku J Exp Med. 2010 Sep;222(1):7-13. PMID: 20805679.

 

Titterington JS, Sukhanov S, Higashi Y, et al. Growth hormone-releasing peptide-2 suppresses vascular oxidative stress in ApoE-/- mice but does not reduce atherosclerosis. Endocrinology. 2009 Dec;150(12):5478-87. PMID: 19819949.

 

Kudoh K, Shibata C, Funayama Y, et al. The effect of growth hormone releasing peptide-2 on upper gastrointestinal contractile activity and food intake in conscious dogs. J Gastroenterol. 2009;44(4):297-304. PMID: 19271111.

" Not dangerous goods.

LKT G2968 Growth Hormone Releasing Peptide 2 1 mg 183 Endogenous peptide hormone, involved in growth hormone secretion; ghrelin agonist. Pralmorelin, KP 102; GHRP-2 158861-67-7 ≥95% 818 C45H54O6N9 CC(C(=O)NC(=O)C(CCCCN)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(C)NC(=O)C(CC4=CC5=CC=CC=C5C=C4)N)N Ambient -20°C "Zeng P, Chen JX, Yang B, et al. Attenuation of systemic morphine-induced analgesia by central administration of ghrelin and related peptides in mice. Peptides. 2013 Dec;50:42-9. PMID: 24113541.

 

Peroni CN, Hayashida CY, Nascimento N, et al. Growth hormone response to growth hormone-releasing peptide-2 in growth hormone-deficient little mice. Clinics (Sao Paulo). 2012;67(3):265-72. PMID: 22473409.

 

Tsukamoto N, Otsuka F, Miyoshi T, et al. Functional interaction of bone morphogenetic protein and growth hormone releasing peptide in adrenocorticotropin regulation by corticotrope cells. Mol Cell Endocrinol. 2011 Sep 15;344(1-2):41-50. PMID: 21742013.

 

Li G, Li J, Zhou Q, et al. Growth hormone releasing peptide-2, a ghrelin agonist, attenuates lipopolysaccharide-induced acute lung injury in rats. Tohoku J Exp Med. 2010 Sep;222(1):7-13. PMID: 20805679.

 

Titterington JS, Sukhanov S, Higashi Y, et al. Growth hormone-releasing peptide-2 suppresses vascular oxidative stress in ApoE-/- mice but does not reduce atherosclerosis. Endocrinology. 2009 Dec;150(12):5478-87. PMID: 19819949.

 

Kudoh K, Shibata C, Funayama Y, et al. The effect of growth hormone releasing peptide-2 on upper gastrointestinal contractile activity and food intake in conscious dogs. J Gastroenterol. 2009;44(4):297-304. PMID: 19271111.

" Not dangerous goods.

LKT G2968 Growth Hormone Releasing Peptide 2 2.5 mg 324 Endogenous peptide hormone, involved in growth hormone secretion; ghrelin agonist. Pralmorelin, KP 102; GHRP-2 158861-67-7 ≥95% 818 C45H54O6N9 CC(C(=O)NC(=O)C(CCCCN)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(C)NC(=O)C(CC4=CC5=CC=CC=C5C=C4)N)N Ambient -20°C "Zeng P, Chen JX, Yang B, et al. Attenuation of systemic morphine-induced analgesia by central administration of ghrelin and related peptides in mice. Peptides. 2013 Dec;50:42-9. PMID: 24113541.

 

Peroni CN, Hayashida CY, Nascimento N, et al. Growth hormone response to growth hormone-releasing peptide-2 in growth hormone-deficient little mice. Clinics (Sao Paulo). 2012;67(3):265-72. PMID: 22473409.

 

Tsukamoto N, Otsuka F, Miyoshi T, et al. Functional interaction of bone morphogenetic protein and growth hormone releasing peptide in adrenocorticotropin regulation by corticotrope cells. Mol Cell Endocrinol. 2011 Sep 15;344(1-2):41-50. PMID: 21742013.

 

Li G, Li J, Zhou Q, et al. Growth hormone releasing peptide-2, a ghrelin agonist, attenuates lipopolysaccharide-induced acute lung injury in rats. Tohoku J Exp Med. 2010 Sep;222(1):7-13. PMID: 20805679.

 

Titterington JS, Sukhanov S, Higashi Y, et al. Growth hormone-releasing peptide-2 suppresses vascular oxidative stress in ApoE-/- mice but does not reduce atherosclerosis. Endocrinology. 2009 Dec;150(12):5478-87. PMID: 19819949.

 

Kudoh K, Shibata C, Funayama Y, et al. The effect of growth hormone releasing peptide-2 on upper gastrointestinal contractile activity and food intake in conscious dogs. J Gastroenterol. 2009;44(4):297-304. PMID: 19271111.

" Not dangerous goods.

LKT G3351 Ginkgolic Acid Mixture 5 mg 88.3 Mixture of alkylphenols found in Ginkgo; HIV protease inhibitor, indirect PP2C activator. ≥98% Ambient -20°C "Fu Y, Hong S, Li D, et al. Novel chemical synthesis of ginkgolic acid (13:0) and evaluation of its tyrosinase inhibitory activity. J Agric Food Chem. 2013 Jun 5;61(22):5347-52. PMID: 23701207.

 

Oh J, Hwang IH, Hong CE, et al. Inhibition of fatty acid synthase by ginkgolic acids from the leaves of Ginkgo biloba and their cytotoxic activity. J Enzyme Inhib Med Chem. 2013 Jun;28(3):565-8. PMID: 22380770.

 

Lü JM, Yan S, Jamaluddin S, et al. Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro. Med Sci Monit. 2012 Aug;18(8):BR293-298. PMID: 22847190.

 

Zhou C, Li X, Du W, et al. Antitumor effects of ginkgolic acid in human cancer cell occur via cell cycle arrest and decrease the Bcl-2/Bax ratio to induce apoptosis. Chemotherapy. 2010;56(5):393-402. PMID: 20948210.

 

Yang X, Chen J, Qian Z, et al. Study on the antibacterial activity of ginkgolic acids. Zhong Yao Cai. 2002 Sep;25(9):651-3. PMID: 12451978.

 

Ahlemeyer B, Selke D, Schaper C, et al. Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C. Eur J Pharmacol. 2001 Oct 26;430(1):1-7. PMID: 11698056.

" Not dangerous goods.

LKT G3351 Ginkgolic Acid Mixture 25 mg 305.9 Mixture of alkylphenols found in Ginkgo; HIV protease inhibitor, indirect PP2C activator. ≥98% Ambient -20°C "Fu Y, Hong S, Li D, et al. Novel chemical synthesis of ginkgolic acid (13:0) and evaluation of its tyrosinase inhibitory activity. J Agric Food Chem. 2013 Jun 5;61(22):5347-52. PMID: 23701207.

 

Oh J, Hwang IH, Hong CE, et al. Inhibition of fatty acid synthase by ginkgolic acids from the leaves of Ginkgo biloba and their cytotoxic activity. J Enzyme Inhib Med Chem. 2013 Jun;28(3):565-8. PMID: 22380770.

 

Lü JM, Yan S, Jamaluddin S, et al. Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro. Med Sci Monit. 2012 Aug;18(8):BR293-298. PMID: 22847190.

 

Zhou C, Li X, Du W, et al. Antitumor effects of ginkgolic acid in human cancer cell occur via cell cycle arrest and decrease the Bcl-2/Bax ratio to induce apoptosis. Chemotherapy. 2010;56(5):393-402. PMID: 20948210.

 

Yang X, Chen J, Qian Z, et al. Study on the antibacterial activity of ginkgolic acids. Zhong Yao Cai. 2002 Sep;25(9):651-3. PMID: 12451978.

 

Ahlemeyer B, Selke D, Schaper C, et al. Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C. Eur J Pharmacol. 2001 Oct 26;430(1):1-7. PMID: 11698056.

" Not dangerous goods.

LKT G3352 Ginkgolic Acid (13:0) 1 mg 163.2 Alkylphenol found in Ginkgo; HIV protease inhibitor, indirect PP2C activator. 6-n-Tridecylsalicylic acid, Ginkgoneolic acid 20261-38-5 ≥98% 320.47 C20H32O3 CCCCCCCCCCCCCC1=C(C(=CC=C1)O)C(=O)O Ambient -20°C "Fu Y, Hong S, Li D, et al. Novel chemical synthesis of ginkgolic acid (13:0) and evaluation of its tyrosinase inhibitory activity. J Agric Food Chem. 2013 Jun 5;61(22):5347-52. PMID: 23701207.

 

Oh J, Hwang IH, Hong CE, et al. Inhibition of fatty acid synthase by ginkgolic acids from the leaves of Ginkgo biloba and their cytotoxic activity. J Enzyme Inhib Med Chem. 2013 Jun;28(3):565-8. PMID: 22380770.

 

Lü JM, Yan S, Jamaluddin S, et al. Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro. Med Sci Monit. 2012 Aug;18(8):BR293-298. PMID: 22847190.

 

Zhou C, Li X, Du W, et al. Antitumor effects of ginkgolic acid in human cancer cell occur via cell cycle arrest and decrease the Bcl-2/Bax ratio to induce apoptosis. Chemotherapy. 2010;56(5):393-402. PMID: 20948210.

 

Yang X, Chen J, Qian Z, et al. Study on the antibacterial activity of ginkgolic acids. Zhong Yao Cai. 2002 Sep;25(9):651-3. PMID: 12451978.

 

Ahlemeyer B, Selke D, Schaper C, et al. Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C. Eur J Pharmacol. 2001 Oct 26;430(1):1-7. PMID: 11698056.

" Xi Not dangerous goods.

LKT G3352 Ginkgolic Acid (13:0) 5 mg 516.4 Alkylphenol found in Ginkgo; HIV protease inhibitor, indirect PP2C activator. 6-n-Tridecylsalicylic acid, Ginkgoneolic acid 20261-38-5 ≥98% 320.47 C20H32O3 CCCCCCCCCCCCCC1=C(C(=CC=C1)O)C(=O)O Ambient -20°C "Fu Y, Hong S, Li D, et al. Novel chemical synthesis of ginkgolic acid (13:0) and evaluation of its tyrosinase inhibitory activity. J Agric Food Chem. 2013 Jun 5;61(22):5347-52. PMID: 23701207.

 

Oh J, Hwang IH, Hong CE, et al. Inhibition of fatty acid synthase by ginkgolic acids from the leaves of Ginkgo biloba and their cytotoxic activity. J Enzyme Inhib Med Chem. 2013 Jun;28(3):565-8. PMID: 22380770.

 

Lü JM, Yan S, Jamaluddin S, et al. Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro. Med Sci Monit. 2012 Aug;18(8):BR293-298. PMID: 22847190.

 

Zhou C, Li X, Du W, et al. Antitumor effects of ginkgolic acid in human cancer cell occur via cell cycle arrest and decrease the Bcl-2/Bax ratio to induce apoptosis. Chemotherapy. 2010;56(5):393-402. PMID: 20948210.

 

Yang X, Chen J, Qian Z, et al. Study on the antibacterial activity of ginkgolic acids. Zhong Yao Cai. 2002 Sep;25(9):651-3. PMID: 12451978.

 

Ahlemeyer B, Selke D, Schaper C, et al. Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C. Eur J Pharmacol. 2001 Oct 26;430(1):1-7. PMID: 11698056.

" Xi Not dangerous goods.

LKT G3353 Ginkgolic Acid 1 mg 251.3 Found in Ginkgo; HIV protease and fatty acid synthase inhibitor. Romanicardic acid 22910-60-7 ≥98% 346.5 C22H34O3 CCCCCCC=CCCCCCCCC1=C(C(=CC=C1)O)C(=O)O Ambient -20°C Soluble in acetone. "Fu Y, Hong S, Li D, et al. Novel chemical synthesis of ginkgolic acid (13:0) and evaluation of its tyrosinase inhibitory activity. J Agric Food Chem. 2013 Jun 5;61(22):5347-52. PMID: 23701207.

 

Oh J, Hwang IH, Hong CE, et al. Inhibition of fatty acid synthase by ginkgolic acids from the leaves of Ginkgo biloba and their cytotoxic activity. J Enzyme Inhib Med Chem. 2013 Jun;28(3):565-8. PMID: 22380770.

 

Lü JM, Yan S, Jamaluddin S, et al. Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro. Med Sci Monit. 2012 Aug;18(8):BR293-298. PMID: 22847190.

 

Zhou C, Li X, Du W, et al. Antitumor effects of ginkgolic acid in human cancer cell occur via cell cycle arrest and decrease the Bcl-2/Bax ratio to induce apoptosis. Chemotherapy. 2010;56(5):393-402. PMID: 20948210.

 

Yang X, Chen J, Qian Z, et al. Study on the antibacterial activity of ginkgolic acids. Zhong Yao Cai. 2002 Sep;25(9):651-3. PMID: 12451978.

 

Ahlemeyer B, Selke D, Schaper C, et al. Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C. Eur J Pharmacol. 2001 Oct 26;430(1):1-7. PMID: 11698056.

" Xi Not dangerous goods.

LKT G3353 Ginkgolic Acid 5 mg 837.2 Found in Ginkgo; HIV protease and fatty acid synthase inhibitor. Romanicardic acid 22910-60-7 ≥98% 346.5 C22H34O3 CCCCCCC=CCCCCCCCC1=C(C(=CC=C1)O)C(=O)O Ambient -20°C Soluble in acetone. "Fu Y, Hong S, Li D, et al. Novel chemical synthesis of ginkgolic acid (13:0) and evaluation of its tyrosinase inhibitory activity. J Agric Food Chem. 2013 Jun 5;61(22):5347-52. PMID: 23701207.

 

Oh J, Hwang IH, Hong CE, et al. Inhibition of fatty acid synthase by ginkgolic acids from the leaves of Ginkgo biloba and their cytotoxic activity. J Enzyme Inhib Med Chem. 2013 Jun;28(3):565-8. PMID: 22380770.

 

Lü JM, Yan S, Jamaluddin S, et al. Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro. Med Sci Monit. 2012 Aug;18(8):BR293-298. PMID: 22847190.

 

Zhou C, Li X, Du W, et al. Antitumor effects of ginkgolic acid in human cancer cell occur via cell cycle arrest and decrease the Bcl-2/Bax ratio to induce apoptosis. Chemotherapy. 2010;56(5):393-402. PMID: 20948210.

 

Yang X, Chen J, Qian Z, et al. Study on the antibacterial activity of ginkgolic acids. Zhong Yao Cai. 2002 Sep;25(9):651-3. PMID: 12451978.

 

Ahlemeyer B, Selke D, Schaper C, et al. Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C. Eur J Pharmacol. 2001 Oct 26;430(1):1-7. PMID: 11698056.

" Xi Not dangerous goods.

LKT G3356 Ginkgolide AB 25 mg 67.6 Mixture of terpene lactones found in Ginkgo. ≥90% Ambient -20°C Insoluble in water.  Soluble in DMSO. None Not dangerous goods.

LKT G3356 Ginkgolide AB 50 mg 126.5 Mixture of terpene lactones found in Ginkgo. ≥90% Ambient -20°C Insoluble in water.  Soluble in DMSO. None Not dangerous goods.

LKT G3358 Ginkgolides 100 mg 129 Mixture of Ginkgolides A, B and C, found in Ginkgo. ≥98% Ambient -20°C Insoluble in water.  Soluble in DMSO. Not dangerous goods.

LKT G3358 Ginkgolides 500 mg 367 Mixture of Ginkgolides A, B and C, found in Ginkgo. ≥98% Ambient -20°C Insoluble in water.  Soluble in DMSO. Not dangerous goods.

LKT G3358 Ginkgolides 1 g 543.6 Mixture of Ginkgolides A, B and C, found in Ginkgo. ≥98% Ambient -20°C Insoluble in water.  Soluble in DMSO. Not dangerous goods.

LKT G3359 Ginkgolide J 1 mg 136 Terpene lactone found in Ginkgo. 107438-79-9 ≥98% 424.4 C20H24O10 CC1C(=O)OC2C1(C34C(=O)OC5C3(C2)C6(C(C5O)C(C)(C)C)C(C(=O)OC6O4)O)O Ambient -20°C Insoluble in water.  Soluble in DMSO. "Vitolo O, Gong B, Cao Z, et al. Protection against beta-amyloid induced abnormal synaptic function and cell death by Ginkgolide J. Neurobiol Aging. 2009 Feb;30(2):257-65. PMID: 17640772.

 

Ahlemeyer B, Krieglstein J. Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease. Pharmacopsychiatry. 2003 Jun;36 Suppl 1:S8-14. PMID: 13130383.

 

Scholtyssek H, Damerau W, Wessel R, et al. Antioxidative activity of ginkgolides against superoxide in an aprotic environment. Chem Biol Interact. 1997 Oct 24;106(3):183-90. PMID: 9413545.

" None Not dangerous goods.

LKT G3359 Ginkgolide J 5 mg 339.8 Terpene lactone found in Ginkgo. 107438-79-9 ≥98% 424.4 C20H24O10 CC1C(=O)OC2C1(C34C(=O)OC5C3(C2)C6(C(C5O)C(C)(C)C)C(C(=O)OC6O4)O)O Ambient -20°C Insoluble in water.  Soluble in DMSO. "Vitolo O, Gong B, Cao Z, et al. Protection against beta-amyloid induced abnormal synaptic function and cell death by Ginkgolide J. Neurobiol Aging. 2009 Feb;30(2):257-65. PMID: 17640772.

 

Ahlemeyer B, Krieglstein J. Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease. Pharmacopsychiatry. 2003 Jun;36 Suppl 1:S8-14. PMID: 13130383.

 

Scholtyssek H, Damerau W, Wessel R, et al. Antioxidative activity of ginkgolides against superoxide in an aprotic environment. Chem Biol Interact. 1997 Oct 24;106(3):183-90. PMID: 9413545.

" None Not dangerous goods.

LKT M1560 Methyl Caffeate 50 mg 61.1 Polyphenol found in species of Solanum and Magnolia; α-glucosidase inhibitor. Methyl 3-(3,4-dihydroxyphenyl)-2-propenoate 3,4-Dihydroxycinnamic acid methylester 3843-74-1 ≥98% 194.19 C10H10O4 COC(=O)C=CC1=CC(=C(C=C1)O)O Ambient -20°C Soluble in acetone, methanol, or DMSO "Balachandran C, Duraipandiyan V, Al-Dhabi NA, et al. Antimicrobial and Antimycobacterial Activities of Methyl Caffeate Isolated from Solanum torvum Swartz. Fruit. Indian J Microbiol. 2012 Dec;52(4):676-81. PMID: 24293730.

 

Gandhi GR, Ignacimuthu S, Paulraj MG, et al. Antihyperglycemic activity and antidiabetic effect of methyl caffeate isolated from Solanum torvum Swartz. fruit in streptozotocin induced diabetic rats. Eur J Pharmacol. 2011 Nov 30;670(2-3):623-31. PMID: 21963451.

 

Takahashi K, Yoshioka Y, Kato E, et al. Methyl caffeate as an alpha-glucosidase inhibitor from Solanum torvum fruits and the activity of related compounds. Biosci Biotechnol Biochem. 2010;74(4):741-5. PMID: 20378981.

 

Ho CC, Lin SS, Chou MY, et al. Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo. J Antimicrob Chemother. 2005 Aug;56(2):372-9. PMID: 16002419.

 

Pyo MK, Lee Y, Yun-Choi HS. Anti-platelet effect of the constituents isolated from the barks and fruits of Magnolia obovata. Arch Pharm Res. 2002 Jun;25(3):325-8. PMID: 12135105.

 

Rao CV, Desai D, Kaul B, et al. Effect of caffeic acid esters on carcinogen-induced mutagenicity and human colon adenocarcinoma cell growth. Chem Biol Interact. 1992 Nov 16;84(3):277-90. PMID: 1423745.

" Not dangerous goods.

LKT M1560 Methyl Caffeate 100 mg 108.8 Polyphenol found in species of Solanum and Magnolia; α-glucosidase inhibitor. Methyl 3-(3,4-dihydroxyphenyl)-2-propenoate 3,4-Dihydroxycinnamic acid methylester 3843-74-1 ≥98% 194.19 C10H10O4 COC(=O)C=CC1=CC(=C(C=C1)O)O Ambient -20°C Soluble in acetone, methanol, or DMSO "Balachandran C, Duraipandiyan V, Al-Dhabi NA, et al. Antimicrobial and Antimycobacterial Activities of Methyl Caffeate Isolated from Solanum torvum Swartz. Fruit. Indian J Microbiol. 2012 Dec;52(4):676-81. PMID: 24293730.

 

Gandhi GR, Ignacimuthu S, Paulraj MG, et al. Antihyperglycemic activity and antidiabetic effect of methyl caffeate isolated from Solanum torvum Swartz. fruit in streptozotocin induced diabetic rats. Eur J Pharmacol. 2011 Nov 30;670(2-3):623-31. PMID: 21963451.

 

Takahashi K, Yoshioka Y, Kato E, et al. Methyl caffeate as an alpha-glucosidase inhibitor from Solanum torvum fruits and the activity of related compounds. Biosci Biotechnol Biochem. 2010;74(4):741-5. PMID: 20378981.

 

Ho CC, Lin SS, Chou MY, et al. Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo. J Antimicrob Chemother. 2005 Aug;56(2):372-9. PMID: 16002419.

 

Pyo MK, Lee Y, Yun-Choi HS. Anti-platelet effect of the constituents isolated from the barks and fruits of Magnolia obovata. Arch Pharm Res. 2002 Jun;25(3):325-8. PMID: 12135105.

 

Rao CV, Desai D, Kaul B, et al. Effect of caffeic acid esters on carcinogen-induced mutagenicity and human colon adenocarcinoma cell growth. Chem Biol Interact. 1992 Nov 16;84(3):277-90. PMID: 1423745.

" Not dangerous goods.

LKT M1560 Methyl Caffeate 500 mg 434.9 Polyphenol found in species of Solanum and Magnolia; α-glucosidase inhibitor. Methyl 3-(3,4-dihydroxyphenyl)-2-propenoate 3,4-Dihydroxycinnamic acid methylester 3843-74-1 ≥98% 194.19 C10H10O4 COC(=O)C=CC1=CC(=C(C=C1)O)O Ambient -20°C Soluble in acetone, methanol, or DMSO "Balachandran C, Duraipandiyan V, Al-Dhabi NA, et al. Antimicrobial and Antimycobacterial Activities of Methyl Caffeate Isolated from Solanum torvum Swartz. Fruit. Indian J Microbiol. 2012 Dec;52(4):676-81. PMID: 24293730.

 

Gandhi GR, Ignacimuthu S, Paulraj MG, et al. Antihyperglycemic activity and antidiabetic effect of methyl caffeate isolated from Solanum torvum Swartz. fruit in streptozotocin induced diabetic rats. Eur J Pharmacol. 2011 Nov 30;670(2-3):623-31. PMID: 21963451.

 

Takahashi K, Yoshioka Y, Kato E, et al. Methyl caffeate as an alpha-glucosidase inhibitor from Solanum torvum fruits and the activity of related compounds. Biosci Biotechnol Biochem. 2010;74(4):741-5. PMID: 20378981.

 

Ho CC, Lin SS, Chou MY, et al. Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo. J Antimicrob Chemother. 2005 Aug;56(2):372-9. PMID: 16002419.

 

Pyo MK, Lee Y, Yun-Choi HS. Anti-platelet effect of the constituents isolated from the barks and fruits of Magnolia obovata. Arch Pharm Res. 2002 Jun;25(3):325-8. PMID: 12135105.

 

Rao CV, Desai D, Kaul B, et al. Effect of caffeic acid esters on carcinogen-induced mutagenicity and human colon adenocarcinoma cell growth. Chem Biol Interact. 1992 Nov 16;84(3):277-90. PMID: 1423745.

" Not dangerous goods.

LKT G3453 Ginsenoside Rh2 1 mg 89.3 Triterpene saponin found in Panax. 20S-GinsenosideRh2; 20S-protopanaxdiol-3-O-β-D- glucopyranoside; β-D-Glucopyranoside 78214-33-2 ≥98% 640.89 C36H62O8 H2O CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C Ambient 4°C Soluble in ethanol to 10 mM. Insoluble in water. "Fatmawati S, Ersam T, Yu H, et al. 20(S)-Ginsenoside Rh2 as aldose reductase inhibitor from Panax ginseng. Bioorg Med Chem Lett. 2014 Aug 12. [Epub ahead of print]. PMID: 25152999.

 

Shi Q, Li J, Feng Z, et al. Effect of ginsenoside Rh2 on the migratory ability of HepG2 liver carcinoma cells: Recruiting histone deacetylase and inhibiting activator protein 1 transcription factors. Mol Med Rep. 2014 Jul 18. [Epub ahead of print]. PMID: 25051397.

 

Li S, Gao Y, Ma W, et al. EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2. Tumour Biol. 2014 Jun;35(6):5593-8. PMID: 24557544.

 

Qiu J, Li W, Feng SH, et al. Ginsenoside Rh2 promotes nonamyloidgenic cleavage of amyloid precursor protein via a cholesterol-dependent pathway. Genet Mol Res. 2014 May 9;13(2):3586-98. PMID: 24854439.

 

Yi PF, Bi WY, Shen HQ, et al. Inhibitory effects of sulfated 20(S)-ginsenoside Rh2 on the release of pro-inflammatory mediators in LPS-induced RAW 264.7 cells. Eur J Pharmacol. 2013 Jul 15;712(1-3):60-6. PMID: 23665488.

 

Choi WY, Lim HW, Lim CJ. Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20(R)-ginsenoside Rh2 in cultured macrophages and keratinocytes. J Pharm Pharmacol. 2013 Feb;65(2):310-6. PMID: 23278699.

 

He L, Lee J, Jang JH, et al. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos. Bone. 2012 Jun;50(6):1207-13. PMID: 22484180.

 

Wang Y, Wang H, Liu Y, et al. Antihyperglycemic effect of ginsenoside Rh2 by inducing islet β-cell regeneration in mice. Horm Metab Res. 2012 Jan;44(1):33-40. PMID: 22205570.

" Xn Not dangerous goods.

LKT G3453 Ginsenoside Rh2 5 mg 216.3 Triterpene saponin found in Panax. 20S-GinsenosideRh2; 20S-protopanaxdiol-3-O-β-D- glucopyranoside; β-D-Glucopyranoside 78214-33-2 ≥98% 640.89 C36H62O8 H2O CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C Ambient 4°C Soluble in ethanol to 10 mM. Insoluble in water. "Fatmawati S, Ersam T, Yu H, et al. 20(S)-Ginsenoside Rh2 as aldose reductase inhibitor from Panax ginseng. Bioorg Med Chem Lett. 2014 Aug 12. [Epub ahead of print]. PMID: 25152999.

 

Shi Q, Li J, Feng Z, et al. Effect of ginsenoside Rh2 on the migratory ability of HepG2 liver carcinoma cells: Recruiting histone deacetylase and inhibiting activator protein 1 transcription factors. Mol Med Rep. 2014 Jul 18. [Epub ahead of print]. PMID: 25051397.

 

Li S, Gao Y, Ma W, et al. EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2. Tumour Biol. 2014 Jun;35(6):5593-8. PMID: 24557544.

 

Qiu J, Li W, Feng SH, et al. Ginsenoside Rh2 promotes nonamyloidgenic cleavage of amyloid precursor protein via a cholesterol-dependent pathway. Genet Mol Res. 2014 May 9;13(2):3586-98. PMID: 24854439.

 

Yi PF, Bi WY, Shen HQ, et al. Inhibitory effects of sulfated 20(S)-ginsenoside Rh2 on the release of pro-inflammatory mediators in LPS-induced RAW 264.7 cells. Eur J Pharmacol. 2013 Jul 15;712(1-3):60-6. PMID: 23665488.

 

Choi WY, Lim HW, Lim CJ. Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20(R)-ginsenoside Rh2 in cultured macrophages and keratinocytes. J Pharm Pharmacol. 2013 Feb;65(2):310-6. PMID: 23278699.

 

He L, Lee J, Jang JH, et al. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos. Bone. 2012 Jun;50(6):1207-13. PMID: 22484180.

 

Wang Y, Wang H, Liu Y, et al. Antihyperglycemic effect of ginsenoside Rh2 by inducing islet β-cell regeneration in mice. Horm Metab Res. 2012 Jan;44(1):33-40. PMID: 22205570.

" Xn Not dangerous goods.

LKT G3453 Ginsenoside Rh2 10 mg 368.8 Triterpene saponin found in Panax. 20S-GinsenosideRh2; 20S-protopanaxdiol-3-O-β-D- glucopyranoside; β-D-Glucopyranoside 78214-33-2 ≥98% 640.89 C36H62O8 H2O CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C Ambient 4°C Soluble in ethanol to 10 mM. Insoluble in water. "Fatmawati S, Ersam T, Yu H, et al. 20(S)-Ginsenoside Rh2 as aldose reductase inhibitor from Panax ginseng. Bioorg Med Chem Lett. 2014 Aug 12. [Epub ahead of print]. PMID: 25152999.

 

Shi Q, Li J, Feng Z, et al. Effect of ginsenoside Rh2 on the migratory ability of HepG2 liver carcinoma cells: Recruiting histone deacetylase and inhibiting activator protein 1 transcription factors. Mol Med Rep. 2014 Jul 18. [Epub ahead of print]. PMID: 25051397.

 

Li S, Gao Y, Ma W, et al. EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2. Tumour Biol. 2014 Jun;35(6):5593-8. PMID: 24557544.

 

Qiu J, Li W, Feng SH, et al. Ginsenoside Rh2 promotes nonamyloidgenic cleavage of amyloid precursor protein via a cholesterol-dependent pathway. Genet Mol Res. 2014 May 9;13(2):3586-98. PMID: 24854439.

 

Yi PF, Bi WY, Shen HQ, et al. Inhibitory effects of sulfated 20(S)-ginsenoside Rh2 on the release of pro-inflammatory mediators in LPS-induced RAW 264.7 cells. Eur J Pharmacol. 2013 Jul 15;712(1-3):60-6. PMID: 23665488.

 

Choi WY, Lim HW, Lim CJ. Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20(R)-ginsenoside Rh2 in cultured macrophages and keratinocytes. J Pharm Pharmacol. 2013 Feb;65(2):310-6. PMID: 23278699.

 

He L, Lee J, Jang JH, et al. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos. Bone. 2012 Jun;50(6):1207-13. PMID: 22484180.

 

Wang Y, Wang H, Liu Y, et al. Antihyperglycemic effect of ginsenoside Rh2 by inducing islet β-cell regeneration in mice. Horm Metab Res. 2012 Jan;44(1):33-40. PMID: 22205570.

" Xn Not dangerous goods.

LKT G3453 Ginsenoside Rh2 25 mg 737.1 Triterpene saponin found in Panax. 20S-GinsenosideRh2; 20S-protopanaxdiol-3-O-β-D- glucopyranoside; β-D-Glucopyranoside 78214-33-2 ≥98% 640.89 C36H62O8 H2O CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)C)C)O)C)O)C Ambient 4°C Soluble in ethanol to 10 mM. Insoluble in water. "Fatmawati S, Ersam T, Yu H, et al. 20(S)-Ginsenoside Rh2 as aldose reductase inhibitor from Panax ginseng. Bioorg Med Chem Lett. 2014 Aug 12. [Epub ahead of print]. PMID: 25152999.

 

Shi Q, Li J, Feng Z, et al. Effect of ginsenoside Rh2 on the migratory ability of HepG2 liver carcinoma cells: Recruiting histone deacetylase and inhibiting activator protein 1 transcription factors. Mol Med Rep. 2014 Jul 18. [Epub ahead of print]. PMID: 25051397.

 

Li S, Gao Y, Ma W, et al. EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2. Tumour Biol. 2014 Jun;35(6):5593-8. PMID: 24557544.

 

Qiu J, Li W, Feng SH, et al. Ginsenoside Rh2 promotes nonamyloidgenic cleavage of amyloid precursor protein via a cholesterol-dependent pathway. Genet Mol Res. 2014 May 9;13(2):3586-98. PMID: 24854439.

 

Yi PF, Bi WY, Shen HQ, et al. Inhibitory effects of sulfated 20(S)-ginsenoside Rh2 on the release of pro-inflammatory mediators in LPS-induced RAW 264.7 cells. Eur J Pharmacol. 2013 Jul 15;712(1-3):60-6. PMID: 23665488.

 

Choi WY, Lim HW, Lim CJ. Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20(R)-ginsenoside Rh2 in cultured macrophages and keratinocytes. J Pharm Pharmacol. 2013 Feb;65(2):310-6. PMID: 23278699.

 

He L, Lee J, Jang JH, et al. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos. Bone. 2012 Jun;50(6):1207-13. PMID: 22484180.

 

Wang Y, Wang H, Liu Y, et al. Antihyperglycemic effect of ginsenoside Rh2 by inducing islet β-cell regeneration in mice. Horm Metab Res. 2012 Jan;44(1):33-40. PMID: 22205570.

" Xn Not dangerous goods.

LKT G3454 Ginsenoside Rb1 5 mg 173 Triterpene saponin found in species of Panax. Arasaponin E1; Gypenoside III; Sanchinoside E1 41753-43-9 ≥98% 1109.29 C54H92O23 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)C Ambient 4°C "Soluble in water.

Soluble in methanol or ethanol" "Tan SJ, Li N, Zhou F, et al. Ginsenoside Rb1 improves energy metabolism in the skeletal muscle of an animal model of postoperative fatigue syndrome. J Surg Res. 2014 May 2. [Epub ahead of print]. PMID: 24881470.

 

Wu LL, Jia BH, Sun J, et al. Protective effects of ginsenoside Rb1 on septic rats and its mechanism.  Biomed Environ Sci. 2014 Apr;27(4):300-3. PMID: 24758759.

 

Liu D, Zhang H, Gu W, et al. Ginsenoside Rb1 protects hippocampal neurons from high glucose-induced neurotoxicity by inhibiting GSK3β-mediated CHOP induction. Mol Med Rep. 2014 Apr;9(4):1434-8. PMID: 24535619.

 

Ni N, Liu Q, Ren H, et al. Ginsenoside Rb1 protects rat neural progenitor cells against oxidative injury. Molecules. 2014 Mar 7;19(3):3012-24. PMID: 24662068.

 

Xiong Y, Shen L, Liu KJ, et al. Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats. Diabetes. 2010 Oct;59(10):2505-2512. PMID: 20682695.

 

Shen L, Xiong Y, Wang DQ, et al. Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats. J Lipid Res. 2013 May;54(5):1430-1438. PMID: 23434611.

 

Lee JS, Song JH, Sohn NW, Shin JW. Inhibitory effects of ginsenoside Rb1 on neuroinflammation fl=ollowing systemic lipopolysaccharide treatment in mice. Phytother Res. 2013 Sep;27(9):1270-1276. PMID: 23042638.

" Xn Not dangerous goods.

LKT G3454 Ginsenoside Rb1 10 mg 292.5 Triterpene saponin found in species of Panax. Arasaponin E1; Gypenoside III; Sanchinoside E1 41753-43-9 ≥98% 1109.29 C54H92O23 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)C Ambient 4°C "Soluble in water.

Soluble in methanol or ethanol" "Tan SJ, Li N, Zhou F, et al. Ginsenoside Rb1 improves energy metabolism in the skeletal muscle of an animal model of postoperative fatigue syndrome. J Surg Res. 2014 May 2. [Epub ahead of print]. PMID: 24881470.

 

Wu LL, Jia BH, Sun J, et al. Protective effects of ginsenoside Rb1 on septic rats and its mechanism.  Biomed Environ Sci. 2014 Apr;27(4):300-3. PMID: 24758759.

 

Liu D, Zhang H, Gu W, et al. Ginsenoside Rb1 protects hippocampal neurons from high glucose-induced neurotoxicity by inhibiting GSK3β-mediated CHOP induction. Mol Med Rep. 2014 Apr;9(4):1434-8. PMID: 24535619.

 

Ni N, Liu Q, Ren H, et al. Ginsenoside Rb1 protects rat neural progenitor cells against oxidative injury. Molecules. 2014 Mar 7;19(3):3012-24. PMID: 24662068.

 

Xiong Y, Shen L, Liu KJ, et al. Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats. Diabetes. 2010 Oct;59(10):2505-2512. PMID: 20682695.

 

Shen L, Xiong Y, Wang DQ, et al. Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats. J Lipid Res. 2013 May;54(5):1430-1438. PMID: 23434611.

 

Lee JS, Song JH, Sohn NW, Shin JW. Inhibitory effects of ginsenoside Rb1 on neuroinflammation fl=ollowing systemic lipopolysaccharide treatment in mice. Phytother Res. 2013 Sep;27(9):1270-1276. PMID: 23042638.

" Xn Not dangerous goods.

LKT G3454 Ginsenoside Rb1 25 mg 571.9 Triterpene saponin found in species of Panax. Arasaponin E1; Gypenoside III; Sanchinoside E1 41753-43-9 ≥98% 1109.29 C54H92O23 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)C Ambient 4°C "Soluble in water.

Soluble in methanol or ethanol" "Tan SJ, Li N, Zhou F, et al. Ginsenoside Rb1 improves energy metabolism in the skeletal muscle of an animal model of postoperative fatigue syndrome. J Surg Res. 2014 May 2. [Epub ahead of print]. PMID: 24881470.

 

Wu LL, Jia BH, Sun J, et al. Protective effects of ginsenoside Rb1 on septic rats and its mechanism.  Biomed Environ Sci. 2014 Apr;27(4):300-3. PMID: 24758759.

 

Liu D, Zhang H, Gu W, et al. Ginsenoside Rb1 protects hippocampal neurons from high glucose-induced neurotoxicity by inhibiting GSK3β-mediated CHOP induction. Mol Med Rep. 2014 Apr;9(4):1434-8. PMID: 24535619.

 

Ni N, Liu Q, Ren H, et al. Ginsenoside Rb1 protects rat neural progenitor cells against oxidative injury. Molecules. 2014 Mar 7;19(3):3012-24. PMID: 24662068.

 

Xiong Y, Shen L, Liu KJ, et al. Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats. Diabetes. 2010 Oct;59(10):2505-2512. PMID: 20682695.

 

Shen L, Xiong Y, Wang DQ, et al. Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats. J Lipid Res. 2013 May;54(5):1430-1438. PMID: 23434611.

 

Lee JS, Song JH, Sohn NW, Shin JW. Inhibitory effects of ginsenoside Rb1 on neuroinflammation fl=ollowing systemic lipopolysaccharide treatment in mice. Phytother Res. 2013 Sep;27(9):1270-1276. PMID: 23042638.

" Xn Not dangerous goods.

LKT G3455 Ginsenoside Rc 1 mg 101.7 Triterpene saponin found in species of Panax; AMPK inhibitor, potential TRPV1 antagonist. Panaxoside RC 11021-14-0 ≥98% 1079.27 C53H90O22 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(O8)CO)O)O)O)O)O)C Ambient 4°C "Kim DH, Park CH, Park D, et al. Ginsenoside Rc modulates Akt/FoxO1 pathways and suppresses oxidative stress. Arch Pharm Res. 2014 Jun;37(6):813-20. PMID: 23918648.

 

Lee MS, Hwang JT, Kim SH, et al. Ginsenoside Rc, an active component of Panax ginseng, stimulates glucose uptake in C2C12 myotubes through an AMPK-dependent mechanism. J Ethnopharmacol. 2010 Feb 17;127(3):771-6. PMID: 19961916.

 

Lee JH, Choi SH, Kwon OS, et al. Effects of ginsenosides, active ingredients of Panax ginseng, on development, growth, and life span of Caenorhabditis elegans. Biol Pharm Bull. 2007 Nov;30(11):2126-34. PMID: 17978487.

 

Jung SY, Choi S, Ko YS, et al. Effects of ginsenosides on vanilloid receptor (VR1) channels expressed in Xenopus oocytes. Mol Cells. 2001 Dec 31;12(3):342-6. PMID: 11804333.

 

Shin YH, Jung OM, Nah JJ, et al. Ginsenosides that produce differential antinociception in mice. Gen Pharmacol. 1999 Jun;32(6):653-9. PMID: 10401990.

" Xn Not dangerous goods.

LKT G3455 Ginsenoside Rc 5 mg 254.3 Triterpene saponin found in species of Panax; AMPK inhibitor, potential TRPV1 antagonist. Panaxoside RC 11021-14-0 ≥98% 1079.27 C53H90O22 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(O8)CO)O)O)O)O)O)C Ambient 4°C "Kim DH, Park CH, Park D, et al. Ginsenoside Rc modulates Akt/FoxO1 pathways and suppresses oxidative stress. Arch Pharm Res. 2014 Jun;37(6):813-20. PMID: 23918648.

 

Lee MS, Hwang JT, Kim SH, et al. Ginsenoside Rc, an active component of Panax ginseng, stimulates glucose uptake in C2C12 myotubes through an AMPK-dependent mechanism. J Ethnopharmacol. 2010 Feb 17;127(3):771-6. PMID: 19961916.

 

Lee JH, Choi SH, Kwon OS, et al. Effects of ginsenosides, active ingredients of Panax ginseng, on development, growth, and life span of Caenorhabditis elegans. Biol Pharm Bull. 2007 Nov;30(11):2126-34. PMID: 17978487.

 

Jung SY, Choi S, Ko YS, et al. Effects of ginsenosides on vanilloid receptor (VR1) channels expressed in Xenopus oocytes. Mol Cells. 2001 Dec 31;12(3):342-6. PMID: 11804333.

 

Shin YH, Jung OM, Nah JJ, et al. Ginsenosides that produce differential antinociception in mice. Gen Pharmacol. 1999 Jun;32(6):653-9. PMID: 10401990.

" Xn Not dangerous goods.

LKT G3455 Ginsenoside Rc 10 mg 445 Triterpene saponin found in species of Panax; AMPK inhibitor, potential TRPV1 antagonist. Panaxoside RC 11021-14-0 ≥98% 1079.27 C53H90O22 CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(O8)CO)O)O)O)O)O)C Ambient 4°C "Kim DH, Park CH, Park D, et al. Ginsenoside Rc modulates Akt/FoxO1 pathways and suppresses oxidative stress. Arch Pharm Res. 2014 Jun;37(6):813-20. PMID: 23918648.

 

Lee MS, Hwang JT, Kim SH, et al. Ginsenoside Rc, an active component of Panax ginseng, stimulates glucose uptake in C2C12 myotubes through an AMPK-dependent mechanism. J Ethnopharmacol. 2010 Feb 17;127(3):771-6. PMID: 19961916.

 

Lee JH, Choi SH, Kwon OS, et al. Effects of ginsenosides, active ingredients of Panax ginseng, on development, growth, and life span of Caenorhabditis elegans. Biol Pharm Bull. 2007 Nov;30(11):2126-34. PMID: 17978487.

 

Jung SY, Choi S, Ko YS, et al. Effects of ginsenosides on vanilloid receptor (VR1) channels expressed in Xenopus oocytes. Mol Cells. 2001 Dec 31;12(3):342-6. PMID: 11804333.

 

Shin YH, Jung OM, Nah JJ, et al. Ginsenosides that produce differential antinociception in mice. Gen Pharmacol. 1999 Jun;32(6):653-9. PMID: 10401990.

" Xn Not dangerous goods.

留言框

  • 产品:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 省份:

  • 详细地址:

  • 补充说明:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7
网站首页 公司简介 产品中心 招聘中心 技术支持 企业动态 联系我们 管理登陆
上海易汇生物科技有限公司主营:Eaivelly封板膜|Eaivelly八联管|Eaivelly针式过滤器|Eaivelly光学平盖|Eaivelly荧光定量|代理GE
GoogleSitemap ICP备案号:沪ICP备16010708号-3 技术支持:化工仪器网
张经理
  • 电话

    021-62962298

在线客服
扫一扫访问手机站扫一扫访问手机站
访问手机站